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GENERAL ABSTRACT 
The depression of immune cell function that is typically observed after prolonged 
exercise is thought to be largely mediated by increased plasma concentrations of 
stress hormones and cytokines and possibly oxidative stress. The aims of this thesis 
were to determine the effects of acute and longer term oral antioxidant 
supplementation on immunoendocrine responses following prolonged exercise. 
In study 1 (Chapter 3) it was shown that vitamin C ingested acutely before and during 
prolonged exercise has little or no effect on immunoendocrine responses. 
Furthermore, the combined ingestion of vitamin C with carbohydrate provides no 
additional effects compared with carbohydrate alone. However, when vitamin C was 
supplemented acutely, 2 h prior to, and during prolonged exercise in addition to on the 
night before (14 h prior) exercise this limited the fall in neutrophil oxidative burst 
activity (study 2, Chapter 4). This was probably a result of reduced direct oxidative 
damage to neutrophils with vitamin C supplementation since there were no effects on 
the cortisol, interleukin-6, leukocytosis or neutrophilia responses. Longer periods of 
antioxidant supplementation (2 - 4 weeks) may be effective at blunting the cortisol, 
leukocytosis and neutrophilia responses to prolonged exercise (Chapters 5 and 6) but 
this had no effect on in vitro measures of neutrophil function. In study 5 (Chapter 7) it 
was shown that acute pre-exercise dark chocolate (which contains polyphenols) 
ingestion has some effects on plasma oxidative stress markers and circulating insulin 
and glucose responses but not the immunoendocrine responses to prolonged exercise. 
Key words: neutrophil function, stress hormone, cytokine, cortisol, interleukin-6, 
oxidative stress. 
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Chapter I Literature Review 
CHAPTER ONE 
Literature Review 
1.1 Prolonged exercise, immune function and infection risk 
There is ever increasing research evidence for the originally anecdotal notion that 
athletes participating in regular intensive training, especially endurance athletes, are 
more susceptible than normal to infection, especially upper respiratory tract infection 
(URTI) (Bishop, 2006; Gleeson, 2000b; Nieman, 1997c; Pedersen et aI., 1999; Peters, 
1997b, 1996, 1993). Prolonged exercise may result in an increased susceptibility to 
infection resulting from exercise-induced depression of immune system function 
(Bishop, 2006; Gleeson, 2000a; Mackinnon, 1999; Nieman et ai, 1997a; Pedersen et 
ai, 1999). Infections could impair performance, prevent an athlete from competing 
altogether and/or interfere with training (Gleeson, 2000a), which is detrimental for 
athletes wishing to maintain a high level of performance and/or attain 'peak' 
physiological condition for a specific competition. Nevertheless, to be successful at 
the highest level athletes must train intensively so any intervention that can counter 
the exercise-induced alterations in immune function will be beneficial to the athlete 
(Nieman, 2000a). There has been a number of studies over the past 10-15 years 
investigating the effectiveness of various nutritional strategies at minimising immune 
perturbations following prolonged exercise. The greatest effects are often observed 
with acute carbohydrate ingestion (before and during the exercise) but there is also 
evidence to show that antioxidant supplementation (Fischer et aI., 2004; 
Vassilakopoulos et ai, 2003) can significantly blunt the stress hormone and systemic 
cytokine responses to prolonged exercise. This may also have beneficial effects on 
immune function and this will be discussed in greater detail in the following sections. 
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The leukocytes comprise the main component of the immune system; however, the 
immune response to infection is complex, requiring the co-ordinated action of several 
types of cells, tissues and many messenger molecules (for example, the thymus, the 
bone marrow, the spleen, the lymphatic system, antibodies, the complement system 
and many cytokines have major roles in the normal immune response), (Gleeson, 
2006; Mackinnon, 1999; Roitt et aI., 200 I). There are a variety of different forms of 
stress (e.g. physical stress, psychological stress, environmental stress), each of which 
can affect the immune system and its function. All forms of stress may act at any 
number of points in the closely regulated sequence that is the normal immune 
response (Gleeson 2006; Mackinnon, 1999). The immunological responses to exercise 
are a subset of physical stress reactions that include thermal and traumatic injury, 
surgery, acute myocardial infarction, sepsis and haemorrhagic shock (Hoffman-Goetz 
and Pedersen, 1994; Pedersen et aI., 1994). Such stress can be a short event (acute) or 
a regular occurrence (chronic). 
Exercise-induced changes in circulating leukocyte numbers and function usually 
return to normal by 24 h post-exercise, suggesting few chronic effects provided that 
the blood samples are obtained in a truly rested state (Mackinnon, 2000). However, it 
is not unusual to find significantly lower than normal immune function in athletes 
during periods of very intense training or periods of intensified training in 
combination with inadequate recovery (overreaching) (Halson et aI., 2004). For 
example, when subsequent strenuous exercise bouts are commenced before the 
immune system has recovered fully from the previous bout(s». This is probably a 
result (at least in part) of those athletes not being in a truly rested state when blood 
2 
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samples are obtained. The observation of slightly lower than normal resting blood 
leukocyte counts in this situation may also be related partly to haemodilution effects 
resulting from an expansion of plasma volume. There is generally little difference 
between athletes who are not overreached and non-athletes in terms of resting 
immune cell function. The somewhat lower than normal values that can be observed 
in some athletes are usually still within the clinically normal range (Nieman, 2000b; 
Pyne et aI., 1995). The magnitude of the acute exercise-induced alterations in 
circulating leukocyte numbers and function probably has more significance than 
training (chronic)-induced alterations in resting immune function (Nieman, 2000b; 
Nieman, 1997c; Pedersen et aI., 1997). The acute changes in the immune system 
following intense exercise of a prolonged duration are remarkably similar in many 
respects to those induced by infection. These changes include (but are not limited to): 
1. A transient increase In the number of circulating leukocytes (primarily 
neutrophils; there is also an initial increase of circulating lymphocytes 
followed by a significant decrease below resting values), (Bishop, 2006; 
Pedersen et aI., 1997) 
2. Increases in the plasma concentrations of various substances that are known to 
influence leukocyte functions, including: 
a. some cytokines, such as tumour necrosis factor-a (TNF-a), interleukin 
(IL)-I, IL-6, IL-I0 and IL-l receptor antagonist (IL-lra) (Bury et aI, 
1996; Mackinnon et aI., 2000). 
b. several hormones that are known to have immunomodulatory effects, 
including adrenocorticotrophic hormone (ACTH) and cortisol, 
(Brenner et aI., 1998; Pedersen et aI., 1997). 
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3. The function of some immune cells is also affected, including: 
a. In vitro stimulated neutrophil function (killing capacity) often 
decreases (discussed in more detail below) (Bishop et ai, 2000; 
Blannin, 2006; Li et aI., 2005; Nieman, 2000b; Pyne, 1994; Robson et 
ai, 1999; Scharhag et aI., 2002). 
b. Natural killer cell cytotoxic activity (NKCA) may increase 
immediately after exercise but soon decreases below resting values for 
up to 6 h (McFarlin et aI., 2004; Nieman et aI., 1993). 
c. A number of monocyte/macrophage functions may be decreased 
following prolonged exercise, including toll like receptor (TLR) 
expression and function, upregulation (following activation) of CDSO, 
CDS6, IL-6 and antigen presenting function/major histocompatabiIity 
complex (MHC) class II expression (Mackinnon, 2000; Lancaster et 
aI., 2005b; Shephard et aI., 1999). 
d. A number of lymphocyte functions may be diminished, including 
mitogen-stimulated lymphocyte proliferation and cytokine production 
and B-lymphocyte production of immunoglobulins (Lancaster et aI., 
2005a; Mitchell et aI., 1995). 
e. The concentration and secretion rate of salivary immunoglobulin (s-Ig) 
A and s-IgM may decrease after prolonged exercise (Mackinnon et aI., 
1993; Krzywkowski et aI., 2001). 
1.1.2 NeutrophiIs 
The neutrophil is a major phagocytic cell and is the most abundant circulating white 
blood cell, constituting 50-60% of totalleukocytes and > 90% of total granulocytes. It 
4 
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is a non-dividing (therefore short-lived) cell formed and matured in the bone marrow 
and possesses a characteristic multi-lobed nucleus (hence the term polymorphonuclear 
leukocyte) and an array of cytoplasmic granules (Gleeson, 2006; Roitt et aI., 2001). 
The neutrophil granules are of 2 main types,. 'primary azurophil' granules, which 
contain hydrolytic and proteolytic enzymes such as myeloperoxidase (MPO) and 
elastase, and 'secondary specific' granules, which contain lactoferrin, lysozyme, 
alkaline phosphatase and membrane bound cytochrome bsss (Roitt et aI., 200 I). They 
are able to destroy phagocytosed pathogens/microorganisms by degranulation (fusing 
of granules with a phagosome containing engulfed material and releasing into it the 
granular contents) but also possess membrane bound NADPH oxidase to initiate 
reactive oxygen species (ROS) generation during the oxidative burst process 
(Blannin, 2006; Mackinnon, 2000; Peake, 2002; Pyne, 1994). 
Neutrophils contribute significantly to innate immunity but also work in co-operation 
with specific-defences. Hence, the neutrophil is critical to host defence, possessing 
microbicidal, bactericidal and viricidal activities (Pyne, 1994). The neutrophil is one 
of the first cells to arrive at sites of injury or infection, where it releases a number of 
chemoattractants to amplify the response by recruiting additional neutrophils and a 
variety of mononuclear cells to the local area (Pyne, 1994). The neutrophil functional 
response involves a complex sequence of events, including migration to sites of 
infection/injury, the phagocytosis of foreign material or debris, and killing by 
degranulation and oxidative burst activity (OBA), (Mackinnon, 2000; Smith et aI., 
1997). A significant decrease in in vitro measures of neutrophil function following 
prolonged exercise is a consistent observation in the exercise immunology literature 
(Bishop et ai, 2000, 2003; Li et ai, 2004a, 2005; Nieman et aI., 1997b; Pedersen et aI., 
5 
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1997; Pyne, et aI, 1996; Robson, et aI, 1999; Scharhag aI, 2002). The depressive 
effects of prolonged exercise on neutrophil functions are thought to be largely 
mediated by increased levels of hypothalamic-pituitary-adrenal (HP A) axis stress 
hormones and some cytokines, metabolic factors, and possibly oxidative stress. 
1.1.3 Infection risk 
It is quite clear that the immune system may be transiently perturbed following 
prolonged endurance exercise (as discussed above) which may result in an increased 
risk of contracting URTI; especially during periods of intense training, exposure to 
novel pathogens and other stressors to the immune system (such as environmental or 
psychological stress) (Nieman, 2000b). The period following exercise during which 
immune function is transiently depressed has been termed the "open window" during 
which the risk of UR TI is increased (Hoffinan-Goetz et aI., 1994). This may last 
between 3 and 72 h after the exercise bout, depending on the immune parameter 
measured and factors such as intensity and duration of the exercise (Pedersen et aI., 
1999). During this period, viruses and bacteria may "gain a foothold, increasing the· 
risk of subclinical and clinical infection" (Nieman, 2000b; Pedersen et aI., 1999). In 
spite of this, the open window theory cannot be wholly accepted until well-designed 
and controlled experiments are able to demonstrate that those athletes experiencing 
the greatest immunodepression are those that contract an infection in the weeks that 
follow (Nieman, 2000b). Direct evidence of this nature is not yet available and such 
studies are logistically difficult. However, there is convincing evidence that the ability 
of the immune system to respond is compromised following prolonged strenuous 
exercise which may render individuals more susceptible to infection. For example, 
Bruunsgaard et al. (1997a) showed that the delayed hypersensitivity response (a 
6 
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marker of whole body ability to respond to antigen challenge vIa cell-mediated 
mechanisms) was significantly lower in a group of athletes subsequent to a half-
ironman triathlon compared with matched controls who did not participate and 
moderately trained controls who also did not participate. In this study several antigens 
were injected into the skin of the athlete's forearm at the same time of day in all 
participants (equivalent to 30 min post-exercise in those who took part in the triathlon 
event). This stimulates a local cell-mediated response which can be measured semi-
quantitatively by size of epidermal inflammation and induration 24-48 h later and is 
thus described as the delayed-type hypersensitivity (DTH) response (Albers et aI., 
2005). Therefore, a larger area of induration is associated with a stronger cell-
mediated immune response. Bruunsgaard et al. (1997a) showed the smallest responses 
were seen in those athletes that had participated in the triathlon compared with both 
matched non-participating athletes and sedentary controls. This study suggests that 
prolonged strenuous exercise is associated with a depressed 'whole body' ability to 
respond to an infectious challenge for up to 48 h (possibly weakening the first line of 
defence and providing an 'open window' for infection). However, no differences were 
observed in the antibody response to vaccination measured 2 weeks later which 
suggests that the ultimate establishment of specific immunity was not compromised. 
Furthermore, decreased neutrophil function following prolonged exercise is a 
common observation in the exercise immunology literature (as mentioned previously) 
and it is known that neutrophils are a key first line of defence against infection. This 
is highlighted, for example, by the fact that patients suffering from hereditary MPO 
deficiency are known to have an increased incidence of infection compared with 
healthy controls (Kutter, 2000; Pyne, 1994) which supports the notion that neutrophil 
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dysfunction following prolonged exercise may be associated with increased infection 
risk. 
The possible mechanisms that cause the temporary exercise-induced decrease in 
immune function are discussed in greater detail in the following sections but may 
include hormonal, metabolic and physiological changes. It has been suggested that the 
notable increase in HPA axis stress hormones, particularly glucocorticoids and 
catecholamines, is likely to be major contributing factors (Mackinnon, 1999; Nieman, 
1997c). Additionally, the increased production of oxygen free radicals during exercise 
(Goldfarb, 1993; Packer, 1997) can have detrimental effects on immune cell function 
(Peters, I 997a, b; Robson et aI., 2003). For the purpose of this thesis the focus is on 
the potential role of antioxidant supplementation in modulating some of these 
responses (cortisol, IL-6 and oxidative stress responses) following prolonged exercise 
and how this may affect leukocytosis and/or the functional capacity of neutrophils. 
1.2 Antioxidant supplementation and the cortisol response to prolonged exercise 
Cortisol is the main corticosteroid secreted by the adrenal cortex in humans. It is a 
glucocorticoid and can be described as a stress hormone, with a generally catabolic 
action. The main biological effects of cortisol are promotion of gluconeogenesis, and 
an increase in the pool of free amino acids (Viru et aI., 2004). Therefore, cortisol may 
play a critical role in maintaining plasma glucose concentration and substrate 
availability during periods of physiological stress such as prolonged exercise. The 
release of cortisol begins with the release of corticotrophin-releasing hormone (CRH) 
from the hypothalamus. CRH stimulates the anterior lobe of the pituitary gland to 
release ACTH which in turn stimulates the secretion of cortisol from the adrenal 
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cortex. McCarthyand Dale (1988) state that cortisol exhibits a large diurnal variation 
between approximately 400 nM at 08:00 and 100 nM at 20:00. Hence, during exercise 
between these hours plasma cortisol concentration will typically increase but may 
decrease (generally, if the intensity of exercise is < 50% VOzmax) because the rate of 
cortisol clearance is higher than the rate of secretion (McCarthy et aI., 1988). The 
effects of cortisol exhibit a lag because the action of steroid hormones involves a 
complex cascade of processes including translocation into cells, binding with 
cytoplasmic receptor proteins and ultimately activation of gene expression and 
specific messenger RNA (mRNA) production (McCarthy et aI., 1988; Viru and Viru, 
2004). Cortisol also has significant effects on the circulating number of leukocytes 
and possibly modulates leukocyte function (as described in more detail below) but is 
also considered part of the normal physiological response to exercise and may thus be 
required for the subsequent physiological adaptation process (Viru and Viru, 2004). 
Therefore, it remains contentious as to whether any intervention which blunts the 
cortisol response to exercise is, on the whole, beneficial or detrimental to the athlete. 
Factors such as mode, duration and intensity of exercise have a significant impact on 
the cortisol response but it is not uncommon for plasma cortisol to increase by - 1.5 
to 3-fold following exercise of up to 3 h duration (Bishop et aI., 2003; Fischer et aI., 
2004; Li et aI., 2005; Robson et aI., 1999) or by > 4-fold following particularly long 
events such as an ultramarathon run (Peters et aI., 2001a, 2001b) and even> 8-fold 
following an "iron-man" triathlon event (Nieman et aI., 2004). 
The release of cortisol during exercise is part of the normal stress response and it was 
originally suggested that cortisol and vitamin C (VC) were co-released from the 
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adrenal glands (Chen, 2000; Evans et aI., 1982; Gleeson et aI., 1987) as part of this 
stress response but also in response to oxidative stress (Peters, 2001a, 2001b). There 
is evidence suggesting a link between redox balance, antioxidants and plasma cortisol 
responses to exercise (Fischer et aI., 2004; Peters, 2001a, 2001b) which may suggest a 
direct link between plasma VC concentration and the cortisol response to prolonged 
exercise. However, there is some opposition to the suggestion that cortisol and VC 
release are coupled in this way (Peake, 2003). 
There are a number of hypotheses regarding the mechanism by which VC 
supplementation may affect cortisol production and/or its release into the circulation 
during exercise. As discussed above, cortisol is produced in and released from the 
adrenal glands which also have one of the highest concentrations of VC in the body (> 
100 times that in the plasma). Plasma VC concentration may be elevated after 
exercise (Evans, 1982; Gleeson et al. 1987). It has been suggested that cortisol and 
VC are co-released from the adrenal glands during exercise (Chen, 2000) possibly in 
response to oxidative stress (Peters et aI., 2001 b). This is one mechanism originally 
believed to account for the effects of antioxidant supplementation on the cortisol 
response to exercise (Peters et aI., 2001 a, b). Peters et al. (Peters et aI., 2001 a, b) 
found that 10 days (7 days before-, on the day of- and 2 days post-exercise) of high 
dose VC supplementation (1000-1500 mg.dai l ) markedly increased plasma VC 
concentration, and decreased post-exercise (90 km run) cortisol concentration, 
possibly by inhibiting adrenal VC and cortisol co-release or mobilisation. This is 
further evidenced by the observation of a post-race increase in plasma VC 
concentration in the control groups, whereas the VC supplemented groups had a 
significantly higher pre-race plasma VC concentration that was not significantly 
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changed post-race. Interestingly, supplementation with 500 mg VC per day had no 
effect on the cortisol response to prolonged exercise (Peters et aI., 200Ib). It was 
suggested by Peters et al. (200Ia) that the production (and subsequent release) of 
cortisol by corticotrophic cells in response to ACTH is linked to adrenal VC 
mobilisation which is partly attributable to its the inhibitory effects on some of the 
enzymes involved in steroidogenesis. That is, cortisol secretion as part of the normal 
stress response cannot occur until VC is first secreted from the adrenal glands because 
a high VC concentration prevents the adrenocortical cells from synthesising cortisol. 
Peake (2003) suggested that cortisol production is not coupled with VC release from 
the adrenal glands in this way. This argument is based on observations from animal 
studies in which there was no difference in ACTH-stimulated adrenal cortisol release 
with or without VC supplementation. Peake (2003) suggested this to show that there 
is some other explanation for the possible attenuation of plasma cortisol increases 
during exercise by VC. Indeed, there may be other factors present during exercise that 
contribute to cortisol release, such as increased plasma IL-6 concentration for 
example, which is known to be influenced by antioxidant supplementation (Fischer et 
aI., 2004). In his review however, Peake (2003) suggests that it may actually be a pro-
oxidant effect of high doses of VC that causes a reduction in the magnitude of cortisol 
release in response to prolonged exercise. 
In high concentrations VC can act as a pro-oxidant in the presence of transition metals 
because of its ability to reduce ferric iron (Fe3+) to the ferrous state (Fe2+) which is 
known to catalyse the production of free radicals. However, it could be argued that 
this is not physiologically significant in vivo given the high iron affinity of transferrin, 
high iron storage capacity of ferritin and the wide variety of other proteins such as 
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albumin which bind iron (Childs et aI., 2001; Powers et aI., 2004). Furthermore, it is 
extremely unlikely that oral supplementation can increase the plasma concentration of 
VC to the levels (1 mM) which are necessary for a pro-oxidant effect (Powers et aI., 
2004; Vu, 1994) although little is known about the effects on the concentration of VC 
in the adrenals. Peake (2003) however, suggests that under certain conditions, such as 
exercise, a pro-oxidant effect of VC supplementation may occur. For example, 
exercised-induced neutrophil activation may result in the neutrophilic-superoxide-
induced release of iron from ferritin and myoglobin. Therefore, the combined effects 
of increased plasma VC concentration and exercise could initiate the formation of 
more ROS which could impair the activity of key enzymes involved in cortisol 
synthesis within the adrenal glands. Adrenal steroidogenesis involves. many 
cytochrome P450 type enzymes and the reactions involve the transfer of electrons 
from NADPH (Rapoport et aI., 1998). Electrons may 'leak' and generate ROS which 
would inactivate these enzymes if not scavenged. An important step in adrenal 
cortisol synthesis involves the enzyme I1-P-hydroxylase which is particularly 
vulnerable to oxidative inactivation. Conditions of oxidative stress (following chronic 
vitamin E deficiency and depletion) within the adrenal glands are associated with 
suppression of steroidogenesis in the rat (Abidi et aI., 2004). Hence, the high 
concentration of VC in the adrenals helps to protect these key enzymes and allow a 
normal rate of cortisol synthesis. It is theoretically possible that the combined effects 
of exercise and a high plasma VC concentration may have a pro-oxidant effect 
resulting in less cortisol synthesis. 
On the other hand, if this was the case we would expect to see an increase in the 
markers of oxidative stress and lipid peroxidation but antioxidant supplementation 
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studies have observed no effect (Nieman et aI., 2002) or even a reduction in markers 
of oxidative stress during and following exercise (Alessio et aI., 1997; Ashton et aI., 
1999; Mastaloudis et aI., 2004) when high doses of VC were included (alone or in 
combination with other antioxidants) in the supplements. This suggests that VC does 
not have a pro-oxidant effect in these situations but the oxidative stress measures were 
surrogate markers and represent oxidative stress in the body or blood compartment as 
a whole. This may be insufficient to determine if a pro-oxidant state does exist at the 
site of cortisol synthesis, the adrenal glands. This is speculative but seems feasible 
since there is already an extremely high concentration of VC in the adrenal glands. 
Therefore, supplementation of VC may increase its concentration in the adrenal 
glands possibly reSUlting in a pro-oxidant state which could interfere with cortisol 
production. Furthermore, exercise may add to this (or possibly tip the balance more 
toward a pro-oxidant state) since VC in the plasma will be oxidised to 
dehydroascorbate (DHA) in order to maintain redox balance. However, it is worth 
noting here that VC (molecular formula, C6HS06) has a similar molecular structure to 
glucose and in the oxidised state (DHA) is quickly transported by hexose transport 
proteins (e.g. GLUT I and GLUT 3), against concentration gradients, into cells where 
it is immediately reduced back to VC (Peake, 2003; Vera et aI., 1993). Hence, an 
exercise-induced increase in plasma DHA may ultimately contribute to a greater 
accumulation of VC in tissues, including the adrenal glands. Furthermore, since the 
oxidation of VC to DHA is one of the mechanisms employed in maintaining redox 
balance, oxidative stress localised within the adrenal glands may not be detectable by 
plasma markers of oxidative stress. 
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1.3 Antioxidant supplementation and the IL-6 response to prolonged exercise 
IL-6 has previously been classified as both a pro- and an anti-inflammatory cytokine 
and is sometimes termed as simply an inflammatory mediating cytokine. Recent 
opinion is that IL-6 has primarily anti-inflammatory effects (Pedersen et aI., 2001). 
For example, infusion of IL-6 into humans does not cause shock or capillary-Ieakage-
like syndrome as typically observed with pro-inflammatory cytokines (although it will 
result in fever). IL-6 does not upregulate major inflammatory mediators and appears 
to be the primary inducer of hepatic acute-phase proteins, many of which have anti-
inflammatory properties. Furthermore, IL-6 stimulates the production and release of 
the anti-inflammatory cytokine IL-IO and of IL-Ira, which exerts anti-inflammatory 
activity by antagonism of the action of the pro-inflammatory IL-I (Pedersen et aI., 
2001; Steensberg et aI., 2003). 
In one of the first studies into the effects of exercise on cytokines, Northoff et al. 
(1991) observed an elevated systemic concentration of several cytokines following a 
marathon race. There have been numerous studies since and it is consistently 
observed that the circulating level of IL-6 is markedly increased following prolonged 
strenuous exercise, by anything from 2 - 100 fold (Bishop et aI., 2002; Li et aI., 2005; 
Nehlsen-Cannarella et aI., 1997; Lancaster, 2006; Ostrowski et aI., 2000; Nieman et 
aI., 2004). It was initially thought that muscle IL-6 release was part of the 
inflammatory response and associated with exercise-induced muscle damage 
(Bruunsgaard et aI., 1997b; Ostrowski et aI., 1998). However, similar results are 
observed in response to concentric exercise (associated with minimal muscle 
damage). For example, the systemic IL-6 response following 60 min of cycling 
(predominantly concentric) was similar to the response with 60 min of running when 
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both exercise modes were performed at the same mode specific relative intensity 
(Starkie et aI., 2001). It is now apparent that the major contributor to circulating IL-6 
is the active skeletal muscle (Keller et aI., 2001; Steensberg et aI., 2000) and Hiscock 
et al. (2004) have confirmed that it is the myocytes of active skeletal muscle which 
are the source of IL-6 during prolonged exercise. Indeed, skeletal muscle IL-6 
synthesis (and release) is a normal physiological response to exercise (Pedersen et aI., 
2001) and the IL-6 response to prolonged exercise may function, in a hormone-like 
manner, as a signalling mechanism for an 'energy-crisis' and low muscle glycogen 
which subsequently stimulates substrate mobilisation via activation of lipolysis (see 
below) and hepatic glucose output (Febbraio et aI., 2004; Gleeson, 2000c; Lancaster, 
2006; Steensberg et aI., 2000). Support for this hypothesis also comes from the 
observation that carbohydrate ingestion during exercise attenuates the systemic IL-6 
response (Bishop et aI., 2002; Li et aI., 2005; Nehlsen-CannareIla et aI., 1997). 
Exercise-induced elevations of plasma IL-6 also influence fat metabolism and 
infusion of IL-6 into resting humans (to match typical increases in plasma IL-6 
concentration during prolonged exercise) results in an increased rate of lipolysis and 
fat oxidation (van Hall et aI., 2003). Furthermore, IL-6 stimulates the release of 
cortisol (Steensberg et aI., 2003) suggesting that muscle derived IL-6 may contribute 
to the cortisol response to exercise, which may also help to maintain plasma glucose 
concentration and substrate availability during prolonged exercise. 
Fischer et al. (2004) demonstrated that 28 days of supplementation with antioxidants 
(including 500 mg VC and 400 IV vitamin E, as RRR-a-tocopherol, per day) 
completely blunted the cortisol response to exercise. Fischer et al. (2004) also 
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observed a significantly decreased exercise-induced release of IL-6 from the 
contracting skeletal muscle, in their supplemented participants, and suggest that this 
may contribute to attenuation of the cortisol response. This is in line with Steensberg 
et al. (2003) who demonstrated that IL-6 infusion in humans stimulates an increase in 
plasma cortisol concentration. A reduced IL-6 response to exercise, with antioxidant 
supplementation, has also been shown by Vassilakopoulos et al. (2003). They 
observed a post-exercise increase in plasma IL-6 concentration which was 
significantly reduced when participants were supplemented daily with an antioxidant 
mixture of vitamin A (50 000 IU), VC (1000 mg) and vitamin E (200 mg) for 60 days, 
allopurinol (600 mg) for IS days and N-acetylcysteine (2000 mg) for 3 days prior 
(and 800 mg immediately prior) to exercise (45 min cycling at 70% V02max). 
Furthermore, Thompson et al. (200 I) observed similar increases in plasma IL-6 in 
placebo and VC supplemented groups, subsequent to 90 min of intermittent shuttle 
running but values in the VC group were significantly lower, compared with placebo, 
at 2 h post-exercise. Taken together, these studies provide substantial evidence for the 
notion that supplementation with antioxidants can reduce the cortisol and IL-6 
responses to exercise; little is known about the effects this may have on immune 
function but it may possibly reduce the magnitude of exercise-induced 
immunodepression. This would certainly help to explain the findings, by Peters et al. 
(1993, 1996) of a lower URTI incidence following an ultramarathon race in athletes 
that had ingested VC supplements for 3 weeks prior compared with athletes on 
placebo. 
Vassilakopoulos et al. (2003) suggest that antioxidant supplementation modulates the 
cytokine (including IL-6) responses to exercise by interfering with redox sensitive 
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intracellular signalling pathways which are involved in gene expressIOn and 
transcription. For example, ROS act as intracellular messengers involved with the 
activation of transcription factors, and antioxidants are known to have inhibitory 
effects on ROS-controlled transcription factors such as nuclear factor-kappa beta (NF-
KB) and activator protein-I (AP-I) (Niess et aI., 1999; Sen 2001). However, in the 
study by Fischer et al. (2004) there was no difference between groups in terms of gene 
expression or IL-6 protein content within the muscle fibres despite a significant 
blunting in the antioxidant group of oxidative stress (measured by the marker of lipid 
peroxidation, plasma F2-isoprostane concentration). They concluded that the reduced 
IL-6 response with antioxidant supplementation is likely to be due to inhibition of 
translocation from the tissue into circulation. 
1.4 Antioxidant supplementatiou and oxidative stress during prolonged exercise 
VC (ascorbic acid) is the main antioxidant vitamin in aqueous environments whereas 
the main lipid soluble antioxidant vitamin is vitamin E and their antioxidant functions 
are co-related. VC directly reduces the peroxyl radical and superoxide anion (02') 
and indirectly reduces other free radicals by regenerating vitamin E after it is oxidised 
by either peroxyl or hydroxyl radicals (Alessio et aI., 1997; Packer, 1997; Powers et 
aI., 2004). VC has an important role in neutrophils which contain a high concentration 
(up to 50 times greater than the plasma concentration) to protect them from 'self-
destructive' oxidative damage. Indeed, stimulated neutrophils release VC into the 
extracellular fluid, which is thought to protect these and other cells from free radical 
damage (Peters, 1997a). 
Athletes may require higher than normal quantities of vitamins with antioxidant 
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properties to inactivate the increased production of free radicals and ROS associated 
with exercise (Gleeson and Bishop, 2000; Goldfarb, 1993; Packer, 1997). Strenuous 
or prolonged (> 2 h) aerobic exercise can cause disturbance to cellular redox balance, 
leading to oxidative stress and lipid peroxidation. The mitochondrial electron 
transport chain, neutrophil OBA, ischemia-reperfusion, xanthine oxidase activation 
and auto-oxidation of catecholamines have been identified as major sources of free 
radicals and other ROS during exercise (Hessel et aI., 2000; Niess et aI., 1999; Packer, 
1997; Powers et aI., 2004; Urso et aI., 2003; Vollaard et al. 2005). The body 
obviously has natural defence mechanisms to counteract increased free radical 
production in the form of antioxidant enzymes and compounds. In fact, endurance 
training actually enhances these endogenous antioxidant defences; however, such 
adaptations may be insufficient when exercise exceeds the level for which an 
individual has been 'trained' and/or is ofa prolonged duration (Packer, 1997; Vollaard 
et aI., 2005). Indeed, this is a regular occurrence in many endurance athletes who may 
include prolonged exercise bouts (> 2 h) and/or progressively increase their volume 
and intensity of training in order to satisfY the training principles of overload and 
progressIOn. 
Supplementation with dietary antioxidants has proved effective in a number of studies 
(Alessio et aI., 1997; Ashton et aI., 1999; Fischer et aI., 2004; Mastaloudis et aI., 
2004; Morillas-Ruiz et aI., 2005, 2006) at reducing the magnitude of exercise-induced 
oxidative stress. In 2 recent studies, when a high phenolic content antioxidant 
beverage (Morillas-Ruiz et al. 2005) or a polyphenol-containing sports drink 
(Morillas-Ruiz et al. 2006) was consumed shortly before submaximal aerobic exercise 
(90 min duration) the magnitude of exercise-induced oxidative stress was significantly 
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reduced. The previously mentioned study by Fischer et al. (2004) also provides 
evidence that antioxidant supplementation is effective at reducing the magnitude of 
oxidative stress during and following prolonged exercise (3 h in that case). 
Interestingly, Watson et al. (2005) investigated the effect of antioxidant restriction 
rather than supplementation. They manipulated the normal diet of athletes for 2 
weeks, restricting them to I or 2 servings per day of fruit or vegetables. They 
observed that when athletes followed the restricted diet oxidative stress markers were 
significantly higher following exercise, as was rating of perceived exertion, compared 
with when they were allowed to follow their normal habitual diet (which was 
relatively high in antioxidants). This further emphasises the role of dietary 
antioxidants in protecting the body from exercise-induced oxidative stress and lipid 
peroxidation. 
It has also been suggested that exercise-induced oxidative stress can in some 
situations lead to auto-oxidation and impaired function of neutrophils (Peters, 1997a; 
Peters, 1997b; Robson et aI., 2003) which is discussed in further detail in section 1.6. 
1.5 Antioxidant supplementation and exercise-induced ieukocytosis 
Strenuous exercise causes an increase in the number of circulating leukocytes, the 
magnitude of which is related to exercise intensity and duration (Mackinnon, 2000, 
Mackinnon, 1999). This leukocytosis is predominantly influenced by changes in the 
neutrophil count, evidenced by an increase in circulating neutrophil numbers 
(neutrophilia) which mirrors, relatively closely, the changes in total leukocyte 
numbers. For intense, short duration exercise the response is biphasic with increased 
cell counts (leukocytosis and neutrophilia) during and for up to 30 min after the 
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exercise, this is followed by a return to baseline before a second increase at 1 - 3 h 
post-exercise which is dominated by neutrophilia as Iymphocyte count typically 
decreases during this period. For prolonged exercise lasting more than 90 min the 
response is not biphasic as the two increases in cell counts tend to be superimposed on 
one and other (MacKinnon, 2000). Neutrophil numbers may increase up to 4-fold 
following prolonged exercise but normally return to baseline by 1- 6 h after cessation 
(Mackinnon, 1999). 
The mechanisms that underlie the changes in neutrophil numbers after exercise 
include demargination caused by increased cardiac output, and the release of 
catecholamines (immediate neutrophilia) (Robson et aI., 1999; Mackinnon, 2000). 
The size of the marginated and circulating leukocyte pools are similar at rest, so 
complete demargination may double the circulating leukocyte count (Blannin, 2006). 
Greater increases are often observed following prolonged exercise mainly because the 
release of cortisol during prolonged exercise also causes mobilization of neutrophils 
from bone marrow pools, but there is a typical lag between the increase in plasma 
cortisol concentration and increased neutrophil counts (delayed neutrophilia) 
(McCarthy and Dale, 1988; Nieman, 1997c; Pedersen et aI., 2000). Neutrophils 
released prematurely from the bone marrow have a lower functional capacity than the 
fully mature neutrophils already in the circulation (Berkow et aI., 1986). IL-6 may 
also contribute to delayed neutrophilia, by directly stimulating the mobilisation of 
neutrophils into the circulation (Yamada et aI., 2002) or indirectly by inducing an 
increase in plasma cortisol concentration (Steensberg et aI., 2003). Furthermore, it is 
suggested that the post-exercise increase in plasma concentration of neutrophil-
derived proteins (as a result of neutrophil activation and degranulation) can activate 
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granulopoiesis in the bone marrow and stimulate movement of these cells into the 
circulation (Morozov et aI., 2003). Therefore, the major mechanisms by which 
antioxidant supplementation may affect leukocytosis/neutrophilia is via modulation of 
the cortisol and IL-6 responses (as outlined above in sections 1.2 and 1.3) 
1.6 Antioxidant supplementation, prolonged exercise and neutrophil function 
1.6.1 Exercise and neutrophil function 
Changes in the function of circulating neutrophils may be attributable to a number of 
factors. It has been suggested that cortisol may have a direct inhibitory effect on these 
cells (Robson et aI., 1999). For example, cortisol may inhibit the neutrophilic 
generation of ROS by inhibiting the synthesis of leukotriene B4 (LTB4), which is 
required for receptor-dependent activation ofNADPH oxidase during neutrophil OBA 
(Peake, 2002). However, LTB4 is not the rate limiting factor in the signalling cascade 
leading to the oxidative burst and there is some evidence that increased cortisol alone 
does not have a direct inhibitory effect on neutrophil functional capacity, both in 
terms of OBA (Nieman 1997a) and degranulation (Walsh et aI, 2000). Furthermore, 
prolonged exercise can result in decreased phorbol-12-myristate-13-acetate (PMA)-
stimulated (receptor independent) neutrophil OBA. PMA directly stimulates protein 
kinase C (PKC) which in turn activates NADPH oxidase in the activation pathway 
leading to oxidative burst, so some other mechanism(s) must be involved as LTB4 is 
bypassed in this receptor-independent process. 
The mobilisation of immature neutrophils from marginal and bone marrow pools is 
likely to have a significant effect on measures of blood neutrophil function. Exercise-
induced neutrophil mobilisation from the bone marrow results in immature 
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neutrophils constituting a larger proportion of total circulating neutrophils. These cells 
may possess a lower capacity to respond to stimulation, as discussed in more detail 
below. Furthermore, exercise may cause activation of neutrophils which could leave 
them in a refractory state. This could also result in a lower capacity to respond to 
subsequent stimulation (Pyne, 1994). In the study by Suzuki et al. (2003) neutrophils 
were obtained from a single volunteer at rest and aliquots were incubated with either 
pre- or post-race plasma from participants in a marathon (n = 6). Therefore, any 
differences in neutrophil measures cannot be attributed to an altered subpopulation or 
the maturation status of these cells. Nonetheless, incubation with post-race plasma 
caused the OBA to be reduced compared with pre-race plasma. This suggests that 
prolonged exercise caused a change in some factor(s) in plasma which had a direct 
inhibitory effect on the neutrophil capacity for OBA. However, it was also noted that 
this might simply indicate an increased plasma antioxidant capacity owing to 
antioxidant mobilisation into the plasma post-exercise and is not necessarily 
associated with decreased function per se (peake et ai, 2004; Suzuki et al., 2003). It 
would have been interesting, in this study, therefore to also examine the degranulation 
response in the same way. 
It has also been suggested that the large quantity of ROS produced during prolonged 
intensive exercise can overwhelm and deplete VC pools in the body, leading to auto-
oxidation and impaired function ofneutrophils (Peters, 1997a, b; Robson et aI., 2003), 
although some researchers suggest that oxidative stress has little effect on immune 
changes during and after prolonged exercise (Nieman et aI., 2002). 
22 
Chapter I Literature Review 
It has been observed that the phagocytic activity of blood granulocytes, following 
prolonged endurance exercise (of up to 2.5 h duration) is increased (Blannin et aI., 
1996; Henson et aI., 2000; Nieman et aI., 1998). Henson et al. (2000) observed a 
significant increase in phagocytosis post-exercise, with a further increase 1.5 h after a 
2 h rowing training session (average of 57% V02max, 82% of maximal heart rate and 
RPE of - 15) in elite female rowers. Likewise, Nieman et al. (1998) showed that 2.5 h 
of prolonged exercise (either running or cycling at 75% V02max) in trained triathletes 
caused an increase in blood granulocyte phagocytosis. However, Gabriel et al. (1995) 
found that longer duration exercise (100 km run; average duration> 8 h) resulted in 
an increase of the total phagocytic capacity of the blood (2-3 fold) but the actual 
phagocytic activity per neutrophil was significantly decreased for at least 3 h. In a 
rather novel study Muns (1994) obtained neutrophils from a nasal lavage following a 
20 km run, which may be a more appropriate subpopulation to study in relation to 
URTI incidence in athletes. Muns (1994) observed a significant increase in the 
number of neutrophils immediately after completion of the race which had not 
returned to normal levels I day later. Normal levels were regained by 3 days post-
race. The phagocytic activity (ingestion of E. coli) on a per neutrophil basis was 
significantly decreased immediately after the race and had not recovered to pre-race 
levels at 3 days post-race. The author suggests that this could impair the defence 
barrier of the upper respiratory tract and contribute to increased susceptibility to 
URTI. Furthermore, the presence of high numbers of neutrophils in nasal lavage fluid 
and altered microcirculation in the upper airways are thought to be detrimental to the 
mucosal defence barrier (Muns, 1994). 
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It may be that observations of increased phagocytosis by circulating neutrophils after 
prolonged exercise (Blannin et aI., 1996; Henson et aI., 2000; Nieman et aI., 1998) are 
perhaps a result of exercise-induced skeletal muscle damage and the leaking of tissue 
fragments from myofibrils and components from the extracellular matrix (Pyne, 
1994). For example, prolonged exercise may cause micro-injury to the muscle fibres, 
initiating the inflammatory response during which neutrophils invade the inflamed 
area to phagocytose debris (Nieman, 1997c). In this case a post-exercise increase in 
blood neutrophil phagocytosis may be more related to inflammatory processes than 
host protection against infection (Nieman et aI., 1998; Smith et aI., 1997). However, 
increased phagocytosis has also been observed with cycling which is mainly 
concentric and associated with minimal muscle damage (Nieman et aI., 1998). 
Nevertheless, it has been suggested that measures of phagocytosis only have a low 
suitability in assessing neutrophil function (Albers et aI., 2005) and measures of actual 
killing capacity may be more appropriate. 
Neutrophil OBA has been shown to increase after prolonged exercise (Pyne, 1994; 
Shephard et aI., 1999; Suzuki et aI., 1996a), decrease (Li et aI., 2005; Nieman, 2000b; 
Scharhag et aI., 2002) or initially decrease immediately post-exercise before 
increasing (Hack et aI., 1992). Suzuki et al. (1996a) found that an acute bout of 
prolonged exercise causes a temporary increase in the ability of neutrophils to 
produce ROS (OBA) with a return to pre-exercise levels by 1 h of recovery. In this 
study Suzuki et al. (l996a) observed that 1.5 h of cycling at 70% V02max was 
associated with an increase in the capacity of neutrophils to produce ROS, upon in 
vitro stimulation, immediately post-exercise which had returned to 'normal' after 1 h 
of recovery. These findings show that the ability of neutrophils to produce ROS 
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immediately after endurance-type exercise of less than 2 h duration may be enhanced. 
However, the time to peak chemiluminescence (CL) was not significantly different 
immediately post-exercise (compared with baseline) and was significantly longer after 
I h of recovery which may suggest a slower response and possible negative effect on 
killing ability (note that the actual peak CL was not different from baseline at this 
time). Suzuki et al. (1996b) suggest that the use of different techniques for detecting 
ROS in the OBA assays can explain at least some ofthe discrepancy between studies. 
For example, detection ofthe 02'" response (i.e. CL enhanced with Lucigenin) tends to 
decrease whereas MPO-dependent formation of hypochlorous acid (i.e. CL enhanced 
with Luminol) tends to increase but these findings were following short-intense 
exercise to fatigue (Suzuki et aI., I 996b ). 
Generally, when exercise is of2.5 h duration or more and results in a significant stress 
response, neutrophil OBA will decrease following the exercise (Li et aI., 2005; 
Nieman, 2000b; Scharhag et aI., 2002). For example, Scharhag et al. (2002) observed 
a decrease in neutrophil OBA after a prolonged (4 h) exercise bout when the 
participants were on a placebo (fluid only) treatment. Similarly, Li et al. (2005) 
observed that neutrophil OBA was significantly decreased following the second of 2 
bouts, each of 90 min, of cycling at 60% V02max (separated by 3 h of rest). Gabriel 
et al. (1994) found that exercise to exhaustion at 1l0% of the individual anaerobic 
threshold, 8 or 9 days after a 240 km cycle race, resulted in decreased granulocyte 
OBA when compared with the same exercise performed 2 weeks before the race. This 
suggests that extremely demanding endurance events such as this may result in the 
depression of neutrophil function following subsequent exercise (even of a relatively 
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shorter duration) and these effects may persist for some time (at least 8 days) 
afterwards. 
Prolonged exercise may cause neutrophil activation during the initial 1 h meaning that 
the activated neutrophils can become depleted of their degranulation enzymes, 
resulting in a transient 'refractory' period during which they are less sensitive to 
subsequent stimulation and have a decreased killing capacity (Smith et aI., 1997). In 
fact neutrophils possess little capacity to 'recharge' their killing mechanisms once 
activated (Gleeson, 2006). Neutrophil degranulation, as measured by the release of 
elastase per neutrophil following in vitro stimulation with a standardised bacterial 
extract is decreased following prolonged exercise (Bishop et aI., 2000; Blannin et aI., 
1996; Robson et aI., 1999). Blannin et al. (1996) showed that neutrophil activation 
occurred during exercise (30 min at 70% V02max) evidenced by an increase in 
plasma elastase concentration immediately after exercise. However, they also 
observed a significant decrease in stimulated elastase release per neutrophil at 150 
min post-exercise, possibly attributable to 'desensitisation' of neutrophils or an altered 
population of cells; with 'less mature' neutrophils (released prematurely from the bone 
marrow) constituting a greater relative proportion of total blood neutrophils. 
Robson et al. (1999) also observed a significant decrease in stimulated elastase 
release, per neutrophil, immediately and 2.5 h after exercise to exhaustion at 
80% V02max (HI trial; mean duration of 37 min) and after prolonged exercise (3 h) at 
55% V02max (LD trial). They also demonstrated that the post-exercise decrease in 
neutrophil degranulation was significantly greater following prolonged endurance 
exercise as compared with more intense and shorter duration exercise. This may 
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suggest that delayed neutrophilia and the associated increase in the relative proportion 
of less mature neutrophils has the greatest impact on reduced neutrophil functional 
capacity following prolonged exercise. The LD trial was also associated with a 
significantly greater neutrophilia immediately post-exercise and at I, 2.5, and 5 h 
post-exercise, compared with the HI trial. Furthermore, blood neutrophil count had 
returned to pre-exercise levels by the following day (24 h post-exercise) in both trials 
but the stimulated neutrophil degranulation response had returned to normal only in 
the HI trial. In line with Blannin et al. (1996) plasma elastase concentration had 
increased immediately after both trials, indicating some degree of neutrophil 
activation (Smith et al., 1997), and had returned to normal by 2.5 h post-exercise. 
1.6.2 Antioxidant supplementation and immune responses to exercise 
Some of the earliest studies were conducted on ultrarnarathon runners and provided 
some of the first experimental evidence to suggest a reduced incidence of URTI in 
athletes after long endurance events when antioxidants or VC alone had been 
supplemented for 1-3 weeks prior to the event (Peters et aI., 1993, 1996). These 
studies provided some provisional evidence for a link between antioxidant 
supplementation and enhanced immune function foIlowing prolonged exercise but 
provided no direct evidence for the mechanisms by which this may occur. Peters et al. 
(1993) provided participants with 600 mg per day of VC or placebo but all 
participants, including controls were instructed to follow their normal diets during the 
study period. They found that the lowest incidence of UR TI in the 2 weeks after 
completion of the race was in those athletes that had the greatest daily (diet plus 
supplementation) VC intake (> 1000 mg.day"I). Furthermore, Peters et al. (1996) have 
also demonstrated that this apparent reduction of URTI incidence is the same with a 
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variety of different antioxidant mixtures (500 mg VC alone, or 500 mg VC and 400 IU 
vitamin E, or 300 mg VC, 300 IU vitamin E and 18mg ~-carotene, compared with 
placebo) which may be further support for the implication of free radicals, ROS and 
oxidative stress in general rather than any specific vitamin interaction with some 
component of the immune system. 
Nieman et al. (1997b, 2002) attempted to advance the findings of Peters et al. (1993, 
1996) and identify potential mechanisms by conducting similar studies which also 
included some measures of immune function. However, Nieman et al. (1997b, 2002) 
found only a weak relationship between oxidative stress and immune changes and 
suggested that antioxidant supplementation is not an effective countermeasure to 
immune perturbation following prolonged exercise. In a double-blind, placebo 
controlled study Nieman et al. (l997b) found no effect of VC supplementation (1000 
mg.dai1 for 7 days prior to and on the day of exercise) on the immune or hormonal 
responses to 2.5 h running at 75-80% V02max although the duration of exercise was 
significantly shorter than that (> 9 h) in the studies by Peters et al. (1993, 1996). In a 
subsequent study Nieman et al. (2002) found similar findings to their earlier study 
(Nieman et aI., 1997b) with ultramarathoners following a run of - 10 h duration. In 
this study they provided runners with 1500 mg of VC per day for 7 days prior to the 
race and on race day but once again found no effects on hormonal, cytokine or 
immune responses. However, all participants (including controls) were also 
supplemented with carbohydrate before and during exercise in the studies by Nieman 
et al. (1997b, 2002) which has a significant effect on these responses and therefore 
may mask any effects arising from VC alone. More recently, Peters et al. (200la, 
2001b) have observed that large doses (> 1000 mg.dai1) of VC supplementation for 7 
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days prior to and on race day significantly reduced the cortisol response (200Ia, b) 
and systemic IL-1O and IL-Ira responses (200Ib) to a 90 km ultramarathon race 
which appears to support their earlier findings (Peters et aI., 1993, 1996) but 
unfortunately there were no measures of immune function in these studies. Moreover, 
it is possible that differences between participants in carbohydrate and fluid 
consumption, which were not controlled during the race, could have confounded the 
results. 
The most effective interventions for reducing the magnitude of neutrophil dysfunction 
following prolonged exercise appear to be those which are associated with the greatest 
blunting of the leukocytosis and neutrophilia responses (such as carbohydrate 
ingestion during exercise). This supports the contention that the increased relative 
proportion of less mature neutrophils is a major factor. Antioxidant supplementation 
may have a beneficial effect via this mechanism but may also act via a different 
mechanism: by protecting neutrophils from direct oxidative damage and modification. 
It has been suggested that the large quantity of ROS produced during prolonged 
intensive exercise can overwhelm and deplete VC pools in the body, leading to auto-
oxidation and impaired function of neutrophils (Peters, I 997a). Increased ROS 
formation during exercise can also inhibit locomotory and bactericidal activity of 
neutrophils and may affect other immune cells (i.e. reduce the proliferation of T and 
B-lymphocytes and inhibit NKCA) (Peters, 1997a; Peters, 1997b). More evidence for 
this was provided from a study by Robson et al. (2003) in which participants ingested 
either a placebo or antioxidant vitamin supplement for 7 days prior to a 2 h treadmill 
run at 65% VOzmax. They observed significantly higher (- 57%) post-exercise E.coli-
stimulated neutrophil OBA in the antioxidant supplemented trial compared with 
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placebo despite there being no difference in the plasma concentrations of cortisol, 
glucose or leukocyte count. This suggests that oxidative damage directly to 
neutrophils may contribute to exercise-induced decreases in this particular function 
and that this can be prevented with antioxidant supplementation. 
1.7 Summary 
Prolonged exercise may result in an increased susceptibility to infection resulting 
from exercise-induced depression of immune system function, particularly that of 
neutrophils. The immunodepressive effects of prolonged exercise are thought to be 
largely mediated by increased levels of HP A axis stress hormones and some 
cytokines, metabolic factors, and possibly oxidative stress. There is evidence to show 
that appropriate pre-exercise antioxidant supplementation (typically for periods of 
between I and 8 weeks) can significantly blunt the stress hormone, systemic cytokine 
and oxidative stress responses to prolonged exercise which are potential mechanisms 
by which it may have beneficial effects on immune function. However, the greatest 
intervention effects reported to date are with acute carbohydrate ingestion (before and 
during the exercise). 
There is a limited number of studies at present on acute antioxidant supplementation, 
and fewer still on the combination of antioxidant and carbohydrate supplementation, 
on hormonal, cytokine, oxidative stress and immune responses to prolonged exercise. 
In order to investigate this further a series of studies was designed to examine the 
hormonal (cortisol, ACTH), IL-6, oxidative stress, leukocyte trafficking, and 
neutrophil functional capacity (in vitro-stimulated degranulation and OBA) responses 
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to prolonged cycle ergometer exercise. The effects of acute VC supplementation alone 
(on the day of exercise only) or in combination with acute carbohydrate beverage 
ingestion were examined (study I, Chapter 3). Study 2 (Chapter 4) further 
investigated the effects of acute VC supplementation on the day of exercise but an 
additional bolus was also ingested on the evening before in an attempt to ensure a 
significant increase in the plasma VC concentration before the exercise commenced. 
The effects of longer periods of antioxidant supplementation (2 weeks of VC 
supplementation and 4 weeks of mixed VC and vitamin E supplementation) were 
examined in study 3 (Chapter 5) and study 4 (Chapter 6), respectively. Dark chocolate 
contains a relatively high amount of antioxidant compounds called polyphenols in 
addition to carbohydrate, fat and protein. Polyphenols are amphipathic meaning that 
they exert their antioxidant effects both in the aqueous (as does VC) and lipid (as does 
vitamin E) milieu. Therefore, a study was designed to investigate the effects of pre-
exercise dark chocolate consumption on the hormonal, cytokine, oxidative stress and 
immune responses to prolonged exercise (study 5, Chapter 7). 
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CHAPTER TWO 
General Methods 
2.1 Ethics approval 
Ethics approval was obtained from the local Research Ethics Committee prior to 
recruitment for each study. Participants in each study were informed of the 
experimental procedures (verbally and in writing) and they gave written informed 
consent. Participants were all physically active and free from injury or infection 
symptoms. They also completed a health screening questionnaire (Appendix I) before 
participating in any study and a general health questionnaire (Appendix 2) on the day 
of each trial. 
2.2 Determination of maximal oxygen uptake ( V 02max). 
Participants performed a continuous incremental exercise test to volitional exhaustion 
on an electrically braked cycle ergometer (Lode Excalibur, Holland). After a warm-up 
(3 min at 70 W plus 3 min at 105 W) participants began cycling at 140 W. The power 
output was increased by 35 W every 3 min, until volitional exhaustion. Expired gas 
was collected in Douglas bags during the final min of each stage. Heart rate (HR) and 
Rating of Perceived Exertion (RPE) were measured during this period using a 
telemetric device (Polar Electro, Kempele, Finland) and the Borg 6-20 point scale 
(Borg, 1982), respectively. The test was ended when the participant signalled that 
they could continue for only I min more at the required intensity. At this point a new 
expired gas collection was commenced and generous verbal encouragement was 
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given. The expired gas was analysed by an 02 and CO2 analyser (Servomex series 
1400, Crowborough, UK) and volume was measured through a dry gas meter 
(Harvard apparatus, Cambridge, UK) allowing determination of the average \;02 at 
each work rate. All gas volumes have been corrected to STPD (standard temperature 
and pressure, dry). The V02-work rate relationship was used to determine the work 
rate that would elicit a \;02 equivalent to - 60% \;02max. 
2.3 Habituation trials 
Participants were required to undertake a habituation ride prior to the main trials. This 
required them to exercise on the cycle ergometer for 2.5 h at the work rate which 
would be required during the main trials (equivalent to - 60% V02max). A placebo 
drink was consumed in the same volumes that would be consumed during the main 
trials. Expired gas (1 min sample) was collected into Douglas bags after 10 and 30 
min of exercise for verification of relative exercise intensity and then every 30 min 
thereafter. The purpose of this trial was threefold. Firstly, to familiarise the 
participants with the procedures and the physical stress of the exercise to be 
encountered during the main trials. Secondly, to ensure that the selected work rate 
actually did elicit a relative intensity of - 60% \;02max. Third, to ensure that the 
participant could maintain the selected intensity for 2.5 h whilst on a placebo 
treatment and after an overnight fast. 
2.4 Analytical methods 
2.4.1 Blood collection and treatment 
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Blood samples were taken by venepuncture from an antecubital vein (with a 21 gauge 
needle, into K3EDT A or heparin pretreated vacutainer tubes). A tourniquet was used 
whilst the needle was introduced into the vein but was released as soon as possible 
afterwards (within 30 seconds). Participants were seated and asked to remain 
stationary for 15 min before all blood samples with the exception of the post-exercise 
samples which were drawn with the subject seated as soon as possible after 
completion of the exercise (within 3 min of exercise cessation). Aliquots of K3EDTA 
treated whole blood were used for haematological analysis. Determination of in vitro 
stimulated neutrophil OBA was carried out using diluted whole blood. A 1 ml aliquot 
of heparin treated whole blood was used for determination of in vitro stimulated 
neutrophil degranulation. The remaining blood (K3EDT A and heparin tubes) was 
centrifuged at 1500 g for 15 min at 4"C and aliquots of plasma were stored at -80"C 
for later analysis. 
2.4.2 Haematology 
Haematological analysis was performed on K3EDTA anticoagulated whole blood 
using an automated haematology analyser (Ac·T 5diff, Beckman Coulter, UK). Blood 
haemoglobin concentration, haematocrit, total and differential leukocyte counts were 
measured. The intra-assay coefficient of variation (CV) was 0.7%, 0.8% and 1.3% for 
haemoglobin concentration, haematocrit and leukocyte counts, respectively, based on 
10 repeated measurements of the same sample. 
2.4.3 Markers of oxidative stress 
Plasma VC concentration and antioxidant capacity. Plasma VC concentration was 
determined, in plasma obtained from heparin anticoagulated blood, according to Liu 
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et al. (1982) using a specific spectrophotometric ascorbate oxidase (E, 1.10.3.3) assay. 
Plasma antioxidant capacity (PAC) was determined using a microplate luminometer 
(Anthos Lucy I, Salzburg, Austria), in plasma obtained from heparin anticoagulated 
blood, using a chemiluminescence (CL) test for measuring the capacity of plasma to 
scavenge 02" (ABEL, Knight Scientific, Plymouth, UK). Ascorbate was used as the 
standard allowing expression of the antioxidant capacity of the sample in ascorbate 
equivalent antioxidant units (IlM). Plasma total antioxidant status (TAS) was 
determined, in plasma obtained from heparin anticoagulated blood, on an automated 
analyser (Cobas-Mira Plus, Roche, Basle, Switzerland) using a commercially 
available kit (Randox, County Antrim, UK) for measuring the capacity of plasma to 
scavenge the 2,2' -azinobis-(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radical 
cation. Trolox was used as the standard so TAS was expressed in Trolox equivalent 
antioxidant units (IlM). The intra-assay CV was 3.4%, 4.5% and 1.1 % for the plasma 
VC, PAC and TAS assays, respectively, based on 20 duplicate samples. 
Plasma Thiobarbituric Acid Reactive Substances (TBARS). The TBARS assay 
was used as a plasma prooxidant biomarker. A specific colorimetric method, based on 
that used by Satoh (1978), was used with malondialdehyde (MDA) as the standard 
allowing TBARS to be expressed in MDA equivalent units (IlM). Briefly, K3EDTA 
plasma samples (250 Ill) were mixed with a solution of 20% trichloroacetic acid (1.25 
ml) and stood at room temperature for 10 min. The mixture was then centrifuged at 
3000 g for 10 min and the supernatant decanted. I ml ofa solution (0.05 M) ofH2S04 
was added to the precipitate which was mixed thoroughly then centrifuged again and 
the supernatant decanted. Both liberation of TBARS and colour reaction were then 
performed simultaneously by heating (30 min in a boiling water bath) the precipitate 
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with another 1.25 ml of H2S04 and 1.5 ml of sodium sulphatelthiobarbituric acid 
(Na2S04rrBA) reagent mixture (the concentration ofTBA was 0.2% and Na2S04 was 
2 M; the solution also contained 20 JlM Fe2+ to aid colour development). Resulting 
chromogen was extracted, after cooling, with the addition of butyl alcohol (2 ml). The 
mixture was shaken then centrifuged at 3000 g for 10 min. The absorbance of the 
organic phase was read immediately at 535 nm against butyl alcohol. The intra-assay 
CV was 5.7%, based on at least 20 duplicate samples. 
Plasma free Fz-isoprostane concentration. For the determination of plasma free Fz-
isoprostane, K3EDTA plasma samples were stored at -80'C in the presence of 0.005% 
3,5-Di-tert-4butylhydroxytoluene (BHT) prior to analysis. Plasma free Fz-isoprostane 
concentration was determined using an ELlSA kit according to the manufacturer's 
instructions (Cayman Chemical Co., MI, USA). The intra-assay CV was 2.8%, based 
on 20 duplicate samples. 
2.4.4 Plasma glucose, hormones and IL-6 concentrations 
Aliquots of K3EDTA plasma were analysed to determine the concentrations of 
cortisol (DRG Diagnostics, MarburglLahn, Germany), ACTH (Biomercia, Ca, USA), 
insulin (Ultrasensitive kit, DRG Diagnostics, MarburglLahn, Germany) and IL-6 
(Diaclone, Besancon, France) using commerciaIly available ELlS A kits. Plasma 
glucose concentration was determined on an automated analyser (Cobas Mira Plus, 
Roche, Basle, Switzerland) using a glucose oxidase-PAP kit (Randox, County Antrim, 
UK). The intra-assay CV was 2.7%, 4.3%, 2.2%, 3.9% and 1.3% for the plasma 
cortisol, ACTH, insulin, lL-6 and glucose assays, respectively, based on 20 duplicate 
samples (or 10 repeated measurements of the same sample for the glucose assay). 
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2.4.5 Measures of Neutrophil Function 
In vitro stimulated neutrophil oxidative burst activity. Aliquots of K3EDTA whole 
blood were stored at room temperature in an eppendorf tube for analysis of in vitro 
stimulated-neutrophil OBA within 3 h of collection. The neutrophil OBA response to 
PMA and formyl-leucyl-methionyl-phenylalanine (tMLP) were determined in a 
microplate luminometer (Anthos Lucy 1, Salzburg, Austria) using a commercially 
available CL kit (ABEL, Knight Scientific, UK). The assays were performed at 3TC 
and the stimulant (either PMA or tMLP) was injected manually. When PMA was used 
CL was recorded in duplicate as relative light units (RLU) at 1 min intervals for 30 
min and the integral of the CL curve was calculated. The integral of the baseline curve 
(CL response without PMA stimulation) was subtracted to calculate the PMA-
stimulated CL. For tMLP, CL was measured after an initial 30 second incubation 
every second for 100 seconds and the peak difference between stimulated and 
unstimulated was recorded. It was assumed that the CL response depends almost 
entirely on neutrophils (Morozov et al. 2003) therefore the PMA-stimulated area 
under the curve or tMLP-stimulated peak CL responses were divided by the number 
of neutrophils per well to give CL per neutrophil, a measure of in vitro stimulated 
OBA. All CL values were corrected for changes in plasma VC concentration to 
account for the fact that in this assay VC competes with Pholasin for ROS, reducing 
the emitted light energy (measurable CL). 
The unstimulated spontaneous CL response represents a snapshot of the amount of 
ROS present in the blood at a given time and is associated with the antioxidant 
potential of the sample. Therefore the unstimulated CL responses from the PMA-
stimulated OBA assay were also expressed per litre of blood to give a snapshot 
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indication of the amount of ROS and magnitude of blood oxidative stress at specific 
times. The intra-assay CV was 5.7%, 9.1 % and 4.7% with PMA stimulation, fMLP 
stimulation and spontaneous CL, respectively, based on 20 duplicate samples. 
In vitro stimulated neutrophil degranulation. The neutrophil degranulation 
response to bacterial stimulant (840-15, Sigma, Poole, UK) was determined according 
to Robson et al. (1999). Neutrophil degranulation was expressed as the amount of 
stimulated elastase release per neutrophil (with the unstimulated elastase 
concentration subtracted). Elastase concentration was determined using an ELISA kit 
(Merck Calibiochem, Darmstadt, Germany). The intra-assay CV was 2.7%, based on 
20 duplicate samples. 
2.4.6 Estimation of plasma volume changes 
It is generally accepted that it is not valid to estimate plasma volume changes using 
haematocrit (Hct) values derived from automated analysers such as a Coulter counter, 
as discussed by Maughan et al. (2001): Measurement of Hct on a Coulter counter 
involves dilution of blood with a medium, the osmolality of which may not 
necessarily be the same as that of plasma. Therefore, the measured Hct may not truly 
reflect the actual in vivo Hct. Moreover, if plasma osmolality changes as a result of 
exercise then repeated measures of Hct can not be validly used to estimate plasma 
volume changes. However, there is a great deal of controversy over the use ofHct and 
haemoglobin to estimate plasma volume changes regardless of how Hct is measured 
(Johansen et aI., 1998; Kelly et aI., 1994; Schmidt et aI., 1989). However, it may be 
the actual plasma concentration of the solute (e.g. metabolite, hormone, cytokine) to 
which the body responds, regardless of changes in plasma volume (Mastaloudis et aI., 
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2001). Moreover, any shift in plasma volume resulting from hydrostatic mechanisms 
probably does not significantly affect the plasma concentration of most solutes which 
may also move out of the vascular space. Therefore, data throughout this thesis are 
reported uncorrected for changes in plasma volume. Also, adjusting for changes in 
plasma volume had little or no effect on the outcome of the statistical analysis 
throughout this thesis. Furthermore, in a pilot study (n = 8, Table 2.1) Hct values 
measured manually (Hawksley micro centrifuge technique) were compared with Hct 
measured on a Coulter counter at rest and following 2 - 2.5 h of exercise at 60 -
65% V02max. There is little difference between the mean values obtained with the 
different methods. However, the agreement between methods is not as convincing 
when assessed with a Bland and Altman plot (Table 2.1 and Figure 2.1). Therefore, 
plasma volume changes estimated using the method of Dill and Costill (1974) are 
presented for reference only (not used to correct data) in Table 2.2 below. Finally, the 
major variables throughout this thesis are the functional neutrophil measures (in vitro 
stimulated degranulation and OBA responses). These variables are expressed per 
neutrophil (i.e. per neutrophil in the in vitro stimulated whole blood sample) and thus 
are not affected by any acute changes in plasma volume. 
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Table 2.1: Pilot study (n = 8) comparing Hct measured with Hawksley micro 
centrifuge or with a Coulter counter before and after 2-2.5 h of exercise at 60 -
65%V02max. 
Pre-exercise Hct 
Coulter counter 
Micro centrifuge 
Post-exercise Hct 
Coulter counter 
Micro centrifuge 
Fluid intake during exercise 
(litres) 
Mean 
(standard deviation) 
44.5 (4.0) 
45.0 (2.7) 
44.4 (3.3) 
44.7 (3.\) 
1.56 (0.40) 
Body mass change, corrected -1.68 (0.42) 
for fluid intake (kg) 
Cl, confidence intervals. 
Comparisons 
Bland & Altman plot 
statistics 
Mean difference = -0.500 
SO of differences = 1.622 
Lower limit = -3.679 
(95% Cl = -6.104 to -1.255) 
Upper limit = 2.679 
(95% Cl = 0.255 to 5.104) 
Bland & Altman plot 
statistics 
Mean difference = -0.300 
SO of differences = 1.1 02 
Lower limit = -2.460 
(95% Cl = -4.107 to -0.813) 
Upperlimit = 1.860 
(95% Cl = 0.213 to 3.507) 
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Figure 2.1: Bland and Altman plots: Comparison of Coulter counter and Hawksley 
micro centrifuge methods ofHct measurement pre-exercise (A) and post-exercise (8). 
Table 2.2: Estimated post-exercise plasma volume changes 
Chapter Trial 
PLA 
3 CHO 
VC 
CHO+VC 
4 PLA 
VC 
5 PLA 
VC 
6 PLA 
AO 
7 DC 
WC 
CON 
Post-exercise 
plasma volume 
change(%) 
-7.0 (S.2) 
-8.1 (6.0) 
-8.3 (5,8) 
-6.0 (S,I) 
-3.7 (4,7) 
-3.7 (3.4) 
-10.1 (4.5) 
-9.6 (2.6) 
-S.5 (6.1) 
-7.5 (S.6) 
-8.1 (S.O) 
-7.9 (3.7) 
-6.7 (4.8) 
Comparisons 
No significant difference between trials: 
I-way ANOVA, P= 0.801 
No significant difference between trials: 
Paired t test, P = 0.991 
No significant difference between trials: 
Paired t test, P = 0.743 
No significant difference between trials: 
Independent t test, P = 0.470 
No significant difference between trials: 
I-way ANOV A, P = 0.SS8 
Values are mean (standard deviation). PLA, Placebo trial; CHO, carbohydrate trial; VC, 
vitamin C trial; CHO+VC, combined carbohydrate and vitamin C trial; AO antioxidant 
vitamins trial; DC, dark chocolate trial; WC, white chocolate trial; CON, control trial. 
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2.5 General statistical methods 
All of the statistical analysis throughout this thesis was carried out using the statistical 
computer software package SPSS (SPSS for Windows vI2.00; SPSS Inc., Chicago, 
IL, USA). Two-way repeated measures analysis of variance (ANOVA) (trial x time) 
has been used throughout to compare the temporal responses between trials. Post hoc 
analysis was carried out, where appropriate, using paired samples t tests with the 
Holm-Bonferoni correction. Furthermore, main effects of time were explored further 
(when there was also evidence of an interaction) using I-way ANOV A on each trial 
(e.g. PLA, VC etc.), individually. According to Field (2000) it would be beneficial to 
compare repeated measures using the Multivariate Analysis of Variance (MANOVA), 
when there are multiple dependent variables. However, a MANOV A is not 
appropriate when the sample size is small (Schutz et aI., 1987). Furthermore, a small 
sample size can contribute to violations of many of the additional assumptions 
associated with MANOVA (Coakes et aI., 2001; Field, 2000). Hence, repeated 
measures, within-participant AN OVA was used independently for each dependent 
variable. The Greenhouse Geisser correction was applied to all ANOV A P values. All 
results throughout this thesis are presented as mean ± standard deviation (SD) unless 
stated otherwise. 
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CHAPTER THREE 
Study 1: Influence of acute vitamin C and/or carbohydrate ingestion on 
hormonal, cytokine and immune responses to prolonged exercise. 
Abstract 
The depression of immune cell function that is typically observed after prolonged 
exercise is thought to be largely mediated by increased concentrations of stress 
hormones and cytokines and possibly oxidative stress. The aim of this study was to 
investigate the effect of VC with or without carbohydrate (CHO) consumed acutely in 
beverages before and during prolonged cycling on immunoendocrine responses. In a 
single blind, randomised manner 6 healthy moderately trained males exercised for 2.5 
hat 60% VOzmax and consumed either placebo (PLA), CHO (6% w/v), VC (0.15% 
w/v) or CHO+VC beverages I h before (5 ml.kg·' body mass), immediately before, 
every 15 min during, and on completion of the bouts (2.5 ml.kg·' body mass); trials 
were separated by I week. CHO and CHO+VC significantly blunted the post-exercise 
increase in plasma concentrations of cortisol, ACTH, total circulating leukocyte and 
neutrophil counts and limited the decrease in plasma glucose concentration and 
bacteria-stimulated neutrophil degranulation (P < 0.05). VC increased plasma 
antioxidant capacity (PAC) during exercise (P < 0.05) but had no effect on any ofthe 
immunoendocrine responses (P > 0.05). CHO+VC increased PAC compared with 
CHO but had no greater effects, above those observed with CHO alone, on any ofthe 
immunoendocrine responses. In conclusion, acute supplementation with a high dose 
of VC has little or no effect on the hormonal, IL-6 or immune response to prolonged 
exercise and combined ingestion of VC with CHO provides no additional effects 
compared with CHO alone. 
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3.1 Introduction 
The consumption of a CHO-containing beverage before, during and after prolonged 
exercise, compared with water or placebo ingestion, can reduce the alterations in 
immunity by better maintaining plasma glucose levels and reducing the magnitude of 
release of HP A axis stress hormones and cytokines (Bishop et aI., 2002; Nehlsen-
Cannarella et aI., 1997; Nieman et aI., 1997a; Pedersen 1997), reducing the trafficking 
of most leukocyte and Iymphocyte subsets (Bishop et aI., 2000, 2002, Hensen et aI., 
2000; Nehlsen-Cannarella et aI., 1997), and limiting the reduction in neutrophil 
function (Bishop et aI., 2000, 2002). 
There is also evidence showing that supplementation with large doses of VC can 
reduce infection incidence following prolonged exercise (Peters et aI., 1993, 1996) 
which may also be related to reduction of the HP A axis stress hormone response to 
such exertion (Peters et al., 2001a, 2001b) and/or improved antioxidant defence and 
reduced oxidative damage directly to neutrophils (Peters et aI., 1997a, b; Robson et 
aI., 2003). Plasma VC concentration is elevated after exercise, suggesting an increased 
release from the adrenal glands, and other tissues, (Evans, 1982; Gleeson et al. 1987) 
and it has been suggested that cortisol is co-released with VC during exercise (Chen, 
2000), in response to oxidative stress (Peters et aI., 2001b). Hence, supplementation 
with VC could reduce exercise-induced oxidative stress, (auto)oxidative damage to 
neutrophils and/or reduce the concentration gradient between the adrenal glands and 
plasma, consequently reducing adrenal cortisol mobilisation (Peters et aI., 2001a, 
2001b). 
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VC alone or in combination with other antioxidants has been taken for periods of 1-8 
weeks in most previous supplementation studies (Fischer et aI., 2004; Peters et aI., 
1993, 1996, 2001a, 2001b, Robson et aI., 2003; Vassilakopoulos et aI., 2003). 
However, Alessio et al. (1997) found that post-exercise oxidative stress was lower 
when participants were supplemented with VC (1000 mg.da/) compared with 
placebo, but there appeared to be a more marked effect after only 1 day of 
supplementation compared with a 2-week period. It is possible, therefore, that acute 
supplementation with VC may also have an effect on the immunoendocrine responses 
and if so that the acute effects of VC and CHO could be additive. Furthermore, if 
attenuation of stress hormone release and/or oxidative stress is related to increased 
plasma concentrations of the vitamin then acute supplementation, before and during 
exer~ise, may be sufficient to have similar effects. Hence, the aims of this study were 
to examine the effects of acute oral supplementation with a high dose of VC, alone 
and in combination with CHO, prior to and during prolonged exercise on PAC, 
plasma cortisol, ACTH and IL-6 concentrations, circulating leukocyte and neutrophil 
counts and neutrophil degranulation and OBA. 
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3.2 Methods 
3.2.1 Participants 
Six healthy moderately trained males participated in this study (age 25 ± 5 years, body 
mass 70.6 ± 5.9 kg, V02max 55.3 ± 4.4 ml.kg-1.min-1). All participants completed 2 
preliminary trials (V02max determination and habituation) and 4 main trials on 
separate occasions separated by I week. 
3.2.2 Main trials 
Participants arrived at the laboratory at 09:30 following an overnight fast of at least IO 
h. They were asked to empty their bladder before body mass was measured with the 
participant wearing shorts only. A resting venous blood sample (Rest) was taken at 
10:00, before the consumption of 5 ml.kg·1 body mass of beverage. A second resting 
blood sample (Pre-Ex) was taken 1 h later, immediately before beginning to cycle for 
2.5 hat 60% V02max. Beverages (2.5 ml.kg-I body mass) were consumed at the onset 
of exercise, every 15 min during exercise, and on completion of the bout, Expired gas 
was collected in Douglas bags (1 min sample), during the 60th and 120th min of 
exercise, for analysis of V02 and RER. HR and RPE were recorded every 15 min 
during exercise. Further venous blood samples were taken immediately post-exercise 
(Post-Ex) and after I h of recovery (I h Post-Ex). During the I h post-exercise 
recovery participants remained in the laboratory but were allowed to towel dry and 
change their clothes. They remained seated and were allowed to undertake restful 
activities such as reading or using a computer. 
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The composition of the beverage given before and during each trial was either placebo 
(PLA): 700 ml water, 300 ml low calorie lemon cordial, and 8 sweetener tablets 
(CandereI™) per litre of solution; CHO: dextrose monohydrate (6% w/v) made up to 
I litre with 300 ml of low calorie lemon cordial and the remainder with water; YC: 
the same composition as PLA but with the addition ofL-ascorbic acid (0.15% w/v); or 
CHO+YC: the same composition as CHO but with the addition of L-ascorbic acid 
(0.15% w/v). This provided approximately 2.3 litres of fluid, 137 g of carbohydrate 
and 3400 mg of YC, for the average (70 kg) participant, in the appropriate beverages 
over the course of a main trial. The drinks were taste matched (following pilot work 
with a series of blinded taste testing sessions using different amounts of the sweetener 
tablets). This proved effective as participants were not able to distinguish between the 
beverages. This study was conducted in a single blind, randomised-crossover manner. 
The order of treatments was randomised using an incomplete Latin Squares design so 
that each participant received each of the beverages, in the main trials, in a different 
order. 
Participants completed a food record diary for the 24 h period before the first main 
trial and were required to follow the same diet during the 24 h prior to each 
subsequent main trial. They were also required to abstain from alcohol, caffeine and 
heavy exercise for 48 h prior to each trial and to have a rest day (no exercise other 
than activities of normal daily living, such as walking to and from work/university) on 
the day immediately before each trial. It was also stipulated that participants should 
not take any vitamin or mineral supplement during and for 2 weeks before the study 
period. 
47 
Chapter 3 Acute VC and/or CHO supplementation 
3.2.3 Data analysis 
First of all, the mean group values, for each of the dependent variables, were 
compared across the 4 repeated measures for each treatment individually using one-
way ANOV A. This was done to determine the temporal response with exercise. 
Secondly, each trial was compared with the placebo using a two-way repeated 
measures ANOVA (trial x time) to determine if the effect of time was different 
depending on which treatment was administered. Finally, the CHO+VC treatment was 
compared with the CHO alone treatment using a two-way repeated measures ANOVA 
(treatment x time) to determine ifCHO+VC had a greater effect than CHO alone. 
3.3 Results 
The dietary composition for the 24 h period prior to main trials was as follows: total 
energy intake of 11.8 ± 0.4 MJ, percentage energy derived from carbohydrate, protein 
and fat was 58 ± 7%, 14 ± 2%, and 28 ± 7%, respectively. This was equivalent to an 
average intake of 6.1 ± 1.0 g.kg- I body mass of carbohydrate and 1.5 ± 0.2 g.kg- I body 
mass of protein. The average VC intake was 57 ± 12 mg which is equivalent to 95 ± 
20% of the current UK Recommended Daily Allowance (RDA). The average 
% V02max during each trial was 59.4 ± 4_7%, 60.5 ± 3.2%, 59.7 ± 2.7% and 57.8 ± 
2.4%, respectively for PLA, CHO, VC and CHO+VC trials. There was no difference 
between all 4 treatments for average % \/02 max during the 2.5 h of exercise. The 
average HR during each trial was 146 ± 14, 147 ± 14, 144 ± 12, and 146 ± 12 
beats.min-I , respectively for PLA, CHO, VC and CHO+VC trials. The average RPE 
during each trial was 12 ± 1, 12 ± 1, 12 ± 1, and 12 ± 2, respectively for PLA, CHO, 
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VC and CHO+VC trials. There were no differences between all 4 trials for average 
heart rate or RPE during the 2.5 h of exercise. 
PAC was significantly higher than Rest at Pre-Ex (P = 0.01), Post-Ex (P = 0.003) and 
I h Post-Ex (P = 0.01) on the PLA trial (Table 3.1). Compared with the PLA trial, 
PAC was significantly higher on the VC trial Post-Ex (P = 0.027), and on the 
CHO+VC trial I h Post-Ex (P = 0.009), but not on the CHO trial. PAC was 
significantly higher on the CHO+VC trial I h Post-Ex (P < 0.001) compared with the 
CHO trial. Plasma glucose concentration (Table 3.1) was significantly lower than Rest 
at Post-Ex (P = 0.002) and I h Post-Ex (P < 0.001) on the PLA trial. Plasma glucose 
concentration Post-Ex was significantly higher on the CHO, and CHO+VC trials (P = 
0.003), but not on the VC trial, compared with PLA. There were no differences 
between the CHO, and CHO+VC trials. Plasma ACTH concentration (Table 3.1) was 
significantly higher than Rest at Post-Ex on the PLA trial (P = 0.026). Plasma ACTH 
concentration Post-Ex was significantly lower on the CHO (P = 0.02) and CHO+VC 
trials (P < 0.001), but not on the VC trial, compared with PLA. There was no 
difference between the CHO, and CHO+VC trials. 
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Table 3.1: Plasma biochemical indices before and following exercise. 
Rest Pre-Ex Post-Ex I h Post-Ex 
Glucose PLA 4.9 (0.4) 4.8 (0.6) 4.1 (0.7)** 4.0 (0.3)** 
(mM) CHO 4.9 (0.3) 4.1 (1.1) 5.6 (0.4)** ~~ 4.6 (1.2) 
YC 4.9 (0.4) 5.0 (0.4) 3.9 (0.7)* 3.9 (0.5)* 
CHO+YC 5.0 (0.3) 4.2 (0.6) 5.7 (0.2)** ~~ 4.5 (0.5) 
IL-6 PLA 1.0 (0.4) 0.9 (0.3) 7.9 (5.7) 7.4 (5.8)* 
(pg.mr') CHO 1.0 (0.3) 0.9 (0.2) 3.1 (1.1)* 3.1 (1.3)* 
YC 0.8 (0.1) 0.9 (0.2) 6.2 (3.7)* 5.5 (3.2)* 
CHO+YC 1.1 (0.7) 1.1 (0.6) 3.2 (1.1)* 2.7 (1.0)* 
ACTH PLA 18 (12) 14 (7) 195 (112)* 91 (148) 
(pg.mr') CHO 29 (13) 30 (28) 62 (35) ~ 17 (5) 
YC 21 (13) 14 (7) 230 (188) 43 (57) 
CHO+YC 38 (19) 20 (7) 52 (29) ~~ 17 (5)* 
Cortisol PLA 445 (153) 361 (lOO) 947 (298) * 783 (338) 
(nM) CHO 493 (148) 424 (182) 562 (242) ~ 385 (171) ~ 
YC 483 (148) 396 (158) 768 (256) 655(319) 
CHO+YC 490 (141) 355 (Ill) 503 (232)~ 383 (158) ~~ 
PAC PLA 651 (113) 845 (152)* 863 (145)* 968 (167)** 
(~M) CHO 932 (159) 808 (135) 1014 (355) 986 (252) 
YC 842 (125) 1051 (152)* 1952 (1401)* ~ 2091 (1580)* 
CHO+YC 647 (174) 756 (213) 1116 (372)* 1193 (387)* ~~ ## 
Significantly different from Rest (* p < 0.05; ** P < 0.01), significantly different 
from PLA (~P < 0.05; ~~ P < 0.01), significantly different from CHO (# P < 0.05, ##, 
P < 0.01; comparisons for CHO+YC only). 
Plasma cortisol concentration (Table 3.1) was significantly higher than Rest at Post-
Ex on the PLA trial (P = 0.012). Compared with the PLA trial, plasma cortisol 
concentration was significantly lower on the CHO trial Post-Ex (P = 0.03) and I h 
Post-Ex (P = 0.02) and on the CHO+YC trial Post-Ex (P = 0.004) and 1 h Post-Ex (P 
= 0.003), but not on the YC trial. There was no difference between the CHO, and 
CHO+YC trials. Plasma IL-6 concentration (Table 3.1) was significantly higher than 
Rest at I h Post-Ex on the PLA trial (P = 0.047) but not at Post-Ex (P = 0.07). Plasma 
50 
Chapter 3 Acute YC and/or CHO supplementation 
IL-6 concentration was not significantly different from the PLA trial at any time point 
on the CHO, YC or CHO+YC trials. However, there was large inter-individual 
variation in the plasma IL-6 response which was consistently lower for every 
participant Post-Ex and I h Post-Ex in the CHO and CHO+YC trials. Furthermore, 
there was a trend for IL-6 to be lower 1 h Post-Ex (P = 0.092) on the CHO+YC trial 
compared with the PLA trial. There was no difference between the CHO and 
CHO+YC trials. 
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Figure 3.1: Circulating leukocyte count before and following exercise. Significantly 
different from Rest (* p < 0.05; ** P < 0.01), significantly different from PLA (~ P < 
0.05; W P < 0.01). 
There was a significant leukocytosis and neutrophilia at Post-Ex and 1 h Post-Ex on 
the PLA trial (P < 0.001). The magnitude of leukocytosis and neutrophilia was 
significantly smaller, compared with the PLA trial, on the CHO trial Post-Ex (P = 
0.004 and P = 0.004 for leukocyte count and neutrophil count, respectively) and 1 h 
Post-Ex (P = 0.003 and P = 0.006, respectively) and on the CHO+YC trial Post-Ex 
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and I h Post-Ex (P < 0.001), but not on the YC trial (Figure 3.1 and Figure 3.2). 
There were no differences between the CHO and CHO+YC trials. 
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Figure 3.2: Circulating neutrophil count before and following exercise. Significantly 
different from Rest (* p < 0.05; ** P < 0.01), significantly different from PLA ('1l P < 
0.05; '1l'1l P < 0.01). 
There was a significant decrease below the values at Rest in the bacteria-stimulated 
neutrophil degranulation response at Post-Ex (P = 0.002) and I h Post-Ex (P < 0.001) 
on the PLA trial (Figure 3.3). The magnitude of this decrease was reduced on the 
CHO trial Post-Ex (P = 0.024) and I h Post-Ex (P = 0.016) and CHO+YC trial I h 
Post-Ex (P = 0.050). There were no differences between the CHO and CHO+YC 
trials. There was a significant decrease below the values at Rest in PMA-stimulated 
neutrophil OBA (Figure 3.4) at Post-Ex (P = 0.012) and I h Post-Ex (P = 0.009) on 
the PLA trial. The magnitude of this decrease was not significantly different on the 
CHO, YC or CHO+YC trials but I-way ANOYA on each trial individually showed 
that there was no main effect of time on the CHO trial (P = 0.159). 
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Rest Pre-Ex Post-Ex lh Post-Ex 
Figure 3.3: Bacteria-stimulated elastase release per neutrophil before and following 
exercise. Significantly different from Rest (* p < 0.05; ** p < 0.01), significantly 
different from PLA (~P < 0.05; ~~ P < 0.01). 
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Figure 3.4: PMA-stimulated oxidative burst activity per neutrophil before and 
following exercise. Significantly different from Rest (* P < 0.05; ** P < 0.01). 
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3.4 Discussion 
Cycling for 2.5 h at 60% V02max led to a decrease in plasma glucose concentration 
and an increase in the plasma concentration of ACTH, cortisol and IL-6. There was 
also a - 3-fold increase in the number of circulating leukocytes, predominantly 
neutrophils (- 4-fold increase). However, the functional capacity (degranulation and 
.OBA) of neutrophils, on a per cell basis, was decreased post-exercise. This is in 
agreement with previous findings following prolonged exercise (Bishop et aI., 2000, 
Hensen et aI., 2000, Li et aI., 2005; Nehlsen-Cannarella et ai, 1997). 
Carbohydrate beverage ingestion prevented the decrease in plasma glucose 
concentration and was associated with lower post-exercise plasma ACTH and cortisol 
concentrations. This is consistent with previous research (Bishop et aI., 2000, Hensen 
et aI., 2000, Li et aI., 2005; Nehlsen-Cannarella et ai, 1997) and shows that CHO 
beverage ingestion blunts HP A axis activation in response to prolonged exercise. 
Furthermore, the reduced activation of the HP A axis may explain the smaller 
. leukocytosis and neutrophilia with the CHO beverage, since cortisol may stimulate 
the release of these cells from the bone marrow (Pyne, 1994; Robson et aI., 1999). 
Complete demargination may account for an increase in circulating leukocyte count of 
up to 2-fold (Blannin, 2006). Therefore, it is likely that some of the leukocytosis (- 3-
fold increase) and neutrophilia (- 4-fold increase) observed post-exercise in the 
present study was attributable to some degree of mobilisation of 'less mature' cells 
from the bone marrow. Immature, or prematurely released, neutrophils have a lower 
functional capacity compared with fully mature cells (Berkow et aI., 1986) which may 
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account, at least in part, for the observation in the present study that CHO blunted the 
decrease in bacteria-stimulated elastase release per neutrophil following prolonged 
exercise. CHO did not significantly alter the pattern of change in PMA-stimulated 
OBA per neutrophil which is in agreement with Nieman et al. (1998) and Smith et al. 
(1996). A possible explanation for this could be that PMA-stirnulated OBA is less 
'sensitive' to perturbation because PMA directly stimulates PKC in the activation 
pathway leading to NADPH oxidase activation resulting in the maximal OBA 
response. Therefore, this particular measure may be less 'sensitive', compared with 
bacteria-stimulated degranulation which involves receptor dependent activation of the 
neutrophil. However, I-way ANOVA on each trial individually showed that (for 
OBA) there was a main effect of time in all trials except the CHO trial (P = 0.159) 
which may suggest a trend. 
The lack of effect of CHO beverage ingestion on plasma IL-6 concentration following 
prolonged exercise does not agree with previous studies (Li et aI., 2005; Nehlsen-
Cannarella et aI, 1997). However, it should be noted that there is a trend for plasma 
IL-6 concentration to be lower post-exercise for both the CHO containing beverages 
compared with PLA. Indeed, the post-exercise plasma IL-6 concentration in the CHO 
trial was approximately 40% of that on the PLA trial. It is likely that large inter-
individual variations in the IL-6 response make it difficult to identify differences with 
the relatively Iow number of participants (n = 6) in the present study. 
VC ingestion had no effect, compared with PLA, on the exercise-induced changes in 
plasma glucose, ACTH, cortisol and IL-6 concentrations. There was also no effect on 
the magnitude of leukocytosis, neutrophilia, neutrophil degranulation and OBA. 
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However, the increase in cortisol Post-Ex was significant on the PLA trial (P = 0.012) 
but not on the VC trial (P = 0.06) which may suggest a trend. 
VC ingestion before and during exercise significantly altered the pattern of change in 
PAC. The increase in PAC immediately and I h post-exercise was significantly 
greater with VC compared with PLA ingestion. The increase in PAC immediately 
before exercise (I h after consuming the first drink) was not significantly different 
from PLA. However, it can take 2-3 h after consumption for plasma VC levels to 
reach a peak (Sanchez-Moreno et aI., 2003). Moreover, the increase in PAC observed 
from Rest to Pre-Ex on the PLA trial may account for the lack of difference. It is 
difficult to explain why PAC increases from Rest to Pre-Ex on the PLA trial. It could 
be that this is related to participants remaining fasted. For example, when participants 
were on the CHO trial, PAC tended to decrease in the I h period between Rest and 
Pre-Ex. Therefore, the mobilisation of substrates (such as glucose, to maintain plasma 
glucose concentration, Table 3.1) may be associated with the release of VC and/or 
other antioxidants into the systemic circulation, although this idea is purely 
speculative. Also, there were considerable differences between trials in the baseline 
(Rest) levels ofPAC. This is also difficult to explain as participants followed the same 
diet for the 24 h period before each trial and had a rest day on the day before each 
trial. Therefore, there may be some unforeseen or extraneous factors which contribute 
to this variation. Nonetheless, the significantly greater post-exercise increase in PAC 
on the VC trial is consistent with the findings of Alessio et al. (1997) and Ashton et 
al. (1999) who have shown that acute VC supplementation significantly attenuates 
exercise-induced oxidative stress. The data suggest that acute VC supplementation 
was successful at increasing plasma VC concentration during exercise (as evidenced 
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by P AC), but did not attenuate adrenal cortisol secretion. This does not support the 
idea that blunted cortisol secretion, as sometimes observed with longer periods of YC 
supplementation (Peters et aI., 2001a, 200Ib), is directly related to plasma VC 
concentration and/or oxidative stress. However, there may be a trend, suggesting that 
acute VC supplementation could have some small effects on the cortisol response 
(especially considering that P AC was not significantly higher, compared with PLA, 
immediately before exercise). Furthermore, it is not known at what point during 
exercise the PAC became significantly higher on the VC compared with PLA trial. 
Therefore, in order to have a direct inhibitory effect on adrenal cortisol synthesis 
(Peake, 2003) and/or release (Peters et aI., 2001a, 2001b) it may be necessary to 
consume VC sufficiently early so that PAC (and plasma VC concentration) are 
significantly elevated before exercise begins. Nonetheless, the lack of VC effect 
observed in the present study is in agreement with Nieman et al. (1997b, 2002) who 
reported only a weak relationship between oxidative stress and immune changes 
during and after 2.5 h of running or an ultramarathon run, respectively. 
CHO+VC ingestion before and during 2.5 h of cycling at 60% VOzmax significantly 
altered the pattern of change.in plasma cortisol, ACTH and glucose concentrations, 
circulating leukocyte and neutrophil counts and stimulated neutrophil degranulation 
after exercise, compared with PLA. The pattern of change in PAC was also 
significantly altered by CHO+YC consumption. CHO+VC did not significantly alter 
the pattern of change in plasma IL-6 concentration and neutrophil OBA. These results 
are similar to those discussed above for CHO beverage ingestion, with the addition 
that post-exercise PAC was also significantly greater with CHO+VC. Despite the fact 
that there were no significant effects of acute VC supplementation, it remained 
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possible that trends would, when added to the effects of CHO, have effects above 
those of CHO alone; hence, the hypothesis that CHO and VC could have an additive 
effect was still explored. The increase in PAC with CHO+VC was significantly 
greater than with CHO immediately pre-exercise, immediately post-exercise and I h 
post-exercise which is most likely due to the addition of VC. However, the post-
exercise changes in plasma glucose, ACTH, cortisol and IL-6 concentrations, 
circulating neutrophil numbers and function were not significantly different between 
the CHO and CHO+VC trials. This suggests that CHO and VC in combination does 
not better modulate the exercise-induced immunoendocrine responses to prolonged 
exercise, compared with CHO alone. Acute supplementation with VC may well 
reduce the magnitude of exercise-induced oxidative stress as suggested by Alessio 
(1997); however, this has little or no effect on the immunoendocrine response to 
prolonged exercise and does not add to the effects of CHO alone. This is in line with 
Nieman and colleagues who found that VC supplementation (1500 mg.day"'), before 
and during a 2.5 h treadmill run (Nieman et al., I 997b) or an ultramarathon race 
(Nieman et aI., 2002) did not serve as a countermeasure to oxidative and immune 
changes during or after exercise when CHO was also consumed before, during and 
after the exercise. However, it remains to be determined if there would be any effects 
on the immunoendocrine responses to exercise with acute supplementation if VC is 
consumed sufficiently early to markedly increase PAC before exercise onset. 
In conclusion, the results of this study support the previous research which suggests 
that CHO beverage consumption before and during prolonged exercise modulates the 
post-exercise changes in immune cell number and function. However, acute high dose 
VC supplementation had little or no effect on the hormonal, IL-6 or immune 
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responses to prolonged exercise and the addition of this antioxidant to CHO provides 
no additional effects above those observed with CHO alone. Further research is 
required to determine if acute VC supplementation, when given sufficiently early to 
significantly increase PAC (and VC concentration) before the onset of exercise can 
influence the immunoendocrine responses to prolonged exercise. 
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CHAPTER FOUR 
Study 2: The effects of acute vitamin C supplementation on cortisol, interleukin-
6 and neutrophil responses to prolonged cycling exercise. 
Abstract 
The depression of immune cell function that is typically observed after prolonged 
exercise is thought to be largely mediated by increased concentrations of stress 
hormones and cytokines and possibly oxidative stress. The aim of this study was to 
measure immunoendocrine responses, with acute VC or PLA ingestion, before and 
during prolonged exercise. In a single blind, counterbalanced-crossover design, 8 
healthy males ingested a bolus of500 mg and 1000 mg VC 2 h and 14 h pre-exercise, 
respectively then cycled for 2.5 h at - 60% V 02max. They also consumed either PLA 
or VC (0.15% w/v) beverages (2.5 mI.kg-1 body mass) during exercise. Compared 
with the PLA trial resting and post-exercise plasma VC concentration and antioxidant 
capacity were higher and post-exercise oxidative stress markers were lower in the VC 
trial. There was no difference between trials in the magnitude of post-exercise 
increases in circulating neutrophil numbers, plasma cortisol and IL-6 concentrations. 
There was a significant main effect of trial (P = 0.039) and trial x time interaction (P 
= 0.008) for PMA-stimulated CL per neutrophil with the post-exercise values 
significantly higher in the VC trial (P < 0.05)_ The results suggest that acute VC 
supplementation may improve post-exercise neutrophil OBA. Given that there was no 
effect on the cortisol, IL-6 and circulating neutrophil count a likely explanation is that 
acute VC ingestion reduced (auto)oxidative 'damage' to neutrophils which may result 
in less impairment of their functional capacity after exercise. 
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4.1 Introduction 
In study 1 (Chapter 3) a trend was observed for lower post-exercise plasma cortisol 
concentration when VC was ingested, compared with PLA, shortly before (1 h) and 
during prolonged exercise. However, there was a significant increase above baseline 
in PAC on the PLA trial which was not statistically different from the increase seen at 
the same time on the VC trial. This lead to the hypothesis that ingesting the VC earlier 
(to allow ingested VC to be fully absorbed before exercise is commenced) may result 
in a greater effect. Furthermore, Robson et al. (2003) observed enhanced neutrophil 
OBA post-exercise with 7 days of antioxidant (compared with PLA) supplementation 
and attributed this to reduced oxidative damage directly to neutrophils. However, if 
this is the mechanism by which the antioxidant supplementation improved neutrophil 
function then an acute increase in plasma antioxidant capacity may be sufficient to 
have similar effects. For example, Alessio et al. (1997) have shown that 
supplementation with VC (1000 mg) for just 1 day was an effective countermeasure to 
exercise-induced oxidative stress. Hence, the aims of the present study were to 
examine the effects of oral supplementation with a high dose of VC 14 h, 2 h, and 
immediately pre- and during exercise on plasma VC concentration and PAC, markers 
of oxidative stress, plasma concentrations of cortisol, and IL-6, blood neutrophil 
counts and neutrophil in vitro function. 
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4.2 Methods 
4.2.1 Participants 
Eight healthy moderately trained males (age 20 ± 3 years, body mass 71.7 ± 7.0 
kg, V02max 55.6 ± 5.0 ml.kg·!.min·!, power output at V02max 288 ± 14 W) 
participated in this study. All participants completed 2 preliminary trials (V02max 
determination and habituation)· and 2 main trials, in a counterbalanced crossover 
design, on separate occasions separated by 1 week. 
4.2.2 Main trials 
Participants consumed a beverage (5 ml.kg·! body mass) containing a bolus of 1000 
mg VC (in the VC trial) or PLA, 14 h before exercise (the night before). They then 
arrived at the laboratory at 08:30 after an overnight fast of at least 10 h. They were 
asked to empty their bladder before body mass was measured with the participant 
wearing shorts only. They consumed a beverage (5 mLkg'! body mass) containing 500 
mg VC or PLA between 08:50 and 09:00 (2 h pre-exercise). Commencing at 11:00, 
they cycled for 2.5 h at 60% V02max with 2.5 mLkg'! body mass of the appropriate 
beverage (VC or PLA) consumed at the onset, every 15 min during, and on 
completion of the exercise bout. The PLA beverage was a Iow calorie lemon 
flavoured squash with artificial sweetener. The VC beverage was the same as PLA but 
with the addition of 0.15% w/v L-ascorbic acid (providing - 2900 mg VC for an 
average 70 kg individual during the course of the main trial). The VC and PLA 
beverages were undistinguishable by taste, smell or appearance. Expired gas was 
collected into Douglas bags (1 min sample), during the 30th, 60th, 90th and 120th min of 
62 
Chapter 4 Acute VC supplementation 
exercise, for analysis of V02 and RER. Heart rate and RPE were recorded every 15 
min during exercise. Venous blood samples were taken at 08:50, before the 
consumption of the first beverage on the morning of exercise (Rest), immediately pre-
(Pre-Ex) and post- (Post-Ex) exercise and 1 h after completion of the exercise (1 h 
Post-Ex). During the 1 h post-exercise recovery participants remained in the 
laboratory but were allowed to towel dry and change their clothes. They remained 
seated and were allowed to undertake restful activities such as reading or using a 
computer. 
Participants completed a weighed food record diary for the 24 h period before the 
habituation trial and were required to follow the same diet during the 24 h prior to 
each main trial. They were also required to abstain from alcohol, caffeine and heavy 
exercise for 48 h prior to each trial and to have a rest day (no exercise other than 
activities of normal daily living, such as walking to and from work/university) on the 
day immediately before each trial. None of the participants were smokers. It was also 
stipulated that participants should not take any mineral or vitamin supplement (other 
than those provided) or any other antioxidant supplements for 2 weeks prior until after 
completion ofthe study. 
4.3 Results 
The dietary composition for the 24 h period prior to each trial was as follows: total 
energy intake of 12.9 ± 2.0 MJ, percentage energy derived from carbohydrate, protein 
and fat was 50 ± 6%, 17 ± 6%, and 32 ± 9%, respectively. This was equivalent to an 
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average intake of 5.5 ± 1.0 g.kg·1 body mass of carbohydrate and 1.9 ± 1.0 g.kg-I body 
mass of protein. The average VC intake was 129 ± 110 mg which is equivalent to 215 
± 183% of the current UK RDA. 
There was no difference between the VC and PLA trials for any of the variables 
related to relative physiological demand of the exercise bouts or absolute rate of 
oxygen consumption, as summarised in Table 4.1. 
Table 4.1: Exercise data: averaged over whole 2.5 h trials 
HR (beats.min- I ) 
PLA 145 (16) 
VC 144 (12) 
RPE 
PLA 13 (1) 
VC 14 (2) 
%V02max 
PLA 57.5 (4.4) 
VC 58.7 (4.1) 
"02 (l.min-I ) 
PLA 2.27 (0.31) 
VC 2.32 (0.31) 
RER 
PLA 0.88 (0.07) 
VC 0.91 (0.08) 
Values are mean (SD). 
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4.3.1 Plasma antioxidant measures and markers of oxidativc stress 
There was a main effect of trial (P < 0.001), main effect of time (P < 0.001) and trial 
x time interaction (P < 0.001) for plasma VC concentration (Figure 4.1). Plasma VC 
concentration was higher at all time points during the VC trial compared with the 
PLA trial (P = 0.014, P = 0.002, P < 0.001 and P < 0.001 for Rest, Pre-Ex, Post-Ex 
and 1 h Post-Ex, respectively). There was a trend for a main effect of time on the PLA 
trial (P = 0.057) whereas there was a significant main effect of time on the VC trial (P 
< 0.001), with plasma VC concentration significantly higher than rest at Pre-Ex (P = 
0.038) and significantly higher than Pre-Ex at both Post-Ex and 1 h Post-Ex (P < 
0.001). 
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Figure 4.1: Changes in plasma vitamin C concentration. Values are mean ± SD. 
Significantly different from Rest (* P < 0.05, ** P < 0.01), significantly different 
from Pre-Ex (t P < 0.05, ~ P < 0.01), significantly different from PLA (' P < 0.05, '11 P 
< 0.01). 
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There was a main effect of trial (P < 0.001), main effect of time (P < 0.001) and trial 
x time interaction (P = 0.005) for PAC (Figure 4.2). Resting (P = 0.007) and Post-Ex 
(P < 0.001) PAC were significantly higher in the VC trial compared with the PLA 
trial. Post-Ex PAC was significantly higher than rest in the PLA trial (P = 0.047) and 
in the VC trial (P < 0.001). 
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Figure 4.2: Changes in plasma antioxidant capacity (PAC). Values are mean ± SD. 
Significantli different from Rest (* P < 0.05, ** P < 0.01), significantly different 
fromPLA( P<0.05,1I"Ip<0.01). 
There was a significant main effect of trial (P = 0.006), time (P = 0.0\ 7) and trial x 
time interaction (P = 0.012) for plasma TBARS concentration with values 
significantly lower Post-Ex (P = 0.005) and 1 h Post-Ex (P = 0.006) in the VC trial 
compared with the PLA trial (Figure 4.3). There was a significant effect of time 
within the PLA trial (P = 0.006) with values increasing above Pre-Ex levels at Post-
Ex (P = 0.025) and 1 h Post-Ex (P = 0.002) whereas there was no time effect ( P = 
0.330) within the VC trial. Spontaneous, unstimulated CL per litre of blood (Figure 
4.4) showed a significant trial x time interaction effect (P = 0.010) but post hoc 
analysis showed no significant between trial differences although a trend for lower 
values Post-Ex on the VC trial compared with PLA trial was observed (P = 0.072). 
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There was no main effect of time within the PLA trial (P = 0.086) whereas there was 
a main effect of time within the VC trial (P = 0.025) but post hoc analysis showed no 
significant within trial differences. 
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Figure 4.3: Changes in plasma TBARS concentration. Values are mean ± SD. 
Significantly different from Pre-Ex (t p < 0.05, t P < 0.01), significantly different 
from PLA (' P < 0.05, " P < 0.01). 
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Figure 4.4: Changes in spontaneous, unstimulated CL per litre blood. Values are 
mean±SD. 
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4.3.2 Plasma cortisol and IL-6 responses 
There was no main effect of trial (P = 0.094) or trial x time interaction (P = 0.380) for 
plasma cortisol concentration (Table 4.2). There was a main effect of time (P = 0.005) 
with significant increases above Pre-Ex values at Post-Ex (P < 0.001) and I h Post-Ex 
(P = 0.017). There was no main effect of trial (P = 0.864) or trial x time interaction (P 
= 0.823) for plasma IL-6 concentration (Table 4.2). There was a main effect of time 
(P = 0.014) with significant increases above Pre-Ex values at Post-Ex (P = 0.009) and 
I h Post-Ex (P = 0.042). 
Table 4.2: Changes in plasma cortisol and IL-6 concentrations 
Rest Pre-Ex Post-Ex I h Post-Ex Main Effects 
(trial; time; 
interaction) 
Cortisol 
(nM) 
PLA nlm 
VC nlm 
IL-6 
(pg.mr') 
291 (124) 554 (115) 
292 (65) 585 (123) 
PLA 3.0 (4.6) 3.5 (5.9) 
VC 3.3 (4.6) 3.2 (4.3) 
6.9 (3.9) 
7.1 (4.5) 
Values are mean (SD). nim, not measured. 
496 (204) 
572 (186) 
8.5 (7.4) 
8.6 (4.8) 
0.094 ; 0.005 ; 0.380 
0.864; 0.014; 0.823 
4.3.3 Circulating leukocyte and neutrophil count and neutrophil function. 
There was no main effect of trial (P = 0.782) or trial x time interaction (P = 0.381) for 
total circulating leukocyte count. There was a significant main effect of time (P < 
0.001) with circulating leukocyte count at Post-Ex (P < 0.001) and I h Post-Ex (P < 
0.001) significantly higher than Rest or Pre-Ex (Figure 4.5). There was no main effect 
of trial (P = 0.908) or trial x time interaction (P = 0.570) for circulating neutrophil 
count. There was a significant main effect of time (P < 0.001) with circulating 
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neutrophil count at Post-Ex (P < 0.001) and 1 h Post-Ex (P < 0.001) significantly 
higher than Rest or Pre-Ex (Figure 4.6). 
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Figure 4.5: Changes in circulating leukocyte count. Values are mean ± SO. 
Significantly different from Rest (* P < 0.05, ** P < 0.01), significantly different 
from Pre-Ex (t P < 0.05, t P< 0.01). 
There was a significant main effect of trial (P = 0.039) and trial x time interaction (P 
= 0.008) for in vitro-stimulated CL per neutrophil (Figure 4.7). In the VC trial CL per 
neutrophil was significantly higher Post-Ex (P = 0.021) and 1 h Post-Ex (P = 0.024) 
compared with the PLA trial. There was no main effect of time within the VC trial (P 
= 0.056). There was a significant main effect of time within the PLA trial (P = 0.041) 
but post hoc analysis showed no significant within-trial differences; however, there 
was a trend for values to decrease below Pre-Ex levels at Post-Ex (P = 0.076) and 1 h 
Post-Ex (P = 0.074). 
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Figure 4.6: Changes in circulating neutrophil count. Values are mean ± SD. 
Significantly different from Rest (* P < 0.05, ** P < 0.01), significantly different 
from Pre-Ex (t p < 0.05, t P < 0.01). 
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Figure 4.7: Changes in PMA-stimulated CL per neutrophil. Values are mean ± SD. 
Significantly different from PLA (' P < 0.05). 
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4.4 Discussion 
Acute VC supplementation was effective at increasing plasma VC concentration and 
antioxidant capacity. Plasma TBARS concentration was significantly increased post-
exercise on the PLA trial but this was blunted with acute VC supplementation. 
Spontaneous CL per litre of blood showed a trend towards lower post-exercise values 
in the VC trial compared with the PLA trial. Taken together these results suggest that 
acute VC ingestion was effective at reducing exercise-induced oxidative stress. 
Acute VC supplementation had no effect on the increase in the number of circulating 
leukocytes, neutrophils, plasma cortisol and plasma IL-6 concentrations post-exercise. 
It has been shown that antioxidant supplementation can reduce the cortisol and IL-6 
response to endurance exercise when consumed daily for I week or more and VC 
alone may reduce the cortisol response. Peters et al. (200Ia, b) showed a significant 
reduction in post-exercise plasma cortisol concentration in participants that were 
supplemented with 1000-1500 mg VC daily for 7 days prior to the exercise. They 
suggested that this was related to adrenal VC mobilisation (in response to oxidative 
stress) being coupled to cortisol release. However, the findings of the present study do 
not support this. Acute VC supplementation had no effect on plasma cortisol 
concentration despite significantly reducing oxidative stress markers, compared with 
PLA, which suggests that attenuation of adrenal cortisol release by VC during 
exercise may require a longer period of supplementation. This is in contrast to the 
trend for a lower post-exercise cortisol concentration observed in study I (Chapter 3) 
with acute VC supplementation, and is in opposition to the original hypothesis. It is 
not know if the differences, between studies, in dietary VC intake between studies can 
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account for this difference but in general it would seem that attenuation of the cortisol 
response is not caused simply by increased plasma VC concentration and reduced 
general oxidative stress which agrees with Peake (2003) and the findings of Ni em an et 
al. (I 997b, 2002). In the current study there was only a trend for plasma VC 
concentration to increase during exercise on the PLA trial. However, the absolute 
increase in plasma VC concentration post-exercise (-20 IlM) is comparable with 
Peters et al. (2001 a, b) but it is not possible to determine if this was blunted with acute 
VC supplementation since VC was also provided in beverages consumed during the 
VC trial. This prevents direct comparison with the studies by Peters et al. (200Ia, b). 
There may be an important role for IL-6 in the cortisol response to exercise since IL-6 
markedly increases during prolonged exercise and can stimulate increased cortisol 
release (Steensberg et aI., 2003). Daily supplementation with mixtures of antioxidants 
(including vitamins C and E) for 4-8 weeks can reduce IL-6 release from contracting 
skeletal muscle during exercise, which may be associated with a reduction of the 
cortisol response (Fischer et aI., 2004; Vassilakopoulos et aI., 2003). Therefore, it may 
be that antioxidants actually attenuate the cortisol response to exercise by an effect on 
IL-6 release which may require a longer period of supplementation (as investigated in 
study 3, Chapter 5) and/or additional lipid soluble antioxidants such as vitamin E (as 
investigated in study 4, Chapter 6). 
The significant main effect of time and tendency for a post-exercise decrease in PMA-
stimulated CL per neutrophil in the PLA trial is in agreement with previous findings 
(Li et aI., 2004a, 2005; Nieman et aI., 1997b; Scharhag et aI., 2002). The neutrophilia 
observed post-exercise (partly caused by an influx of immature neutrophils released 
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from the bone marrow) means that a larger proportion of the blood neutrophils will be 
immature and may have an altered capacity to respond to stimulation. This is in line 
with Berkow et al. (1986) who demonstrated that immature neutrophils have lower 
activity ofNADPH oxidase and a lower capacity to produce ROS compared with fully 
matured neutrophils. There is also evidence to suggest that exercise-induced changes 
in neutrophil oxidative capacity are caused by impairment of cells which are already 
in the circulation. For example, there may be a refractory period when neutrophils are 
less able to respond to in vitro stimulation subsequent to exercise-induced activation 
(Smith et aI., 1996; Pyne et aI., 1996). Therefore, the significant main effect of time 
for PMA-stimulated CL per neutrophil on PLA in the present study could be related to 
activation ofneutrophils during the initial 1 h of exercise (Smith et aI., 1996) leading 
to a refractory state at the post-exercise time points. 
Direct oxidative damage to neutrophils and/or auto-oxidation during exercise-induced 
activation have been suggested as other potential mechanisms by which neutrophil 
function may be modulated. Robson et al. (2003) provided participants with a PLA or 
antioxidant vitamin supplement for 7 days prior toa 2 h treadmill run at 
65% V02max. They observed significantly higher (- 57%) post-exercise E.coli-
stimulated neutrophil OBA in the antioxidant supplemented trial compared with PLA 
despite there being no difference in the plasma concentrations of cortisol and glucose 
or blood leukocyte count. This suggests that oxidative damage directly to neutrophils 
contributes to exercise-induced decreases in this particular neutrophil function and 
that this may be prevented with antioxidant supplementation. The results of the 
present study support this idea but also that acute supplementation with VC alone is 
sufficient to have similar effects. In the present study the Post-Ex and I h Post-Ex 
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PMA-stimulated CL per neutrophil values were approximately 53% and 66% higher, 
respectively, in the VC compared with PLA trial, which is comparable with the results 
of Robson et al. (2003). This is not in line with Nieman et aI., (l997b; 2002) who 
suggest that oxidative stress (and consequently, VC supplementation) has little effect 
on immune changes during and after prolonged exercise but participants in those 
studies also consumed CHO which may have resulted in less physiological stress and 
immunodepression even on the PLA treatment. This implies that acute VC 
supplementation may only be beneficial in the fasted state and any minor effects are 
not additive to those with CHO, and are rather small by comparison, which agrees 
with the findings in study 1 (Chapter 3). 
In conclusion, acute VC supplementation was effective at increasing plasma 
antioxidant defence and reducing oxidative stress markers following prolonged 
exercise. This had no effect on exercise-induced changes in plasma cortisol or IL-6 
concentrations, which may require a longer period of supplementation and are not 
caused simply by an increased plasma VC concentration. This is in opposition to the 
notion that adrenal VC and cortisol are co-released during exercise in response to 
oxidative stress. Acute VC supplementation also had no effect on the exercise-
induced changes in circulating neutrophil count but their capacity to produce ROS 
upon in vitro stimulation may be enhanced with VC. Taken together, these results 
suggest that oxidative stress directly acting on neutrophils may contribute to a 
decrease in functional capacity of these immune cells following prolonged exercise. 
Acute VC supplementation may be able to counteract this oxidative stress and reduce 
any consequent decrease in neutrophil oxidative capacity. 
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CHAPTER FIVE 
Study 3: The effect of2 weeks vitamin C supplementation on immunoendocrine 
responses to 2.5 h cycling exercise. 
Abstract 
An increased systemic concentration of stress hormones (of the HPA axis) and some 
cytokines and oxidative stress may all contribute to the depression of immune cell 
function typically observed after prolonged exercise. The aim of the present study was 
to determine the effect of 2 weeks of supplementation with VC on cortisol, ACTH, 
IL-6, oxidative stress and neutrophil responses to a single bout of endurance exercise. 
Nine healthy endurance-trained males exercised for 2.5 h at - 60% V02max after 2 
weeks of PLA or VC (1000 mg.day"l) supplementation. All participants completed 
both trials utilising a randomised crossover design with a minimum 14 day washout 
period between trials. There was a significant trial x time interaction effect for plasma 
cortisol concentration (P = 0.038) which tended to be lower in the VC trial but post 
hoc analysis found no specific between trial differences. There was a significantly 
lower post·exercise neutrophilia in the VC trial, compared with the PLA trial. There 
was no trial x time interaction for measures of neutrophil function (bacteria-
stimulated elastase release, tMLP or PMA-stimulated OBA). However, there was a 
trend for higher tMLP-stimulated neutrophil OBA in the VC compared with PLA trial 
(trial x time interaction, P = 0.075). These results suggest that supplementation with 
VC for a period of up to 2 weeks provides little to no protection against the depression 
of neutrophil function that typically occurs after endurance exercise. 
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5.1 Introduction 
Although it is now well established that between I and 8 weeks of antioxidant 
supplementation may modulate the cortisol and IL-6 responses to prolonged exercise 
it remains unclear as to whether such effects are also associated with a reduction in 
the magnitude of immunodepression. Antioxidant supplementation possibly 
influences immune cell function by reducing the exercise-induced release of HP A axis 
stress hormones (Fischer et al. 2004; Peters et al. 2001a, b). Lower cortisol, IL-6, 
leukocytosis and neutrophilia responses to exercise may be associated with a smaller 
depression in immune cell (neutrophil) function. However, exercise-induced oxidative 
stress and damage directly to neutrophils may also account, in part, for a decrease of 
neutrophil function following prolonged exercise (Peters et al. 1997a, b; Robson et al. 
2003). In study 2 (Chapter 4) it was shown that acute supplementation with VC 14 h 
and 2 h prior to and during prolonged exercise was effective at blunting the fall in 
neutrophil OBA that typically follows. It is likely that this was due to reduced 
oxidative modulation directly to neutrophils since the systemic cortisol and IL-6 
responses and leukocyte and neutrophil counts were not different between trials. 
It is possible that a longer period of supplementation may have similar effects on 
reducing oxidative stress but may also blunt the cortisol, IL-6 and neutrophilia 
responses which could have additional effects on neutrophil function. Hence, the aim 
of the present study was to examine the effects of a 2-week period of oral 
supplementation with a high dose (1000 mg.day"l) of VC only, prior to a single bout 
of prolonged exercise, on markers of oxidative stress, hormones of the HPA axis 
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(plasma cortisol and ACTH concentration), plasma IL-6 concentration, and measures 
of neutrophil functional capacity. 
5.2 Methods 
5.2.1 Participants 
Nine healthy endurance trained males (age 26 ± 6 years, body mass 71.8 ± 6.5 
kg, V02max 61.6 ± 7.2 mI.kg·l.min· l, Power output at V02max 353 ± 16 W) 
participated in this study. All participants completed 4 exercise bouts; 2 preliminary 
trials (V02max determination and habituation) and 2 main trials. Preliminary trials 
were separated by at least 1 week and there was a minimum of 2 weeks washout 
between main trials. 
5.2.2 Main trials 
Participants exercised under 2 different conditions: 2 weeks of PLA or VC (1000 
mg.day'1 which was taken in 2 tablets of 500 mg, one with breakfast and one with 
their evening meal) in a single blind, randomised-crossover design. Participants. 
consumed 2.5 mI.kg·1 body mass of beverage (Iow calorie lemon flavoured squash 
with artificial sweetener) at the onset, every 15 min during, and on completion of the 
exercise bout. Participants also consumed 500 ml of water 2 h pre-exercise. 
Participants arrived at the laboratory at 09:30 following an overnight fast of at least 10 
h. Tbey were asked to empty their bladder before body mass was measured with the 
participant wearing shorts only. A resting (Rest) venous blood sample was obtained at 
10:00, immediately before beginning to cycle for 2.5 h at - 60% V02max. Expired 
gas was collected into Douglas bags (1 min sample), during the 15th, 30th, 60th, 90th 
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and l20th min of exercise, for analysis of\l02 and RER. Heart rate and RPE were 
recorded every 15 min during exercise. Further venous blood samples were taken 
immediately post-exercise (Post-Ex) and at I h post-exercise (I h Post-Ex). During 
the I h post-exercise recovery participants remained in the laboratory but were 
allowed to towel dry and change their clothes. They remained seated and were 
allowed to undertake restful activities such as reading or using a computer. 
Participants completed a food record diary for the 48 h period before the first trial 
(habituation) and were required to follow the same diet during the 48 h prior to each 
main trial. They were all non-smokers and were required to abstain from alcohol, 
caffeine and heavy exercise for 48 h prior to each trial and to have a rest day on the 
day immediately before each trial. It was also stipulated that participants should not 
take any mineral or vitamin supplement (other than those provided) or any other 
antioxidant supplements during and for the 2 weeks before the study. 
5.3 Results 
The average dietary composition for the 48 h period prior to each trial was as follows: 
total daily energy intake of 11.2 ± 1.7 MJ, percentage energy derived from 
carbohydrate, protein and fat was 59 ± 6%, 16 ± 3%, and 26 ± 6%, respectively. This 
was equivalent to an average daily intake of 5.8 ± 1.8 g.kg·1 body mass of 
carbohydrate and 1.5 ± 0.3 g.kg·1 body mass of protein. The average daily dietary VC 
intake was 74 ± 39 mg which is equivalent to 123 ± 65% the current UK RDA. There 
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was no difference between the PLA and VC trials for any of the variables related to 
physiological demand of the exercise, as summarised in Table 5.1. 
Table 5.1: Exercise data: averaged over whole 2.5 h trials 
Heart rate (beats.min· l ) 
RPE 
%V02max 
V02 (1.min-l) 
RER 
PLA 146 (10) 
145 (10) VC 
PLA 
VC 
PLA 
VC 
PLA 
VC 
PLA 
VC 
12 (1) 
12 (1) 
60.9 (2.0) 
61.4 (3.2) 
2.67 (0.18) 
2.70 (0.25) 
0.87 (0.04) 
0.86 (0.04) 
Values are mean (SD). 
5.3.1 Markers of oxidative stress and antioxidant capacity 
A main effect of time was observed for PAC (P = 0.010) which was significantly 
higher than Rest at Post-Ex (P = 0.002) and 1 h Post-Ex (P = 0.027). There was also a 
main effect of trial (P = 0.010) but no interaction indicating higher PAC in the VC 
trial (Table 5.2). A main effect of time was observed for plasma VC concentration (P 
= 0.005) which was significantly higher than Rest at Post-Ex (P = 0.014) and 1 h 
Post-Ex (P = 0.042). There was also a main effect of trial (P < 0.001) but no 
interaction indicating higher plasma VC concentration in the VC trial (Table 5.2). 
Plasma TBARS concentration was unaffected by the exercise and the temporal 
response was not influenced by the VC supplementation (Table 5.2). Spontaneous CL 
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per litre of blood was increased at Post-Ex (P = 0.02) but the temporal response was 
not influenced by the VC supplementation (Table 5.2). 
5.3.2 Plasma glucose, ACTH, cortisol and IL-6 concentrations 
Plasma glucose concentration (Table 5.3) was significantly lower than Rest at Post-Ex 
(P = 0.001) and I h Post-Ex (P < 0.001). This pattern was the same whether on the 
PLA or VC trial (trial x time interaction P = 0.136). Plasma ACTH concentration 
(Table 5.3) was significantly higher than Rest at Post-Ex (P < 0.001) but not at 1 h 
Post-Ex (P = 0.175) but there was no difference between the PLA and VC trials. 
Plasma IL-6 concentration (Table 5.3) increased post-exercise (P = 0.002) and 
remained elevated at 1 h Post-Ex (P = 0.001) but there was no difference between the 
PLA and VC trials. 
Table 5.2: Plasma VC concentration, antioxidant capacity and markers of oxidative stress. 
Plasma VC (flM) 
PLA 
VC 
PAC (flM) 
PLA 
VC 
Spontaneous CL # 
(x 103 RLU.min-'.r') 
PLA 
VC 
Plasma TBARS 
(flM) 
PLA 
VC 
Rest Post-Ex 1 h Post-Ex Main Effects P value 
(trial; time; interaction) 
47 (13) 57 (13) 52 (12) 0.000; 0.005; 0.351 
92 (20) 101 (18) 96 (18) 
595 (105) 703 (159) 638 (93) 0.010; 0.010; 0.456 
790 (207) 938 (234) 915(180) 
820 (272) 1122 (167) 1159 (483) 0.572; 0.034; 0.155 
840 (14) 996 (592) 913 (651) 
2.1 (0.5) 2.2 (0.5) 2.3 (0.3) 0.141; 0.167; 0.750 
1.8 (0.2) 2.0 (0.3) 2.0 (0.4) 
Values are means (± SD). " (n = 8) 
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There was a significant trial x time interaction effect (P = 0.038) for plasma cortisol 
concentration (Table 5.3) however, post hoc analysis found no between trial 
differences. There was a tendency for values to be lower Post-Ex (P = 0.096) and 1 h 
Post-Ex (P = 0.080) in the VC compared with the PLA trial. Furthermore, I-way 
ANOVA analysis on each trial independently revealed a main effect of time (P < 
0.001) in the PLA trial with the Post-Ex and 1 h Post-Ex values significantly 
increased (P = 0.002 and P = 0.008, respectively). In the VC trial there was also a 
main effect of time (P = 0.019) with the values significantly higher than Rest at Post-
Ex (P = 0.032) but not 1 h Post-Ex (P = 0.169). 
Table 5.3: Plasma biochemical indices before and following exercise .. 
Rest Post-Ex 1 h Post-Ex Main effects P values 
{trial; time; interaction} 
Glucose (mM) 
PLA 4.7 (0.4) 3.7 (0.8) 4.0 (0.4) 0.339; < 0.001; 0.136 
VC 4.7 (0.3) 4.0 (0.6) 4.0 (0.3) 
ACTH (pg.mr l ) 
PLA 24 (7) 185(147) 44 (32) 0.376; < 0.001; 0.119 
VC 28 (7) 117 (84) 30 (14) 
IL-6 (pg.mr l ) 
PLA 0.6 (0.4) 8.0 (4.6) 5.9 (3.5) 0.882; < 0.001; 0.875 
VC 0.6 (0.6) 7.7 (5.0) 5.7(3.3) 
Cortisol (oM) 
PLA 326 (103) 712 (230) 622 (271) 0.081; 0.001; 0.038 
VC 337 (127) 564 (210) 430 (152) 
Values are means (± SD). 
5.3.3 Circulating leukocyte number and function 
The number of circulating leukocytes and neutrophils was increased, compared with 
Rest, at Post-Ex and 1 h Post-Ex (P < 0.001). A significant trial x time interaction was 
observed for both variables (P = 0.019 and P = 0.019, respectively) (Figure 5.1 and 
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Figure 5.2). The Post-Ex (P = 0.045 and P = 0.038, respectively) and I h Post-Ex (P = 
0.032 and P = 0.024, respectively) increases were significantly smaller with VC 
compared with PLA supplementation for total leukocyte and neutrophil counts, 
respectively. 
tMLP-stimulated CL per neutrophil (Figure 5.3b) was significantly decreased at 1 h 
post-exercise (P < 0.001) but there was only a trend for a trial x time interaction (P = 
0.075). No main effects were observed for PMA-stimulated CL per neutrophil (Figure 
5.3a) but there was a trend for a main effect of time (P = 0.059). Neutrophil 
degranulation (Figure 5.4), as measured by bacteria-stimulated elastase release per 
neutrophil, was significantly decreased post-exercise (P < 0.001) and 1 h post-
exercise (P = 0.001). The temporal pattern was similar for both trials (interaction, P = 
0.575). 
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Figure 5.1: Circulating leukocyte count. Values are means (± SD). Significantly 
different from Rest <* p < 0.05; •• p < 0.01), significantly different from PLA (' P < 
0.05; TIIp < 0.01). 
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Figure 5.2: Circulating neutrophil count. Values are means (± SD). Significantly 
different from Rest <' p < 0.05; .. p < 0.01), significantly different from PLA (' P < 
0.05; TIIp < 0.01). 
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Figure 5.3: Capacity of neutrophil to generate reactive oxygen species in response to 
in vitro stimulation with (A) PMA (n = 8) and (B) fMLP (n = 7). Values are means (± 
SO). 2-way ANOVA: significantly different from Rest <* p < 0.05; •• p < 0.01). 
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Figure 5.4: Neutrophil bacteria-stimulated degranulation response. Values are means 
(± SD). Significantly different from Rest <* p < 0.05; .. p < 0.01). 
5.4 Discussion 
The main findings of the present study are that VC supplementation for 2 weeks prior 
to an acute bout of prolonged exercise (2.5 h at 60% V02max) resulted in slightly 
lower leukocytosis, neutrophilia and cortisol responses. However, there was no effect 
on plasma IL-6 or ACTH concentrations and no physiologically significant effect on 
the reduction of neutrophil functional capacity (in vitro-stimulated· OBA or 
degranulation) that typically occurs following such exercise. 
It has been shown that antioxidant supplementation can reduce the cortisol (Fischer et 
al. 2004) and IL-6 (Fischer et al. 2004; Vassilakopoulos et al. 2003) responses to 
endurance exercise when consumed daily for 1 week or more and VC alone may 
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reduce the cortisol response (Peters et al. 2001a, b). The findings of the present study 
are in line with those of Peters et al. (2001 a, b) who showed a significant reduction in 
post-exercise plasma cortisol in participants that were supplemented with 1000-1500 
mg VC daily for 7 days prior to prolonged exercise. There is also agreement with the 
findings of Fischer et al. (2004) in regard to the cortisol response, but not the IL-6 
response, to prolonged exercise. It is unlikely that adrenal cortisol and VC release 
occur together in response to oxidative stress (Peake, 2003). Therefore, a reduced 
cortisol response with prolonged, high dose VC supplementation is most likely caused 
by some other mechanism(s). According to Fischer et al. (2004) IL-6 could be 
important since its release from contracting skeletal muscle is reduced with 
antioxidant supplementation and this cytokine is known to stimulate an increase in 
systemic cortisol concentration (Steensberg et al. 2003). However, the present results 
show that when VC was supplemented alone rather than with other antioxidants there 
was a trend for lower cortisol responses but no effect on the systemic IL-6 response. 
Therefore, the present results suggest that there may be some small effects of VC on 
adrenal cortisol synthesis and/or release. This, however, appears to be independent of 
changes in plasma IL-6 concentration or oxidative stress and the precise 
mechanism(s) remains unclear. 
In fact the observations of those studies using both VC and vitamin E (Fischer et al. 
2004; Vassilakopoulos et al. 2003) may actually be caused by an additive effect of VC 
and vitamin E or be related to the fact that vitamin E is lipid soluble. This seems 
feasible because in the study by Fischer et al. (2004) there was no difference between 
the placebo and supplemented groups in IL-6 gene expression or the level of IL-6 
protein within the exercised muscle fibres. This suggests that the reduced systemic IL-
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6 concentration is a result of reduced translocation from the tissue into the circulation. 
Therefore, the site of action could well be the plasma membrane, which could explain 
the need for the lipid soluble vitamin E in addition to VC. Furthermore, in the study 
by Fischer et al. (2004) there was a larger increase of systemic IL-6 post-exercise (in 
the region 20 pg.mr l at 30 min post-exercise in the placebo group) which is where the 
greatest difference between groups was observed. The values observed at 2 h during 
exercise were similar between groups and in line with the values observed in the 
present study. Therefore, it may be that the slight methodological differences between 
that and the present study, such as duration of exercise (3 h compared with 2.5 h) or 
differences in exercise mode (reclined leg extensions compared with 'normal' 
cycling) explain the discrepancy. Furthermore, Fischer et al. (2004) observed a 
significant post-exercise increase in the marker of oxidative stress plasma F2-
isoprostane concentration. There was no evidence of a significant increase in 
oxidative stress during the exercise undertaken by participants in the present study, 
which may go some way to explaining this difference. It should also be noted that in a 
study by Nieman and colleagues (2004) 2 months of vitamin E supplementation 
actually resulted in a greater IL-6 response to prolonged exercise (with no effect on 
the cortisol response). However, the exercise undertaken in that study was extreme by 
comparison (a competitive event of approximately 12 h duration) with post-exercise 
IL-6 values more than 10-fold higher than in the present study. 
Following exercise there was a significant decrease in the bacteria-stimulated elastase 
release (degranulation) per neutrophil and tMLP-stimulated CL per neutrophil. PMA-
stimulated CL per neutrophil showed a trend towards a decrease post-exercise, 
especially in the PLA trial. These findings are in line with previous findings (Li et al. 
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2004a, 2005; Morozov et al. 2003; Nieman et al. 1997; Scharhag et al. 2002) 
suggesting that exercise decreases the killing capacity of neutrophils. Berkow et al. 
(1986) demonstrated that immature (or prematurely released) neutrophils have lower 
activity ofNADPH oxidase and a lower capacity to produce ROS compared with fully 
matured neutrophils. Therefore, since the extent of neutrophilia was greater than 
would be expected from complete demargination (Blannin, 2006) it is probable that 
the post-exercise neutrophilia· resulted in a greater proportion of circulating 
neutrophils being less mature cells from the bone marrow. This may contribute to the 
observations of post-exercise decreases in the functional capacity of neutrophils. 
Regardless of the mechanism, supplementation with VC was not effective at reducing 
the magnitude of this apparent decrease in neutrophil function. This suggests that the 
magnitude of the decreases in neutrophilia and cortisol observed in the present study, 
with VC supplementation, are not great enough to have a significant physiological 
effect on the actual capacity of neutrophils to respond to stimulation. However, it is 
worthy of note that there was a tendency for tMLP-stimulated CL to be higher post-
exercise in the VC trial (P = 0.075 for trial x time interaction effect) and that there 
was only n = 7 for this measure owing to problems with the assay which must be 
performed on fresh (diluted) whole blood. Robson et al. (2003) observed that 7 days 
of supplementation with antioxidants (18 mg Il-carotene, 900 mg VC and 90 mg 
vitamin E) prior to a 2 h treadmill run at 65% V02max significantly enhanced post-
exercise neutrophil OBA, compared with placebo, even though there was no effect on 
leukocyte count or plasma cortisol concentration. This suggests that there may be a 
direct effect on neutrophils, maybe by reducing (auto)oxidative damage or 
modification. The trend for a blunted decrease in tMLP-stimulated CL (but lack of 
88 
Chapter 5 2 weeks VC supplementation 
effect with PMA-stimulated CL), in the present study, in the VC trial also support this 
idea as receptor-dependent activation (fMLP-stimulated) may be more sensitive to 
oxidative modification than receptor-independent activation (PMA-stimulated) 
because the receptors are more likely to be exposed to external damage by ROS. This 
would suggest that greater effects might have been evident if the magnitude of 
oxidative stress experienced by the current participants was greater. However, there 
was no trial x time interaction effect for bacteria-stimulated neutrophil degranulation 
(requiring receptor-dependent activation) which does not support this contention. It is 
worthy of note that in the Robson et aI. (2003) study, supplements were also taken 
acutely before exercise so the beneficial effects seen in that study may also be due to 
the antioxidant acute effects. It is also possible, therefore, that greater effects would 
have been observed in the present study if VC was also provided acutely before and 
during exercise (as in Study 2). 
In conclusion, 2 weeks of supplementation with 1000 mg per day of VC was effective 
at increasing antioxidant defence, modulating the leukocytosis and neutrophilia 
responses and possibly had some small effects on the plasma cortisol response. 
However, there was no effect on plasma ACTH or IL-6 concentrations. This suggests 
that there may be some direct effect on the adrenal glands from the VC 
supplementation, possibly via the mechanisms suggested by Peake (2003). 
Nonetheless, there was no physiologically significant effect on the measures of 
neutrophil functional capacity. This suggests that supplementation with VC alone for 
a period of up to 2 weeks provides very limited, or no protection against the 
depression of neutrophil function that is typically observed after prolonged exercise. 
However, the magnitude of oxidative stress experienced by participants was relatively 
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modest in the present study. It may be possible that there would be greater decreases 
in neutrophil function under conditions of greater physical and/or oxidative stress, the 
magnitude of which could be blunted to a relatively greater degree with VC 
supplementation and further research is required to clarify this. 
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CHAPTER SIX 
Study 4: The effect of 4 weeks of antioxidant vitamin supplementation on 
immunoendocrine responses to 2.5 h cycling exercise. 
Abstract 
Antioxidant supplementation may modulate systemic cortisol and IL-6 responses to 
prolonged exercise but it is unclear if such effects are also associated with a reduction 
in the magnitude of immunodepression. The aim of the present study was to examine 
the effects of daily VC (1000 mg.day"i) and vitamin E (400 IU.day"i) supplementation 
on immunoendocrine responses to prolonged exercise. Twenty healthy males cycled 
for 2.5 h at - 60% V02max after 4 weeks of PLA (n = 10) or antioxidant (AO, n = 
10) supplementation. A significant group x time interaction was observed for plasma 
cortisol concentration (P = 0.008) and the post-exercise increase was greater (P < 
0.050) in the PLA compared with AO group (- 170% compared with - 120% increase 
above pre-exercise). Plasma IL-6 concentration was significantly increased post-
exercise (P < 0.001) to a similar extent in both groups. Blood neutrophil count was 
significantly increased - 4-fold post-exercise (P < 0.001) and in vitro bacteria-
stimulated elastase release per neutrophil was significantly decreased (P < 0.001) to a 
similar extent in both groups. These results suggest that 4 weeks of AO 
supplementation may blunt the cortisol response to a single bout of prolonged 
exercise independent of changes in oxidative stress or plasma IL-6 concentration but 
is not effective at modulating the exercise-induced neutrophilia or depression of 
neutrophil function. It is possible that greater IL-6 responses are required in order for 
AO supplementation to modulate IL-6 and immune function changes with exercise. 
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6.1 Introduction 
There is convincing evidence showing that daily supplementation with a mixture of 
antioxidants for up to 8 weeks can significantly reduce the cortisol and IL-6 responses 
to prolonged exercise (Fischer et al. 2004; Peters et aI., 2001a, b; Vassilakopoulos et 
al. 2003). However, it remains unclear as to whether such effects are also associated 
with a reduction in the magnitude of immunodepression. In study 3 (Chapter 5) it was 
demonstrated that 2 weeks of supplementation with VC (alone rather than with other 
antioxidants) resulted in significantly lower leukocytosis and neutrophilia responses 
and a trend for a lower cortisol response following prolonged exercise. However, 
there was no effect on the systemic IL-6 response and no significant effect on 
neutrophil function. The observations of reduced IL-6 responses in studies using both 
VC and vitamin E (Fischer et al. 2004; Vassilakopoulos et al. 2003) may actually be 
caused by an additive effect of VC and vitamin E or be related to the fact that vitamin 
E is lipid soluble. For example, the reduced systemic IL-6 concentration may actually 
result from reduced translocation from the tissue into the circulation (Fischer et aI., 
2004) so the site of action could well be the plasma membrane, which would explain 
the need for the lipid soluble vitamin E in addition to VC. It is possible that greater 
(than those observed in study 3) modulation of the cortisol and neutrophilia responses 
are required in order for antioxidant supplementation to alter neutrophil function 
changes with exercise. A reduced systemic IL-6 response may contribute to greater 
blunting of the cortisol and neutrophilia responses as suggested by Fischer et al. 
(2004). Therefore, the aim ofthe present study was to examine the effects of a 4-week 
period of oral supplementation with antioxidant vitamins (VC, 1000 mg.daiI and 
vitamin E, 400 IU.daiI) prior to a single bout of prolonged exercise, on markers of 
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oxidative stress, hormones of the HP A axis (plasma cortisol and ACTH 
concentration), plasma IL-6 concentration, and neutrophil functional capacity. 
6.2 Methods 
6.2.1 Participants 
Twenty healthy men (age 23 ± 3 years, body mass 71.7 ± 9.3 kg, V02max 55.3 ± 10.4 
ml.kg-'.min-', power output at V02max 294 ± 50 W) participated in this study. They 
were randomly assigned to I of2 groups, either PLA supplementation (n = 10) or AO 
supplementation (n = 10). Participant characteristics for the 2 groups independently 
are listed in Table 6.1. Participants in the AO group received oral supplementation 
with VC (1000 mg.day"') and vitamin E (as RRR-a-tocopherol, 400 IU.day"') whereas 
the PLA group received a placebo containing calcium carbonate (267 mg.day-') and 
dextrose for 28 days. The supplement or placebo was taken in 2 equal doses per day, I 
with breakfast and I with the evening meal. All participants completed 3 exercise 
bouts; 2 preliminary trials (V02max determination and habituation) and a main trial. 
Trials were separated by at least I week. 
6.2.2 Main trials 
Participants were instructed to consume 500 ml of water 2 h pre-exercise before 
arrival at the laboratory at 09:30, on the morning of the main trial. They arrived at the 
laboratory at 09:30 following an overnight fast of at least 10 h. They were asked to 
empty their bladder before body mass was measured with the participant wearing 
shorts only. They sat quietly in the laboratory before beginning exercise at 10:00 for 
2.5 h at an intensity of - 60% V02max. Expired gas was collected into Douglas bags 
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during the 15th, 30th, 60th, 90th and 120th min of exercise, for analysis ofVOz and RER. 
Heart rate and RPE were recorded every 15 min during exercise. Participants were 
given 2.5 mLkg·1 body mass of a beverage every 15 min as described previously for 
the habituation trial. An initial baseline venous blood sample was taken, after an 
ovemight fast, before beginning the supplementation period. Further venous blood 
samples were taken immediately before beginning the 2.5 h exercise bout (Pre-Ex), 
immediately post-exercise (Post-Ex) and at 1 h post-exercise (1 h Post-Ex). During 
the 1 h post-exercise recovery participants remained in the laboratory but were 
allowed to towel dry and change their clothes. They remained seated and were 
allowed to undertake restful activities such as reading or using a computer. 
Participants completed a food record diary for the 48 h period before the main trial to 
allow dietary analysis. They were all non-smokers and were required to abstain from 
alcohol, caffeine and heavy exercise for 48 h prior to the main trial and to have a rest 
day on the day immediately before the trial. It was also stipulated that participants 
should not take any mineral or vitamin supplement (other than those provided) or any 
other antioxidant supplements during and for the 4 weeks before the study. 
6.3 Results 
There was no difference between groups' demographic data or dietary composition 
during the 48 h prior to the main trial or relative and absolute exercise intensity during 
the main trial (Table 6.1 and Table 6.2). However, retrospectively, the mean body 
mass and VOzmax values of the groups do not look ideally matched. The relatively 
high mean body mass, and low mean VOzmax, of the AO group (compared with the 
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PLA group) is due mainly to I individual with a body mass of98.5 kg (and V02max 
of 47.9 ml.kg·l.min-I). Without this individual the means are 72.1 ± 8.0 kg and 54.4 ± 
7.8 ml.kg-I.min-I for body mass and V02max, respectively, in the AO group. 
Furthermore, the PLA group contained I relatively light individual (61.1 kg) with a 
very high V02max (77.6 ml.kg-l.min·I). Without this individual the means are 69.4 ± 
5.9 kg and 54.6 ± 11.3 ml.kg-I.min-I for body mass and V02max, respectively, in the 
PLA group. Both of these participants had similar responses to the rest of their group 
(PLA or AO) and so were included in all data analysis. 
Table 6.1: Participant characteristics and exercise data. 
PLA group AO group 
Age (years) 23 (3) 22 (3) 
Body mass (kg) 68.6 (6.1) 74.7 (11.2) 
V02max (l.min-I) 3.8 (0.6) 4.0 (0.7) 
V02max (mI.kg"l.min-l) 56.9 (12.9) 53.7 (7.7) 
Peak Power (W) 291 (48) 298 (54) 
During main trial 
HR (beats.min-I) 144 (12) 146 (10) 
RPE I3 (1) I3 (2) 
V02 (l.min-I) 2.26 (0.36) . 2.27 (0.33) 
% V02max 58.7 (3.1) 57.2 (3.1) 
RER 0.89 (0.04) 0.91 (0.04) 
Values are mean (SD). 
6.3.1 Markers of oxidative stress and plasma antioxidant capacity 
Plasma free F2-isoprostane concentration (Table 6.3) was significantly increased post-
exercise (P < 0.001) and 1 h post-exercise (P = 0.002) but there was no difference 
between the PLA and AO groups (interaction P = 0.740). A significant group x time 
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interaction was observed (P = 0.023) for plasma TBARS concentration and there was 
a significant main effect of group (P = 0.008). Plasma TBARS concentration was 
significantly lower than Pre-Ex at Post-Ex (P = 0.003) and I h Post-Ex (P = 0.024) in 
the AO compared with PLA group. Furthermore, I-way ANOV A on each trial 
independently showed that there was no effect of time (P = 0.088) for plasma TBARS 
concentration in the PLA group whereas there was a significant decrease below Pre-
Ex values in the AO group Post-Ex (P = 0.014) but not 1 h Post-Ex (P = 0.086). 
Table 6.2: Dietary composition during the 48 h prior to the main trial. 
PLA group AO group 
Total Energy (MJ) 12.8 (1.8) 14.2 (4.0) 
Total Energy 
(MJ.kgol body mass) 
Percentage derived from: 
Carbohydrate 
Fat 
Protein 
Carbohydrate 
(g.kg body massol.dayOI) 
Protein 
(g.kg body massol.day"l) 
VitaminC 
(mg.dayOI) 
Vitamin E (mg.day"l) 
Water (l.day"l) 
Values are mean (SD). 
0.19 (0.02) 0.18 (0.01) 
54 (11) 57 (8) 
29 (7) 28 (8) 
17 (6) 15 (6) 
6.1 (1.3) 6.7 (2.5) 
1.8 (0.7) 1.7 (0.6) 
99 (52) 95 (68) 
9.9 (5.0) 10.4 (5.2) 
2.6 (0.6) 2.2 (0.9) 
There were significant main effects of group (P = 0.002) and time (P = 0.012) for 
plasma VC concentration (Figure 6.1) but only a trend for a group x time interaction 
(P = 0.056). However, I-way ANOV A on each trial individually revealed no effect of 
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time in the PLA group (P = 00407) whereas in the AO group there was a significant 
increase above baseline after the 4-week supplementation period (P = 0.018) and a 
further increase above Pre-Ex values at Post-Ex (P = 0.034) and I h Post-Ex (P = 
0.042). PAC (Figure 6.2) was not significantly affected by the supplementation 
(interaction P = 0.771, main effect of group P = 0.232) and did not change 
significantly over time in either group (P = 0.506). 
Table 6.3: Plasma biochemical indices before and following exercise. 
Main Effects P values 
Baseline Pre·Ex Post-Ex I h Post·Ex (trial; time; interaction} 
ACTH 
(pg.ml-I) 
PLA 20 (7) 20 (7) 68 (34) 33 (23) 0.179; < 0.001 ; 0.077 
AO 28 (18) 24 (10) 46 (32) 20 (16) 
IL-6 
(pg.ml·l) 
PLA nlm 1.2 (0.3) 5.4 (2.8) 4.9 (2.0) 0.250 ; < 0.001 ; 0.167 
AO nlm 1.6 (0.6) 4.0 (1.8) 3.7 (1.6) 
F2-isprostane 
(pg.ml-l) 
PLA nlm 11.2 (5.5) 22.3 (11.3) 18.3 (7.9) 0.609; 0.001 ; 0.740 
AO nlm 10.6 (11.9) 23.3 (17.3) 22.2 (12.6) 
TBARS 
(flM) 
PLA 2.19 (0.79) 2.41 (1.09) 2.69 (0.93) 2.61 (1.00) 0.008 ; 0.729; 0.023 
AO 2.42 (0.93) 2.24 (0.90) 1.48 (0.51) 1.71 (0.44) 
Values are mean (SD). nim, not measured. 
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6.3.2 Plasma ACTH, cortisol and IL-6 concentrations 
Plasma ACTH concentration (Table 6.3) was significantly higher than Pre-Ex at Post-
Ex (P < 0.001) but not I h post-exercise (P = 0.628); there was a trend for the 
temporal pattern to be different between the PLA and AO groups (interaction P = 
0.077). There was a significant trial x time interaction effect for plasma cortisol 
concentration (Figure 6.3) (P = 0.008) with the increase above Pre-Ex significantly 
greater in the PLA group compared with the AO group at Post-Ex (P = 0.042) and 1 h 
Post-Ex (P = 0.038). Furthermore, I-way ANOV A analysis on each trial 
independently revealed a main effect of time (P < 0.001) in the PLA trial with the 
Post-Ex and 1 h Post-Ex values significantly increased above Pre-Ex (P < 0.001 and P 
= 0.002, respectively) whereas the main effect of time in the AO trial was not 
significant (P = 0.394). Plasma IL-6 concentration (Table 6.3) was significantly 
increased Post-Ex (P < 0.001) and 1 h Post-Ex (P < 0.001) and the temporal pattern 
was not different between the PLA and AO groups (interaction P = 0.167) . 
140 
120 
~ 
:;; 
-5 lOO 
= 
.!: 
-;; 
"- 80 
-= ..u 
= Q 
u 60 U , 
" e 40 ~ 
" 0:: 
20 
0 
IOPLAI 
.AO 
Baseline Pre-Ex 
• 
Post-Ex 
•• 
I 
Ih Post Ex 
Figure 6.1: Plasma vitamin C concentration. Values are means (± SD). 2-way ANOVA: 
significantly different from Baseline (* p < 0.05; •• P < 0.01). 
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Figure 6.2: Plasma antioxidant capacity. Values are means (± SO). 
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Figure 6.3: Plasma cortisol concentration. Values are means (± SO). Significantly 
different from Pre-Ex (t p < 0.05; t p < 0.01), significantly different from PLA (11 P < 
0.05). 
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6.3.3 Circulating leukocyte number and function 
Circulating leukocyte count (Figure 6.4) was significantly increased Post-Ex (P < 
0.001) and I h Post-Ex (P < 0.001) and the temporal pattern was not different 
between the PLA and AO groups (interaction P = 0.441). Similarly, circulating 
neutrophil count (Figure 6.5) was significantly increased Post-Ex (P < 0.001) and I h 
Post-Ex (P < 0.001) and the temporal pattern was not difference between the PLA and 
AO groups (interaction P = 0.459). There was a significant decrease in the amount of 
elastase released per neutrophil in response to in vitro bacteria-stimulation following 
exercise (Figure 6.6) in both groups (P < 0.001). There was no difference, between 
groups, in this response (interaction P = 0.423). 
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Figure 6.4: Circulating leukocyte count. Values are means (± SD). 2-way ANOVA: 
significantly different from Pre-Ex (t p < 0.05; t P < 0.01). 
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Figure 6.5: Circulating neutrophil count. Values are means (± SD). 2-way ANOVA: 
significantly different from Pre-Ex (t p < 0.05; t p < 0.01). 
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Figure 6.6: Circulating neutrophil function: in vitro stimulated elastase release. Values 
are means (± SD). 2-way ANOV A: significantly different from Pre-Ex (t p < 0.05; t P < 
0.01). 
101 
Chapter 6 4 weeks AO vitamin supplementation 
6.4 Discussion 
The main findings of this study are that 4 weeks of mixed antioxidant vitamin 
supplementation may blunt the cortisol response to a single bout of prolonged 
exercise independently of changes in oxidative stress or plasma IL-6 concentration. 
However, there were no significant effects on total leukocyte or neutrophil trafficking 
and it was not effective at modulating the reduction of neutrophil function following 
prolonged cycling. 
The findings from the present study are in line with the suggestion of Peake (2003) 
that adrenal cortisol and VC release do not occur together (co-release) in response to 
oxidative stress. Given the significantly blunted cortisol response with antioxidant 
supplementation it is possible that there are some direct effects upon the HP A axis, 
and it has been suggested that this occurs at the level of the adrenal glands (Peake, 
2003; Peters et aI., 200Ia, b). However, the observation of a trend for a blunted 
ACTH response in the AO compared with PLA group in the present study suggests 
that there may also be some effects elsewhere upon the HP A axis, possibly at the level 
of the hypo thalamus or the anterior pituitary gland. 
The results from the present study agree with Peters et al. (200 I a, b) and Fischer et al. 
(2004), with regard to the plasma cortisol response but they are not in line with the 
studies of Fischer et al. (2004) or Vassilakopoulos et al. (2003) with regard to the 
systemic IL-6 response. Fischer et al. (2004) demonstrated that IL-6 release from 
contracting skeletal muscle is reduced with antioxidant supplementation probably by 
reducing its translocation from active skeletal muscle tissue into the circulation. In 
study 3 (Chapter 5) it was speculated that this may result from vitamin E exerting an 
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effect in the lipid milieu and somehow interfering with cellular membrane transport 
mechanisms and reducing translocation out of the muscle fibres. The present results 
do not support this idea because there was no effect on plasma IL-6 concentration 
despite the inclusion of vitamin E in the AO supplement. However, it is possible that 
greater IL-6 responses are required (as observed with the longer exercise protocol 
used by Fischer et al. 2004) in order for AO supplementation to modulate IL-6 (and 
immune function) changes with exercise. For example, in the study by Fischer et al. 
(2004) there was a greater post-exercise increase in systemic IL-6 in the PLA 
treatment group; to - 16 pg.mr l immediately post-exercise (3 h) and - 20 pg.mr l 30 
min post-exercise and there was only a difference between groups at the latter time 
point. The post-exercise increase in plasma IL-6 concentration was less marked in the 
present study and, unlike other studies (Fischer et aI., 2004; Vassilakopoulos et aI., 
2003), did not continue to increase in the I h following exercise. Furthermore, in 
these studies untrained participants were used and the mode of exercise (reclined leg 
extensions) employed by Fischer et a\. (2004) was not typical of the normal training 
regime of most athletes. Therefore, methodological variations may account for some 
of the different observations between studies. It should also be noted that in a study by 
Nieman et al. (2004) 2 months of vitamin E supplementation actually resulted in a 
greater IL-6 response to prolonged exercise (with no effect on the cortisol response). 
However, the exercise undertaken in that study was extreme by comparison (a 
competitive event of approximately 12 h duration) with mean post-exercise plasma 
IL-6 concentrations more than 12-fold higher than in the present study. However, 
although Nieman et al. (2004) reported no statistically significant effect on the 
cortisol response with vitamin E supplementation, closer examination of the results 
show that there may be some agreement with the present study. For example, the 
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plasma cortisol concentration rose from 570 nM pre-exercise to 1300 nM post-
exercise in the vitamin E group whereas it rose from 270 nM pre-exercise to 2227 nM 
post-exercise in the placebo group (the ANOV A interaction P value was 0.100). 
The marker of lipid peroxidation, plasma TBARS concentration tended to be lower 
and actually decreased post-exercise in the AO group. This is consistent with the 
findings of Watson et al. (2005) who observed decreased plasma F2-isoprostane 
concentration following exhaustive exercise in participants that were allowed to 
consume their 'normal' high-antioxidant diet. Watson et al. (2005) suggest that this 
finding may be related to an increased post-exercise plasma antioxidant capacity. 
They also observed lower post-exercise values in the normallhigh compared with 
restricted antioxidant diets (which were followed for 2 weeks). However, in the 
present study there was no evidence of a post-exercise increase in either plasma total 
antioxidant capacity or VC concentration in the PLA trial. Furthermore, the TBARS 
results in the present study are not in line with the plasma free F2-isoprostane results 
in this study which show a post-exercise increase that was unaffected by AO 
supplementation. This highlights the inherent problems associated with the TBARS 
assay which has been criticised for a lack of specificity (Vollaard et aI., 2005) and 
demonstrates the need for a number of measures of oxidative stress. In the study by 
Watson et al. (2005) there was no increase in oxidative stress markers when 
participants were following their normal habitual diet which was high in antioxidants. 
In the present study the lack of effect of AO supplementation on the free Fr 
isoprostane responses may be related to the high habitual intake of antioxidant 
vitamins by participants (i.e. the average daily intake during the 48 h prior to the main 
exercise trial was - 100 mg of VC and - 10 mg of vitamin E, Table 6.2) meaning that 
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intra- and extra-cellular compartments may have already been saturated in both 
groups before any supplementation was provided. Furthermore, although plasma VC 
concentration was significantly increased following the supplementation period in the 
AO group, the total plasma antioxidant capacity was not significantly changed, 
suggesting that the actual total plasma potential to counteract oxidative stress was not 
different between groups. 
The AO supplementation in the present study was not effective at modulating 
prolonged exercise-induced neutrophilia or depression of neutrophil function. This is 
in line with the findings of study 3 (Chapter 5) in which 2 weeks of VC 
supplementation tended to reduce the cortisol response to prolonged exercise without 
any significant effects on the changes in neutrophil function. This agrees with the 
findings of Walsh et al. (2000) which suggest that cortisol does not have a direct 
inhibitory effect on neutrophil degranulation. In that study cortisol was increased in 
vitro (to match typical increases resulting from prolonged exercise) and there was no 
effect on the bacteria-stimulated degranulation response of neutrophils. Taken 
together, these results highlight the multifaceted nature of exercised-induced 
immunodepression and suggest that the decrease in neutrophil function is not caused 
simply by a direct inhibitory effect of cortisol. 
Robson et al. (2003) demonstrated that the decrease of neutrophil function (measured 
by in vitro stimulated OBA) following prolonged exercise was reduced to a smaller 
degree when athletes were supplemented with an antioxidant mixture, as opposed to 
PLA, for the 7 days prior. Furthermore, in study 2 (Chapter 4) a similar effect was 
observed when VC was supplemented acutely on the day of and night before exercise. 
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Therefore, it may be that a shorter period of supplementation (I day or less) is more 
beneficial by protecting neutrophils from (auto )oxidative damage or modification. 
The same benefit may not occur with longer duration supplementation periods (2 
weeks or more) because it is likely that the natural endogenous antioxidant defences 
are down-regulated in response/adaptation to the higher intake of exogenous 
antioxidant compounds so that total antioxidant capacity is maintained fairly constant 
(Collins, 2005; Powers, 2004). McAnulty et al. (2005) showed that 2 months of 
vitamin E supplementation significantly increased plasma alpha-tocopherol 
concentration without significantly affecting plasma Ferric Reducing Antioxidant 
Power (FRAP). This notion is supported in the present study since there was a clear 
increase in plasma VC concentration in the AO group but the increase of total PAC 
was less marked and not statistically significant. However, if antioxidants were also 
supplemented acutely before and during exercise in the present study, it is possible 
that there would have been and acute increase in plasma antioxidant capacity and 
which would possible protect against the reduction of neutrophil function as observed 
in study 2 (Chapter 4). 
In conclusion, supplementation with high doses of the antioxidant vitamins C and E 
for 4 weeks prior to a single bout of prolonged cycling modulates the cortisol 
response but does not affect the IL-6 response, oxidative stress, or immune 
perturbations that typically follow. It is possible that shorter periods of AO 
supplementation and/or greater IL-6 responses are required in order for AO 
supplementation to modulate IL-6 and immune function changes with exercise but 
this requires further investigation. 
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CHAPTER SEVEN 
Study 5: The effect of acute pre-exercise dark chocolate consumption on 
hormonal, IL-6 and neutrophil responses to prolonged exercise. 
Abstract 
Acute antioxidant supplementation may modulate oxidative stress and some immune 
responses to prolonged exercise. The aims of the present study were to examine the 
effects of acutely consuming dark chocolate (high in polyphenols) on plasma 
antioxidant capacity, markers of oxidative stress, and immunoendocrine responses to 
prolonged exercise. A secondary aim was to compare these responses in the fed 
compared with the fasted state. Fourteen healthy males cycled for 2.5 h at -
60% VOzmax 2 h after the ingestion of 100 g dark chocolate (DC trial), iso-
carbohydrate and iso-fat white chocolate (WC trial) or neither (CON trial). Plasma 
insulin concentration decreased post-exercise but was significantly higher pre-
exercise (P = 0.006) and 1 h Post-Ex (P = 0.025) in the DC compared with WC trial. 
There appeared to be a better maintenance of plasma glucose concentration on the DC 
. trial (trial x time interaction P = 0.007). DC enhanced antioxidant status but the 
marker of oxidative stress, plasma free Fz-isoprostane concentration, was increased 
following exercise to a similar extend in all trials (trial x interaction P = 0.087). There 
were no between trial differences in the temporal responses of immunoendocrine 
measures (plasma HP A axis stress honnones and IL-6 concentrations, leukocytosis, 
neutrophilia and neutrophil function). In conclusion, acute DC consumption may 
affect insulin, glucose and antioxidant responses but not oxidative stress or 
immunoendocrine responses to prolonged exercise. It is possible that a larger dosage 
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or longer term consumption of polyphenols are required in order to modulate 
oxidative stress and immune function changes with prolonged exercise. 
7.1 Introduction 
Supplementation with dietary antioxidants has proved effective in a number of studies 
(Alessio et aI., 1997; Ashton et aI., 1999; Fischer et aI., 2004; Mastaloudis et aI., 
2004; Morillas-Ruiz et aI., 2005, 2006) at reducing the magnitude of exercise-
induced oxidative stress. There has been a great deal of interest in recent research 
literature into the potential beneficial effects of cocoa because of the potent 
antioxidant properties of polyphenols, of which cocoa is an abundant source. 
Polyphenols are amphipathic (they exert their antioxidant effects in both lipid and 
water milieu) and therefore may spare both lipophilic and hydrophilic endogenous 
antioxidants. Kondo et aI. (1996) observed that following the consumption of 35 g of 
delipidated cocoa there was a decrease in plasma low density lipoprotein (LDL) 
susceptibility to oxidation. However, there are limited studies investigating the 
potential of cocoa containing foods to modulate exercise-induced oxidative stress. In 
2 recent studies, when a high phenolic content antioxidant beverage (Morillas-Ruiz et 
al. 2005) or a polyphenol containing sports drink (Morillas-Ruiz et aI. 2006) were 
consumed shortly before submaximal aerobic exercise (90 min duration) the 
magnitude of exercise-induced oxidative stress was significantly reduced. Other 
studies have showed beneficial effects of chronic cocoa or dark chocolate 
consumption, in healthy participants, (usually consumption of - 100g of dark 
chocolate per day for 2 weeks or more) on resting blood pressure and insulin 
sensitivity (Grassi et al., 2005) or on cholesterol profile (increased high density 
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lipoprotein (HDL) concentration and decreased susceptibility of LDL to ex vivo 
oxidation), (Mursu et aI., 2004). Polyphenols have also been shown to interfere with 
glucose transport via GLUT 1 and GLUT 4 transporters (Strobel et aI., 2005) and it 
has been demonstrated that polyphenols (especially epigallocatechin gallate and 
epicatechin gallate) enhance insulin activity in vitro in the insulin-potentiating 
epididymal fat-cell assay with rat adipocytes (Anderson et ai, 2002). There is limited 
information however, on the effects of polyphenols on hormone, cytokine and 
immune responses to exercise. 
It was demonstrated in study 2 (Chapter 4) that acute antioxidant (VC) 
supplementation is associated with a reduction in the magnitude of neutrophil 
function depression, possibly by reducing oxidative damage or modulation directly to 
these cells. However, there is currently no available literature on the effects of acute 
dark chocolate consumption on oxidative stress and immunoendocrine responses 
following prolonged (> 2 h duration) exercise. Hence, the aims of the present study 
were to examine the effects of consuming a single dose of dark compared with white 
chocolate 2 h before prolonged exercise on plasma antioxidant capacity, markers of 
oxidative stress, and immunoendocrine responses. A secondary objective was to 
compare the immunoendocrine responses to prolonged exercise in the fed (white 
chocolate) compared with the fasted state (CON trial). 
7.2 Methods 
7.2.1 Participants 
Fourteen healthy men (age 22 ± 3 years, body mass 71.6 ± 5.9 kg, V02max 53.1 ± 7.3 
ml.kg".min", power output at V02max 300 ± 44 W) participated in this study. All 
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participants completed 5 exercise bouts; 2 preliminary trials (VOzmax determination 
and habituation) and 3 main trials. All trials were separated by I week. 
7.2.2 Main trials 
Participants exercised under 3 different conditions: CON trial, DC trial or WC trial in 
a randomised-counterbalanced manner. They arrived at the laboratory at 08:30 on the 
morning of the main trials after an overnight fast (> 10 h). They were asked to empty 
their bladder before body mass was measured with the participant wearing shorts 
only. Participants consumed the chocolate (or nothing in the CON trial) along with 
200 ml of water at - 09:00, 2 h prior to beginning exercise. After consuming the 
chocolate they sat quietly in the laboratory (and were allowed to read or use a 
computer) before beginning exercise at - 11 :00 for 2.5 h at an intensity of -
60% VOzmax. Expired gas was collected into Douglas bags during the 15t\ 30th, 60th, 
90th and 120th min of exercise, for analysis ofVOz and RER. Heart rate and RPE were 
recorded every 15 min during exercise. Participants were given 2.5 ml.kil body mass 
of a water every 15 min as described previously for the habituation trial. Venous 
blood samples were taken before chocolate consumption (Rest), immediately before 
beginning exercise (Pre-Ex), immediately after completing the bout (Post-Ex) and 
after 1 h of recovery (1 h Post-Ex). During the 1 h post-exercise recovery participants 
remained in the laboratory but were allowed to towel dry and change their clothes. 
They remained seated and were allowed to undertake restful activities such as reading 
or using a computer. 
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Participants completed a food record diary for the 48 h period before the first trial 
(habituation) and were required to follow the same diet during the 48 h prior to each 
main trial. They were all non-smokers and were required to abstain from alcohol, 
caffeine and heavy exercise for 48 h prior to each trial and to have a rest day on the 
day immediately before each trial. It was also stipulated that participants should not 
take any mineral or vitamin supplement or any other antioxidant supplements during 
and for the 4 weeks before the study. Participants were provided with a food 
exclusion list to ensure that they avoided high polyphenol containing foods for the 48 
h before each main trial (appendix 3). 
Pre-exercise chocolate consumption. The order in which each participant undertook 
each condition (DC, WC or CON trials) was randomised and counterbalanced using a 
basic Latin Squares design. There are 6 different possible sequences in which the DC, 
WC and CON trials could be undertaken. Participants were assigned randomly into 
each of the possible sequences resulting in 2 participants in each of the possible 
sequences. Since there were 14 participants 2 out of the 6 sequences each had an 
additional participant. 
Blinding. It was not possible to blind participants from the trial order as the dark and 
white chocolates were different in appearance, taste and mouth feel. However, 
participants consumed the chocolate or water only (CON trial) supervised by an 
independent non-interested party in a separate room and the investigators were 
blinded until after completion of the study. Moreover, participants were not told until 
after the study was complete which was the treatment chocolate, just that the aims of 
the study were concerned with the effects of' different' types of chocolate. 
111 
Chapter 7 Acute dark chocolate consumption 
Chocolate composition. The dark chocolate was a typical commercial 68% cocoa 
product containing the ingredients cocoa liquor, sugar, cocoa butter, milk fat, lecithin 
and vanilla. The dark chocolate (100 g) had a total energy content of - 2.2 MJ (- 1.67 
MJ from fat and - 0.35 MJ from carbohydrate, glycaemic index (Gl) - 22) with 
68.1 % cocoa liquor as the active ingredient. The white chocolate was as closely 
matched as possible in terms of total energy, fat and carbohydrate content. The white 
chocolate (71 g) contained all of the same ingredients except the cocoa liquor (0%). 
The energy content of the white chocolate was - 2.0 MJ (- 1.55 MJ from fat and-
0.40 MJ from carbohydrate, Gl - 44). 
7.3 Results 
The average dietary composition for the 48 h period prior to each main trial was as 
follows: total energy intake of 11.6 ± 1.8 MJ, percentage energy derived from 
carbohydrate, protein and fat was 56 ± 9%, 15 ± 4%, and 28 ± 9%, respectively. This 
was equivalent to an average intake of 5.8 ± 1.7 g.kg"l body mass of carbohydrate and 
1.5 ± 0.3 g.kg·1 body mass of protein. The average daily dietary vitamin A, VC and 
vitamin E intake was 571 ± 401 J.lg, 69 ± 57 mg and 8.8 ± 5.1 mg, respectively. This 
is equivalent to 72 ± 50%, 113 ± 95%, and 85 ± 51% of the current UK RDA, 
respectively. There was no difference between trials for any of the variables related to 
physiological demand of the exercise as summarised in Table 7.1, however, it should 
be noted that the RER values appear exceptionally high for such exercise. 
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Table 7.1: Exercise data: averaged over the whole 2.5 h trials. 
DC WC CON 
Heart rate (beats.min- I ) 143 (15) 143 (15) 140 (13) 
RPE 12 (1) 12 (1) 12 (1) 
% VOzmaxmax 56.8 (3.5) 57.7 (3.7) 56.2 (3.5) 
RER 0.94 (0.07) 0.93 (0.04) 0_93 (0.07) 
Values are mean (SD). 
7.3.1 Markers of oxidative stress and antioxidant capacity 
A significant trial x time interaction was observed (P = 0.007) indicating that plasma 
Total Antioxidant Status (TAS) responded differently depending on trial (Figure 
7.1a). Post hoc analysis showed that plasma TAS was significantly higher Pre-Ex (i.e. 
2 h postprandial) in the DC trial when compared with the WC trial (P = 0.006). 
Furthermore, I-way ANOV A on each trial independently showed that there was a 
significant postprandial increase in plasma T AS following DC consumption (P < 
0.001) but no changes from pre- to post-exercise. There was also a significant (though 
smaller) postprandial increase in plasma TAS following WC consumption (P = 0.033) 
and there was a significant increase above pre-exercise values Post-Ex (P < 0.001) 
and 1 h Post-Ex (P = 0.006). There was no change in plasma TAS during the resting 
period before exercise in the fasting control trial (P = 0.292) and there was a 
significant increase above pre-exercise levels Post-Ex (P < 0.001) and 1 h Post-Ex (P 
= 0.006). 
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Table 7.2: Circulating leukocyte counts and biochemical indices before and following 
exercise. 
Rest Pre-Ex Post-Ex 1 h Post-Ex Main Effects P values 
(trial; time; trial x time} 
Leukocyte count 
(xlO9.r') DC 5.3 (1.6) 5.9 (1.8) 16.0 (5.0) 13.4 (3.0) 0.942; <0.001 ; 0.255 
WC 5.2 (1.9) 5.3 (1.8) 18.0 (6.5) 15.1 (5.6) 
CON 5.1 (2.0) 5.5 (1.9) 16.7 (5.4) 14.7 (4.2) 
Neutrophil count 
(xlO9.r') DC 2.7 (1.3) 3.4 (1.7) 11.0 (3.7) 10.5 (2.8) 0.920 ; <0.001 ; 0.353 
WC 2.5 (1.3) 3.0 (1.4) 12.7 (5.1) 12.0 (5.0) 
CON 2.6 (1.4) 3.1 (1.6) 11.9 (4.6) 11.7 (3.9) 
F,-isoprostane 
(pg.mr') DC 14.4 (1.4) 14.8 (2.3) 16.1 (3.2) 14.3 (2.0) 0.253 ; <0.001 ; 0.014 
WC 14.1 (1.9) 13.2 (3.6) 16.0 (3.9) 15.5 (2.5) 
CON 13.3 (2.0) 12.6 (1.8) 15.7 (2.5) 15.8 (1.8) 
Cortisol (nM) 
DC 545 (170) 360 (131) 703 (299) 546 (281) 0.560; <0.001 ; 0.681 
WC 539 (177) 346 (121) 665 (383) 552 (409) 
CON 541 (195) 366 (165) 737 (341) 610 (447) 
ACTH (pg.mr') 
DC 31 (11) 17 (8) 88 (70) 27 (18) 0.661 ; <0.001 ; 0.331 
WC 33 (13) 20 (6) 81 (74) 23 (13) 
CON 34 (16) 19 (7) 81 (50) 29 (21) 
IL-6 (pg.mr') 
DC 1.9 (1.0) 2.0 (0.7) 4.1 (1.3) 4.3 (1.3) 0.404; <0.001 ; 0.400 
WC 2.1 (1.7) 2.2 (1.5) 3.5 (1.6) 3.9 (2.1) 
CON 2.0 (1.6) 2.1 (1.5) 4.3 (2.5) 4.4 (2.1) 
Glucose (mM) 
DC 5.0 (0.3) 4.8 (0.5) 4.5 (0.6) 4.3 (0.5) 0.052; <0.001 ; 0.007 
WC 5.0 (0.4) 4.6 (0.5) 4.0 (0.5) 3.9 (0.4) 
CON 5.1 (0.4) 5.0 (0.4) 4.0 (0.7) 4.0 (0.5) 
Values are mean (SD). WC (white chocolate trial), DC (dark chocolate trial), CON (control 
trial). Results from 2-way ANOV A are presented in Main Effects P values column. 
A significant trial x time interaction effect (P = 0.041) indicated that spontaneous CL 
per litre of whole blood (Figure 7.lb) responded differently depending on trial. 
However, post hoc analysis showed only a trend for CL to be higher I h Post-Ex in 
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the WC trial compared with the DC trial (P = 0.057). There was a significant main 
trial x time interaction effect (P = 0.014) and main effect of time (P < 0.001) for 
plasma free F2-isoprostane concentration (Table 7.2). The plasma free F2-isoprostane 
concentration was significantly higher Pre-Ex in the DC compared with WC trial. 1-
way ANOVA on each trial individually showed that for the WC trial F2-isoprostane 
concentration was significantly higher than the Pre-Ex levels at Post-Ex (P = 0.027) 
but not 1 h Post-Ex (P = 0.084) and on the CON trial it was a significantly higher than 
the Pre-Ex levels at Post-Ex (P = 0.002) and 1 h Post-Ex (P < 0.001). There was no 
effect of time (P = 0.093) in the DC trial. 
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Figure 7.1: Oxidative stress markers: plasma TAS (A) and spontaneous CL per litre 
blood (B). Values are means (± SO). Significantlf' different from Rest (* P < 0.05; ** 
P < 0.0\), significantly different from pre-ex ( P < 0.05; t P < 0.0\), significant 
difference between DC and WC <' P < 0.05; 'IY P < 0.0\). 
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7.3.2 Plasma hormone, glucose and IL-6 responses 
There were significant main effects of trial (P = 0.003), time (P < 0.001) and trial x 
time interaction (P < 0.001) for plasma insulin concentration. Plasma insulin 
concentration generally decreased post-exercise but the overall temporal response was 
different depending on the trial (Figure 7.2). The plasma insulin concentration was 
significantly higher pre-exercise (P = 0.006) and I h Post-Ex (P = 0.025) in the DC 
trial compared with the WC trial. Plasma insulin concentration was also higher pre-
exercise (P = 0.024) in the WC trial compared with the fasting (CON) trial. I-way 
ANOVA on each trial independently showed no difference between the Rest and Pre-
Ex values in the WC trial (P = 0.240) and a significant decrease below Pre-Ex levels 
Post-Ex (P = 0.002) and I h Post-Ex (P < 0.001). Conversely, there was a significant 
increase above Rest at Pre-Ex in the DC trial (P < 0.001) and a significant decrease 
below Pre-Ex levels Post-Ex (P < 0.001) and I h Post-Ex (P < 0.001). There was a 
significant decrease below Rest at Pre-Ex in the CON trial (P = 0.014) and a 
significant decrease below Pre-Ex levels Post-Ex (P = 0.014) and I h Post-Ex (P = 
0.009). 
Plasma cortisol concentration was significantly lower than Rest (P < 0.001) 
immediately pre-exercise (in line with normal diurnal variation) and higher than pre-
exercise values Post-Ex (P < 0.001) and I h Post-Ex (P < 0.014). However, the 
temporal response was not different between trials (interaction, P = 0.681) (Table 
7.2). Plasma ACTH concentration (Table 7.2) was significantly lower than Rest (P < 
0.001) immediately pre-exercise and higher than Pre-Ex values Post-Ex (P < 0.001) 
but returned to near basal levels by I h Post-Ex (P = 0.068). The temporal response 
was not different between trials (interaction, P = 0.331). Plasma IL-6 concentration 
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(Table 7.2) was not significantly changed (P = 0.432) from Rest to pre-exercise. 
There was a significant increase Post-Ex (P = 0.002) and 1 h Post-Ex (P < 0.001) and 
the temporal response was not different between trials (trial x time interaction, P = 
0.400). 
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Figure 7.2: Plasma insulin responses. Values are means (± SD). Significantly 
different from Rest (* P < 0.05; ** P < O.or), significantly different from Pre-Ex 
(tp < 0.05; t P < 0.01), significant difference between DC and WC 0f P < 0.05; 1I1lp < 
0.01), significantdifference between WC and CON (b P < 0.05). 
Significant main effects of time (P < 0.001) and trial x time interaction (P = 0.007) 
were observed for plasma glucose concentration (Table 7.2) suggesting a different 
temporal response depending on trial. There was also a trend for a main effect of trial 
(P = 0.052). The plasma glucose concentration was significantly higher I h Post-Ex in 
the DC compared with WC trial (P = 0.039). I-way ANOVA on each trial 
independently showed that there was a significant effect of time for each trial (P < 
0.001). In the DC trial plasma glucose was not significantly different from Rest at 
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Pre-Ex (p= 0.091) but was lower at Post-Ex (P = 0.003) and 1 h Post-Ex (P < 0.001). 
It was not significantly lower than Pre-Ex at Post-Ex (P = 0.158) but was significantly 
lower at I h Post-Ex (P = 0.002). In the WC trial plasma glucose was significantly 
lower than Rest at Pre-Ex (P = 0.008), Post-Ex (P < 0.001) and I h Post-Ex (P < 
0.001). It was also significantly lower than Pre-Ex at Post-Ex (P = 0.008) and I h 
Post-Ex (P < 0.001). In the CON trial plasma glucose was not significantly different 
from Rest at Pre-Ex (P = 0.382) but was lower at Post-Ex (P < 0.001) and I h Post-
Ex (P < 0.001). It was also significantly lower than Pre-Ex at Post-Ex (P < 0.001) and 
1 h Post-Ex (P < 0.001). 
7.3.3 Circulating leukocyte number and function 
Circulating leukocyte count (Table 7.2) was slightly but significantly higher than Rest 
at Pre-Ex (P = 0.023) and significantly higher than the Rest and Pre-Ex levels at all 
post-exercise time points (P < 0.001). This temporal pattern was not different between 
trials (interaction P = 0.255). Similarly, circulating neutrophil count (Table 7.2) was 
slightly but significantly higher than Rest at Pre-Ex (P = 0.002) and significantly 
higher than the Rest and Pre-Ex levels at all post-exercise time points (P -< 0.001). 
This temporal pattern was not different between trials (interaction P = 0.353). 
The amount of elastase released per neutrophil in response to in vitro bacteria-
stimulation (Figure 7.3a) was not different from Rest at Pre-Ex (P = 0.162) and 
significantly decreased below the Rest and Pre-Ex levels at all post-exercise time 
points (P < 0.001). This temporal pattern was not different between trials (interaction 
P = 0.296). There was a significant decrease in the in vitro PMA-stimulated OBA 
from Rest to pre-exercise (P = 0.025) and following exercise (P < 0.001) in all trials 
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(Figure 7.3b) and this temporal response was not different between trials (trial x time 
interaction P = 0.364). 
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Figure 7.3: In vitro stimulated neutrophil function: bacteria-stimulated degranulation 
response (A) and capacity to generate reactive oxygen species in response to PMA 
stimulation (B). Values are means (± SD). 2-way ANOVA: significantly different 
from Rest (* p < 0.05; ** P < 0.01), significantly different from Pre-Ex (t p < 0.05; t P 
< 0.01). 
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7.4 Discussion 
The main findings ofthe present study are that dark chocolate consumption 2 h before 
an acute bout of prolonged exercise (2.5 h at - 60% VOzmax) resulted in a significant 
insulinaemia and differential plasma glucose response compared with the 
consumption of white chocolate (with a similar macronutrient and energy content) or 
control (fasting). Dark chocolate ingestion also slightly but significantly increased 
plasma antioxidant capacity but this had minimal effects on the oxidative stress or 
immunoendocrine responses following exercise. There were no significant differences 
between the WC (fed) and CON (fasted) trials. 
It is unlikely that the differences in insulin and glucose responses observed in the 
present study are attributable to slight differences in the GI of the dark and white 
chocolates. For example Li et al. (2004b) examined the effect of high GI (77) versus 
low GI (37) meals (containing 2 g.kg- I body mass of carbohydrate). They observed 
lower plasma insulin after the 3 h postprandial period and higher plasma glucose at 
15, 30 and 45 min during a 90 min treadmill run (which commenced immediately 
after the 3 h postprandial period) in the low compared with high GI trials. This is 
converse to the findings of the present study as dark chocolate has a slightly lower GI 
(- 22) compared with white chocolate (- 44) and suggests that there is some other 
mechanism causing the differential plasma insulin and glucose responses. Anderson et 
al. (2002) have previously demonstrated that tea increases in vitro insulin activity in 
the insulin-potentiating epididymal fat-cell assay with rat adipocytes and that this 
potentiating activity was due mainly to polyphenols (especially epigallocatechin 
gallate and epicatechin gallate). This could be related to polyphenols interfering with 
glucose transport via GLUT I and GLUT 4 transporters as shown by Strobe! et al. 
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(2005). Therefore, it may be that the increased insulin response observed in the 
present study is a result of a reduced efficacy of tissue glucose uptake. Indeed, there 
appeared to be a differential temporal response of plasma glucose concentration 
depending on the trial. However, it is clear that more frequent postprandial blood 
sampling would be required in order to properly determine the effects of dark 
chocolate consumption on the plasma insulin and glucose responses and get a better 
indication of which (if any) of these variables is the cause and which is the effect. 
Moseley et al. (2003) have demonstrated that differences in pre-exercise plasma 
glucose and insulin concentration, following the ingestion of75 g of glucose 15,45 or 
75 min prior to exercise onset, are normalised within 10 min of submaximal exercise. 
The present results are consistent with these findings in that the significant pre-
exercise difference in plasma insulin concentration between trials was markedly 
reduced following exercise. 
The consumption of a CHO containing beverage before, during and after prolonged 
exercise, compared with placebo ingestion, can reduce the alterations in immunity by 
better maintaining plasma glucose levels and reducing the magnitude of systemic 
cytokine and HPA axis stress hormone release, reducing the trafficking of most 
leukocyte subsets and limiting the reduction in neutrophil function (Bishop et aI., 
2000, 2002; Li et aI., 2005; Nehlsen-Cannarella et aI., 1997; Pedersen et aI., 1997). 
There is, however, limited information regarding the immunoendocrine responses to 
prolonged exercise in the fed compared with fasted state. The present results suggest 
that oxidative stress and immunoendocrine responses to prolonged exercise are 
similar in the fed or fasted state. These results are consistent with the findings of 
McAnulty et aI. (2003) who observed no effect of CHO supplementation on the 
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oxidative stress responses to prolonged exercise. The present results demonstrate that 
performing prolonged exercise in the fed state (with at least 2 h between food 
ingestion and exercise onset) does not modulate the imrnunoendocrine responses, 
unlike when CHO is ingested immediately before and during exercise. 
Oxidative stress has been implicated in the depression of immune cell function that 
typically occurs following prolonged exercise, the magnitude of which may be 
decreased with appropriate pre-exercise antioxidant supplementation (Lee et aI., 2000; 
Robson et aI., 2003). Acute antioxidant supplementation may reduce exercise-induced 
oxidative stress (Alessio et aI., 1997; Ashton et aI., 1999) and enhance neutrophil 
function following prolonged exercise but is not effective at reducing the hormonal or 
cytokine responses (study 2, Chapter 4). In line with these findings, acute dark 
chocolate consumption had no effect on plasma HP A axis stress hormone 
concentrations or IL-6 concentration following prolonged exercise. There was also no 
effect of dark chocolate consumption on circulating neutrophil number or function, as 
measured by in vitro stimulated OBA and degranulation. 
The present results do not agree with the findings of study 2 (Chapter 4) which 
suggest that acute antioxidant supplementation may limit falls in neutrophil function 
following prolonged exercise but are similar to those observed in study 1 (Chapter 3) 
when VC was not taken sufficiently early to ensure an acute peak in the plasma VC 
concentration. Therefore, the lack of effect in the present study is possibly related to 
the dark chocolate consumption having only minimal effects on oxidative stress and 
plasma antioxidant status during and following prolonged exercise. Morillas-Ruiz et 
al. (2006) demonstrated that a polyphenol containing sports drink consumed shortly 
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before exercise significantly reduced the magnitude of exercise-induced oxidative 
stress. However, GhiseIIi et al. (2000) observed a significant increase in plasma total 
antioxidant potential (TRAP) from 1353 I1M to 1578 I1M I h after consumption of 
500 ml of beer, which contains polyphenols, but TRAP had returned to basal levels 2 
h after consumption of the beer. The increase of plasma TAS was statistically 
significant but not as large as anticipated in the present study (increase from 1103 I1M 
Trolox at Rest to 1150 I1M Trolox 2 h later, immediately pre-exercise and was I 165 
I1M Trolox immediately post-exercise, which was 4.5 h post-ingestion). However, it is 
not known if plasma TAS actually reached a peak earlier during the 2h postprandial 
period after dark chocolate consumption, consistent with the findings of GhiseIIi et al. 
(2000). Kondo et al. (1996) observed that LDL susceptibility to oxidation was 
reduced 2 h after the ingestion of 35 g of delipidated cocoa in healthy male 
participants but this had returned to basal by 4 h post-ingestion. Therefore, it is 
possible that the relatively smaller blunting of oxidative stress responses observed in 
the present study are a result of the timing of pre-exercise consumption not being 
optimal to enhance plasma antioxidant defence prior to and during exercise. In study 2 
(Chapter 4) beverages consumed every 15 min during. exercise also contained VC. 
Furthermore, in the studies by MoriIIas-Ruiz et al. (2005, 2006) exercise was of 90 
min duration whereas it was 2.5 h in the present study. Therefore, with exercise of 
longer duration a larger dose of polyp he no Is Id ark chocolate (or consumption closer to 
and/or during exercise) may be required. 
In conclusion, the present study demonstrates that dark chocolate consumption 2 h 
prior to prolonged exercise may increase pre-exercise plasma insulin concentration 
and have small effects on plasma antioxidant capacity/oxidative stress and the 
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temporal response of plasma glucose concentration. However, there were no effects 
on the plasma concentration of HP A axis stress hormones, IL-6, total leukocyte or 
neutrophil trafficking and neutrophil function. Furthermore, there were no differences 
in immunoendocrine responses in the fed compared with the fasted state. 
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CHAPTER EIGHT 
General Discussion 
The series of studies presented in this thesis (Chapters 3 - 7) were designed to 
examine the effects, on immunoendocrine responses, of antioxidant supplementation 
alone (Chapters 3-6), in combination with CHO (Chapter 3) or obtained from food 
(dark chocolate, Chapter 7). The focus is on the potential role of antioxidant 
supplementation in modulating the HPA axis stress hormone, IL-6 and oxidative 
stress responses following prolonged exercise and how this may affect leukocytosis 
and/or the functional capacity of neutrophils. In the acute VC supplementation studies 
(Chapters 3-4) VC was ingested acutely before and during the exercise bouts. In 
contrast, in the longer term supplementation studies (Chapters 5-6) no antioxidants 
were ingested on the day of exercise. Any effects observed with supplementation in 
those studies (Chapters 5-6) is likely to be independent of any effects arising from 
acute supplementation. 
In studies 1-4 (Chapters 3-6) participants were allowed to follow their normal habitual 
diet during the days immediately prior to main trials. This was an attempt to make the 
experiments more 'real to life' so that findings could be generalised to 'normal' 
situations. As a result there was a great deal of variation in daily dietary VC intake 
within studies (note that the SD is nearly as large as the mean for daily VC intake in 
some instances). It is possible that there would have been less variation in the 
outcome measures if controlled/standardised diets were used so that all participants 
had similar dietary VC intakes. Furthermore, there was large variation between 
studies in dietary VC intake with mean daily intakes of 57 ± 12 mg, 129 ± 110 mg, 74 
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± 39 mg, 97 ± 60 mg and 69 ± 57 mg for studies 1, 2, 3, 4 and 5, respectively. The 
biggest and most obvious difference is study 2 in which the mean VC intake is over 2-
fold higher than in study 1. This was due largely to 1 individual in study 2 with an 
intake of 389 mg per day. If this individual is removed then the mean VC intake in 
study 2 is 91 ± 36 mg. Furthermore, this individual's responses all followed the same 
pattern as those of the other participants in that study. That is, no effect of acute VC 
supplementation on any measured responses except for OBA, which was enhanced 
post-exercise in the VC compared with the placebo trial. Moreover, given that no 
individuals had a deficient VC intake, the differences between and within studies 
were probably oflittIe significance in comparison to the large supplemental doses (i.e. 
> 3000 mg in the acute studies, 1 and 2, or 1000 mg per day in the longer term 
studies, 3 and 4). 
8.1 Antioxidant supplementation and the cortisol response to prolonged exercise 
At first glance, it appears that there is considerable variation in baseline plasma 
cortisol concentration between studies. Some, but not all, of this variation may be 
related to the normal diurnal rhythm of plasma cortisol concentration because 
baseline measurements were made at different times of day in some studies (Figure 
8.1). For example, in study 1 there were 2 resting samples taken 1 h apart (10:00 and 
11 :00) and the mean decrease of plasma cortisol concentration was - 80 nM in the 
placebo trial. There may also be extraneous variables which contribute to differences 
in baseline plasma cortsiol concentration between studies, such as fitness, training 
status, chronic stress and/or psychological stress. For example, Smorawinski et al. 
(2001) observed lower baseline plasma cortisol in endurance-trained athletes 
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compared with strength-trained individuals and sedentary controls. Time of waking is 
another extraneous variable which was not controlled in the present studies and may 
have an impact on baseline plasma cortisol concentration at any given time of the 
morning. There were no obviously apparent differences between participants in any of 
the studies (with the exception of study 3 in which participants were endurance 
trained and, overall, had higher V02max and attained a higher maximal power output 
in the V02max test). So it is possible, but only speculation, that differences between 
participants in each of the studies, in these (or other unknown) extraneous variables is 
able to account for the variation observed in baseline plasrria cortisol concentration. 
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Figure 8.1: Baseline plasma cortisol concentration for the PLA trial of studies 1-5. 
Acute VC supplementation was not effective at reducing the cortisol response to 
prolonged exercise whether ingested during and 1 h prior (Chapter 3), or during, 2 h 
and 14 h prior (Chapter 4) to exercise. Furthermore, the ingestion of 100 g of dark 
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chocolate (which contains a relatively high concentration of polyphenols) 2 h prior to 
prolonged exercise also had no effect on the cortisol response (Chapter 7). In study 3 
(Chapter 5) 2 weeks of VC (1000 mg.day"l) supplementation resulted in a trend for a 
blunted cortisol response and in study 4 (Chapter 6) 4 weeks of VC (1000 mg.day"l) 
and vitamin E (400 IU.day"l) supplementation significantly blunted the cortisol 
response to prolonged exercise. In some other studies (Fischer et aI., 2004; 
Vassilakopoulos et al. 2003) up to 8 weeks of antioxidant supplementation also 
significantly blunted the IL-6 response. This could account in part for blunting of the 
cortisol response as IL-6 infusion is known to stimulate cortisol release into the 
circulation (Steensberg et aI., 2003). However, there was no effect on the systemic IL-
6 response (discussed below) in any of the present studies so the effects on cortisol 
observed in studies 3 and 4 (Chapters 5 and 6) are most likely due to some other 
mechanism(s). The fact that the supplements were not taken acutely before and during 
exercise in studies 3 and 4 is probably of little significance as no effects of acute VC 
supplementation (in terms of the cortisol or IL-6 responses) were observed in studies 
1 and 2 (Chapters 3 and 4). 
The present findings support the contention that cortisol is not co-released from the 
adrenal glands with VC in response to oxidative stress (Peake, 2003). For example, in 
study 2 (Chapter 4) acute VC supplementation resulted in a significant increase of 
plasma antioxidant capacity before and following prolonged exercise and seemed to 
reduce exercise-induced oxidative stress. Nevertheless, there was still a significant 
post-exercise increase in plasma cortisol concentration which was not different 
between the VC and PLA trials. Furthermore, in study 3 (Chapter 5) there appeared to 
be very little post-exercise increase in oxidative stress markers on either the PLA or 
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VC trials yet plasma cortisol concentration was still seen to significantly increase 
post-exercise. Taken together, these findings suggest that there may be some direct 
effect of VC upon the adrenal glands which does not occur with acute 
supplementation. The suggestion by Peake (2003) that it may actually be a pro-
oxidant effect of high dose VC supplementation that causes a reduction in the 
magnitude of cortisol release may be a possible explanation. It is extremely unlikely 
that oral supplementation can increase the plasma concentration of VC to the levels (I 
mM) which are necessary for a pro-oxidant effect (Powers et aI., 2004; Yu, 1994). 
However, Peake (2003) suggests that under certain conditions, such as exercise, a pro-
oxidant effect of VC supplementation may occur. Exercise may cause increases in the 
concentration of serum free iron which could, at least in part, be related to increased 
neutrophilic-superoxide-induced release of iron from ferritin and myoglobin (Childs 
et aI., 2001; Peake, 2003). In high concentrations VC can act as a pro-oxidant in the 
presence of transition metals because of its ability to reduce ferric iron (Fe3+) to the 
ferrous state (Fe2+) which is known to catalyse the production of free radicals. This 
may not normally be physiologically significant in vivo given the high iron affinity of 
transferrin, high iron storage capacity of ferritin and the wide variety of other proteins 
such as albumin which bind iron (Childs et a\., 2001; Powers et aI, 2004). However, 
Peake (2003) suggests that the combined effects of increased plasma VC 
concentration and serum free iron could promote the formation of oxidants which may 
impair the activity of key enzymes (such as II-P-hydroxylase) involved in cortisol 
synthesis within the adrenal cortex. Therefore, the combined effects of exercise and a 
high plasma VC concentration may have a pro-oxidant effect, localised within the 
adrenal glands, which may result in less cortisol synthesis. However, a prolonged 
period of supplementation may be required to accumulate such VC concentrations 
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within the adrenal glands. On the other hand, if VC and/or antioxidants exerted an 
inhibitory effect on cortisol secretion by acting directly on the adrenal glands it might 
be expected that ACTH concentration would be higher since cortisol provides 
negative feedback (at both hypothalamic and pituitary levels) to inhibit ACTH release 
(Germann et al., 2005). However, there was no significant effect of antioxidant 
supplementation on plasma ACTH concentration in any of the studies of this thesis. In 
fact, there was a trend for plasma ACTH concentration to be lower in the antioxidant 
supplemented group in study 4 (Chapter 6). Therefore, antioxidant supplementation 
may also influence cortisol secretion via effects at a different point of the HP A axis, 
possibly at the level of the hypothalamus or the anterior pituitary gland. 
S.2 Antioxidant supplementation and the IL-6 response to prolonged exercise 
Antioxidant supplementation was not effective at blunting the systemic IL-6 response 
whether taken acutely before and during exercise (Chapters 3, 4 and 7) or for a period 
of 2 - 4 weeks (Chapters 5-6). The findings in studies 3 and 4 (Chapters 5 and 6) are 
not in line with the studies of Fischer et al. (2004) or Vassilakopoulos et al. (2003) 
with regard to the systemic IL-6 response to exercise. Fischer et al. (2004) 
demonstrated that IL-6 release from contracting skeletal muscle is reduced with 
antioxidant supplementation probably by reducing its translocation from active 
skeletal muscle tissue into the circulation. In study 3 (Chapter 5) there was no effect 
of 2 weeks of VC supplementation on the systemic IL-6 response to prolonged 
exercise. Therefore, it was speculated that significant blunting effects (as observed by 
Fischer et aI., 2004 and Vassilakopoulos et aI., 2003) may result from vitamin E 
exerting an effect in the lipid milieu and somehow interfering with cellular membrane 
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transport mechanisms, thus reducing translocation out of the muscle fibres. However, 
the results of study 4 (Chapter 6) do not support this idea because there was no effect 
on plasma IL-6 concentration following prolonged exercise subsequent to 4 weeks of 
antioxidant (VC and vitamin E) supplementation. However, it is possible that greater 
IL-6 responses are required (as observed with the longer exercise protocol used by 
Fischer et al. 2004) in order for antioxidant supplementation to modulate IL-6 
changes with exercise. For example, in the study by Fischer et al. (2004) there was a 
greater-post-exercise increase in systemic IL-6 in the PLA treatment group; to - 16 
pg.mr l immediately post-exercise and - 20 pg.mr l 30 min post-exercise and there 
was only a difference between groups at the latter time point. The post-exercise 
increase in plasma IL-6 concentration was less marked in study 4 (with a post-
exercise peak of - 5 pg.mr l ) consistent with all studies throughout this thesis and, 
unlike other studies (Fischer et aI., 2004; Vassilakopoulos et aI., 2003), plasma IL-6 
concentration did not continue to increase in the 1 h following exercise. However, the 
participants in both of these studies (Fischer et aI., 2004; Vassilakopoulos et aI., 2003) 
were untrained individuals and in the Fischer et al. (2004) study the exercise protocol 
was somewhat artificial (to allow the cannulation of the femoral artery and vein for 
regular blood sampling during exercise). The studies of this thesis were, perhaps, 
more realistic in terms of what athletes would actually do in training. Therefore, 
methodological differences may account for some of the different observations 
between studies. It should also be noted that in a study by Nieman et al. (2004) 2 
months of vitamin E supplementation actually resulted in a greater IL-6 response to 
prolonged exercise. However, the exercise undertaken in thut study was extreme by 
comparison (a competitive event of approximately 12 h duration) with mean post-
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exercise plasma IL-6 concentrations more than lO-fold higher than in the present 
studies. 
8.3 Antioxidant supplementation and oxidative stress during prolonged exercise 
Acute VC supplementation may be effective at reducing the magnitude of increase, 
following exercise, in some surrogate markers of oxidative stress (Chapters 3 and 4). 
In study 2 (Chapter 4) plasma TBARS concentration was significantly increased post-
exercise on the PLA trial but this was blunted with acute VC supplementation. 
Spontaneous CL per litre of blood showed a trend towards lower post-exercise values 
in the VC trial compared with the PLA trial. Taken together these results suggest that 
acute VC ingestion was effective at reducing exercise-induced oxidative stress. There 
was no evidence of a significant increase in plasma TBARS during the exercise 
undertaken by participants in study 3 (Chapter 5) so it is not surprising that there was 
no difference between the placebo and VC trials in this measures of oxidative stress. 
There was a post-exercise increase of spontaneous CL per litre of blood but the 
temporal response was not influenced by the VC supplementation. Overall, the 
magnitude of exercise-induced stress in study 3 was relatively small. It is possible that 
the modest effect of exercise on oxidative stress markers was due to the training status 
of participants in study 3 (Chapter 5) who, on average, had higher V02max values (by 
- 6 ml.kg·1.min·1) and attained a higher maximal power output (by - 50 W) in 
the V02max test, when compared with participants in the other studies of this thesis. 
In study 4 there was a significant post-exercise increase in plasma free F2-isoprostane 
concentration but the 4 week antioxidant supplementation intervention had little 
influence on this response. However, there was no effect of time on plasma TBARS 
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concentration In the placebo group but the post-exercise TBARS values were 
significantly lower in the antioxidant group. Alessio et al. (1997). In that study 
participants ran on a treadmill for 30 min at 80% VOzmax and it was observed that 
post-exercise prooxidant:antioxidant balance (indicated by the TBARS:oxygen radical 
absorbance capacity (ORAC) ratio) was tilted most toward oxidative stress on the 
placebo trial (32.5% increase above baseline). However, after 2 weeks of VC 
supplementation (1000 mg.day"') the exercise resulted in a 25.5% increase, which was 
not significantly different to the change observed on the PLA trial, whereas 1 day of 
supplementation (with 1000 mg) resulted in a significantly smaller post-exercise 
increase (5.8%). 
Taken together, these findings (studies 1-4, Chapters 3-6) are in line with those of 
Alessio et al. (1997) which suggest that acute periods of supplementation are more 
effective at blunting the magnitude of exercise-induced oxidative stress compared 
with longer periods (of2 weeks or more). This could be due to the fact that the natural 
endogenous antioxidant defences are down-regulated in response/adaptation to the 
higher intake of exogenous antioxidant compounds over a prolonged period so that 
total antioxidant capacity is maintained fairly constant (CoIlins, 2005; Powers, 2004). 
This probably does not occur with much shorter periods of supplementation such as 
employed in study 2 (Chapter 4) or the study by Alessio et al. (1997). In line with 
these suggestions, McAnulty et al. (2005) showed that 2 months of vitamin E 
supplementation significantly increased plasma alpha-tocopherol concentration 
without significantly affecting plasma FRAP (a marker of plasma total antioxidant 
capacity). Similarly, in study 4 (Chapter 6) there was a significant increase in plasma 
VC concentration after the 4 week supplementation period but no significant change 
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in plasma total antioxidant capacity. However, it should be noted that supplements 
were taken 2 times per day (with breakfast and evening meals). If samples were 
obtained at some time during the last day of the supplementation period (or if 
supplements were also taken on the day of exercise) then plasma total antioxidant 
capacity would probably have been higher in the antioxidant group owing to the acute 
effects from supplements ingested that day. 
There is considerable variation, between studies, in plasma TBARS concentrations 
with the baseline values of studies 3 and 4 (approximately 2.0 - 2.4 IlM) more than 
double the baseline values observed in study 2 (approximately 0.8 - 0.9 IlM). There is 
no obvious reason for this difference since the same method was used throughout but 
it should be noted that these values are within the range of baseline values typically 
reported using similar methods to determine TBARS (from - 0.1 to > 5.0 IlM, 
Vollaard et aI, 2005). It is known that the results obtained from the TBARS assay may 
suffer from a lack of specificity (Coli ins, 2005; Vollard et aI., 2005) and can be 
affected by a number of factors, including diet. It is possible that some 'unknown' 
differences exist between the participants of study 2 and the other studies which could 
account for the different baseline values observed, in comparison with studies 3 and 4. 
For example, the TBARS assay is non-specific and subject to interference from 
certain carbohydrates, other aldehydes, ascorbate, and amino acids all of which may 
be affected by exercise training and/or diet. Therefore, plasma TBARS may be a 
useful adjunct to other measures of oxidative stress but should not be used in 
isolation. 
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8.4 Antioxidant supplementation and exercise-induced leukocytosis 
The leukocytosis response observed following prolonged exercise (> 2 h) is 
dominated by neutrophilia. This may be largely influenced by the release of cortisol 
during prolonged exercise which causes mobilization of neutrophils from bone 
marrow pools (delayed neutrophilia), (Nieman, I 997c; Pedersen et aI., 2000). 
Therefore, the possible mechanisms by which antioxidant supplementation may affect 
the leukocytosislneutrophilia response to prolonged exercise is via modulation of the 
cortisol (and possibly IL-6) responses. The results from the studies of this thesis 
generally support this because overall (with the exception of study 4, Chapter 6) the 
effects on circulating neutrophil count fail in line with the cortisol results. That is, 
there was no effect of acute VC supplementation (Chapters 3 and 4) or pre-exercise 
dark chocolate consumption (Chapter 7) on the neutrophilia responses to prolonged 
exercise. However, in study 3 (Chapter 5) in which there was a trend for a reduced 
cortisol response on the VC trial, there was also a significant blunting of the post-
exercise leukocytosis and neutrophilia. The exception was in study 4 (Chapter 6) in 
which 4 weeks of antioxidant vitamin supplementation significantly blunted the 
cortisol response but had no effect on the magnitude of the post-exercise leukocytosis 
or neutrophilia. However, in this study there was a trend for plasma cortisol 
concentration to be higher at rest following the supplementation period (immediately 
pre-exercise) in the antioxidant group. Since a between-groups design was employed 
in this study (because of the relatively long wash-out period that would be required 
for vitamin E), it is not known if the higher cortisol observed pre-exercise was a direct 
consequence of the supplementation or due to some unforeseen differences between 
the groups. Therefore, although the antioxidant supplementation appeared to blunt the 
increase in cortisol from pre- to post-exercise the higher levels in the antioxidant 
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group pre-exercise may account for the observation of similar neutrophil counts post-
exercise. 
S.S Antioxidant supplementation and neutrophil responses 
The most effective interventions for reducing the magnitude of neutrophil dysfunction 
following prolonged exercise appear to be those which are associated with the greatest 
blunting of leukocytosis and neutrophilia responses (such as CHO ingestion during 
exercise) which is in line with the findings of study I (Chapter 3). This supports the 
contention that the increased relative proportion of less mature neutrophils is a major 
factor in decreased neutrophil function as typically observed following prolonged 
exercise (Berkow et aI., 1986; Robson et aI., 1999). Antioxidant supplementation was 
not effective in any studies of this thesis, except study 3 (Chapter 5), at reducing the 
magnitude of post-exercise neutrophilia. In this study there were significantly lower 
circulating leukocyte and neutrophil counts post-exercise in the VC trial compared 
with the PLA trial. However, this was not marked enough to have any physiologically 
significant effects on the magnitude of the decrease in neutrophil function following 
prolonged exercise. 
The only significant effects of antioxidants on neutrophil function were in study 2 
(Chapter 4). In this study acute VC supplementation on the night before (-14 h), 
morning of (-2 h) and during prolonged exercise limited the fall in PMA-stimulated 
neutrophil OBA despite having no effects on the cortisol, IL-6 or 
leukocytosis/neutrophilia responses. These findings suggest that acute antioxidant 
supplementation (if taken at appropriate times to sufficiently increase plasma 
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antioxidant capacity before and during exercise) may be beneficial for 
enhancing/maintaining post-exercise innate immune function; probably by protecting 
neutrophils from direct oxidative damage and modification. This is in line with the 
findings of Robson et al. (2003) who demonstrated that a relatively short period (7 
days prior to and, perhaps importantly, on the day of exercise) of antioxidant 
supplementation prior to a 2 h treadmill run at 65% V02max resulted in significantly 
higher(- 57%) post-exercise E.coli-stimulated neutrophil OBA despite there being no 
difference in the plasma concentrations of cortisol and glucose or blood leukocyte 
count. However, the findings of study 2 (Chapter 5) suggest that similar effects can be 
observed with a much shorter period of supplementation. In study 3 (Chapter 5) it was 
concluded that the blunted leukocytosis and neutrophilia responses observed with 2 
weeks of VC supplementation were not marked enough to have any physiologically 
significant effects on the magnitude of the decrease in neutrophil function (although 
there was a trend for higher fMLP-stimulated OBA in the VC trial). As discussed 
previously, however, these effects are probably independent of the effects arising 
from acute supplementation since there was no VC provided on the day of exercise in 
this study. Therefore, it is possible that these effects could be additive with those 
arising from acute supplementation (study 2, Chapter 4) and that neutrophil function 
would have been better maintained post-exercise if VC was also given acutely before 
and during exercise in study 3 (Chapter 5). Note that This is simply conjecture at 
present and requires further study. 
8.6 Summary and conclusions 
The general findings of this thesis are that antioxidant supplementation for a period of 
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up to 4 weeks generally provides little to no protection against the depression of 
neutrophil function that typically occurs following prolonged exercise (> 2 h). 
However, large doses of VC consumed acutely prior to and during (and on the day 
before) prolonged exercise may limit the fall of neutrophil function following that 
exercise. Additionally, acute supplementation may be more appropriate since the 
regular daily intake oflarge doses of VC is not recommended. There are some reports, 
for example, that the regular intake of amounts equivalent to 10 or more times the 
RDA (600 mg or more) per day, in some individuals, are associated with adverse 
effects including diarrhoea, joint pain, and exacerbation of gout and kidney stone 
formation (Williams, 1995). However, for most individuals the regular intake of daily 
high doses of VC is unlikely to have any serious negative effects (Fogelholme, 2000) 
and it has recently been reported that the safe upper limit (the highest level of regular 
daily intake that is likely to pose no risk of adverse effects to almost all persons in the 
general population) for VC is 2000 mg.dai l (Hathcock et aI., 2005). Additionally, for 
acute supplementation, it may be more beneficial to take a number of smaller doses 
because the relative amount of orally ingested ascorbic acid that is absorbed through 
the mucous membranes of the digestive system decreases with increasing dosage 
(Goldfarb,1993). 
Acute antioxidant supplementation (Chapters 3, 4 and 7) was not effective and 
reducing the magnitude of plasma cortisol and IL-6 concentrations or blood leukocyte 
count increases in response to prolonged exercise. Longer periods (2 weeks of VC, 
Chapter 5, or 4 weeks of VC and vitamin E, Chapter 6) of supplementation may blunt 
the cortisol response but had no effect on the IL-6 responses. However, it is possible 
that greater IL-6 responses (generally only associated with rather extreme exercise 
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atypical of training) are required in order for antioxidant supplementation to modulate 
IL-6 changes with exercise but this requires further investigation. Also, it is not 
known if acute supplementation would have any effect under these circumstances. 
8.6.1 Practical implications 
The following practical implications for athletes or healthy active people who might 
include prolonged exercise (> 2 h) in their training regimen, have been derived based 
on the findings of this thesis: 
I. Daily supplementation with large doses of antioxidant vitamins is not 
recommended for the purpose of maintaining immune function following 
prolonged exercise. 
2. Short-tennlacute large doses of VC (i.e. only on the day of and day before 
exercise) may be more appropriate for better maintaining immune cell 
function. However, this should not be a regular occurrence and should only be 
used prior to the most prolonged or unaccustomed exercise bouts (i.e. < once 
per week). 
3. The consumption of a carbohydrate containing beverage before and during 
prolonged exercise appears to be the most effective intervention for 
maintaining immune cell function following prolonged exercise. 
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4. Furthermore, the addition of VC to carbohydrate containing beverages, for 
consumption before and during prolonged exercise, does not add to the 
beneficial effects of carbohydrate alone. 
8.7 Future directions. 
1. Following from the findings of study 2 (Chapter 4) it would be prudent for any 
future investigation into the effects of antioxidants on neutrophil function 
following exercise to also assess some markers of oxidative stress in isolated 
neutrophils. This could help to determine if there is actual antioxidant 
preventable oxidative stress and/or damage directly to these cells. 
Furthermore, it remains to be determined whether the combination of the VC 
supplementation protocol employed in study 2 (Chapter 4) could be additive 
with the effects of carbohydrate supplementation before and during exercise. 
2. Following from the findings of study 3 (Chapter 5) in which there was no 
increase in plasma markers of oxidative stress: it remains to be determined if 
there would be (in these 'trained' athletes) greater decreases in neutrophil 
function under conditions of greater physical and/or oxidative stress, the 
magnitude of which could be blunted to a relatively greater degree with VC 
supplementation (2 weeks). Future studies could therefore employ a different 
exercise protocol in order to stimulate greater oxidative stress. 
3. It is possible that greater lL-6 responses (generally only associated with rather 
extreme exercise atypical of training) are required in order for antioxidant 
supplementation to modulate IL-6 changes with exercise. Further investigation 
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is required to determine if antioxidant supplementation is associated with 
better modulation of immune dysfunction in that case. The exercise required to 
promote such IL-6 responses could be oflonger duration (> 3 h) or perhaps 
performed after a period of muscle glycogen depletion (such as prior exercise). 
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APPENDIX 1 
Health screening questionnaire. 
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HEALTH SCREEN FOR STUDY VOLUNTEERS Name or Number ................ . 
It is important that volunteers participating in research studies are currently in good health and have had no 
significant medical problems in the past. This is to ensure (i) their own continuing well-being and (ii) to 
avoid the possibility of individual health issues confounding study outcomes. 
Please complete this brief questionnaire to confirm fitness to participate: 
I. At present, do you have any health problem for which you are: . 
(a) on medication, prescribed or otherwise .............................. Yes 0 
(b) attending your general practitioner .................................... Yes 0 
(c) on a hospital waiting list ..................................................... Yes 0 
2a. In the past two years, have you had any illness which require you to: 
(a) consult your GP ................................................................ Yes 0 
(b) attend a hospital outpatient department.. ............................ Yes 0 
(c) be admitted to hospital ..................................................... Yes 0 
2b. To the best of your knowledge, how many upper respiratory tract 
infections (e.g. coughs and colds) have you had in the last 12 months? 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
3 or lessO between 4 and 6 0 between 7 and 9 0 10 or more 0 
3. Have you ever had any of the following: 
(a) Convulsions/epilepsy .......................................................... Yes 0 
(b) Asthma .................................. , ............................................. Yes 0 
(c) Eczema ............................................................................... Yes 0 
(d) Diabetes .............................................................................. Yes 0 
(e) A blood disorder ................................................................. Yes 0 
(f) Head injury ......................................................................... Yes 0 
(g) Digestive problems ............................................................. Yes 0 
(h) Heart problems ................................................................... Yes 0 
(i) Problems with bones or joints ......................................... Yes 0 
(j) Disturbance ofbalancelcoordination .................................. Yes 0 
(k) Numbness in hands or feet ................................................. Yes 0 
(1) Disturbance of vision ......................................................... Yes 0 
(m) Ear / hearing problems ....................................................... Yes 0 
(n) Thyroid problems ............................................................... Yes 0 
(0) Kidney or liver problems .................................................... Yes 0 
(p) Allergy to nuts .................................................................... Yes 0 
4. Has any, otherwise healthy, member of your family under the 
age of 35 died suddenly during or soon after exercise? ............ Yes 0 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
If YES to any question, please describe briefly if you wish (eg to confirm problem was/is short-lived, 
insignificant or well controlled.) ........................................................................................................ . 
Thank you for your cooperation! 
Loughborough University 28.5.l999!WJ Clarke 
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APPENDIX 2 
General health questionnaire. 
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...........................•...............................................................•............ 
Title of Study . 
..••..............................•.............................•........•••.......•.................... 
Health Questionnaire 
Please complete the following brief questions to confinn your fitness to participate: 
At present do you have any health problems for which you are: 
I) On medication, prescribed or otherwise YES 0 NO 0 . 
2) Attending your general practitioner YES 0 NO 0 . 
Have you any symptoms of ill health, such as those associated with a cold or other 
common infection? YESO NOD· 
If you have answered yes to any of the above questions please give more details 
below: 
Do you want to take part in today's experiments? YES 0 NO 0 . 
Signature: _____ _ Date: 
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APPENDIX 3 
Food exclusion list given to participants III study 5 (Chapter 7). 
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... 
Study No: OS.07.NRC 
What foods and drinks to avoid and suggestions for replacements 
Please avoid the foods and drinks as indicated below for the 48 hours prior to each of 
your visits to the laboratory for the study. 
Beverages / juices 
. 
Please avoid: Maybe replace with ••• 
Black Tea (normal tea) Fruit teas, herbal teas, e.g. Camomile, 
Green Tea peppermint, hot milk. 
Coffee 
Hot Chocolate / cocoa 
Fruit juices, especially ... Cordials or squashes 
Orange juices 
Grape juices 
Any alcohol 
. 
Fruits / Vegetables / nuts 
. 
.... 
. 
... 
Please avoid: Maybe replace with ••• 
Blackberries Bananas 
Red grapes White grapes 
RaspJ>erries Melon 
Strawberries Peanuts 
Olives 
Redcurrants 
Oranges (or similar, e.g. Satsuma) 
Blueberries 
Pineapple 
Plums 
Apples 
Spinach 
Asp_aragus 
Prunes 
Walnuts 
Hazelnuts 
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Sweet Items 
. 
Please avoid: M avbe replace with ••• 
Chocolate bars / groducts Cereal bars, biscuits 
Chocolate desserts / cakes Non-fiuit yoghurts 
Fruit jams/jellies Honey 
Cereals / breads 
. .. . •..... ' >.. . , . • .. . 
Please avoid: Maybe replace with ••• 
Buckwheat . 
Oats (e.g. porridge, muesli, flapiack etc.) Cornflakes, Frosties 
••••••••• 
Barley Rice-based cereals (e.g. rice cri spies) ... 
Whole wheat (e.g. wholemeal bread 
or cereals like weetabix, shreddies White bread 
cheerios, shredded wheat and similar) 
Broad beans 
Lentils 
. . . 
.. 
Others 
Please avoid: 
Olive oil Ve etable oil 
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